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Abstract 
GABAergic and cholinergic interneurones play an important role in modulating activity 
of neuronal circuits within the spinal cord and medulla oblongata. This study 
investigates the spatial distribution of co-localisation of the synthesising enzymes for 
ACh/GABA in the spinal cord and medulla oblongata. Immunohistochemistry, 
retrograde neuronal tracing and juxtacellular labelling were employed in combination 
with mice in which a green fluorescent protein (GFP) is expressed under the control of 
the promoter of the GABA synthesising enzyme, glutamic acid decarboxylase 67 
(GAD67-GFP mice). Within the cervical, thoracic and lumbar spinal cord the majority of 
GAD67-GFP neurones co-localising with the ACh synthesising enzyme choline 
acetyltransferase (ChAT) were observed in lamina X. Located primarily ventral to the 
central canal, they were neither motoneurones nor preganglionic neurones since they 
were negative for Fluorogold transported retrogradely following intraperitoneal 
injections. On application of juxtacellular labelling to neurones in spinal cord slices from 
young mice, the processes of the ChAT/GAD67-GFP neurone were located in lamina 
X. Investigations into synaptic inputs indicated that ChAT/GAD67-GFP neurones in 
lamina X received inputs from terminals immunoreactive for vesicular glutamate 
transporter 1, vesicular glutamate transporter 2, glycine transporter 2 and GAD67. Co-
expression of ChAT/GAD67-GFP was also observed in the medulla oblongata in the 
nucleus of tractus solitarius, area postrema and reticular formation. Although the 
function of these ChAT/GAD67-GFP neurones is currently unknown, this study has 
furthered knowledge regarding their morphology, location, possible projections and 
inputs. 
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1.1 General Introductory paragraph 
This introductory chapter will describe the gross anatomy of the spinal cord, the laminar 
structure of the spinal grey matter, development of the various neuronal populations in 
the spinal cord with an emphasis on those that develop within the ventral neural tube, 
the neurochemical classification of spinal neurones with a focus on acetylcholine (ACh) 
and gamma amino butyric acid (GABA), plus a general introduction to the autonomic 
nervous system with particular emphasis on the sympathetic nervous system. In 
addition, since the nucleus of tractus solitarius (NTS) of the medulla oblongata has a 
significant role as the primary integration site for the autonomic nervous system (Loewy 
and Burton, 1978, Ross et al., 1985, Zoccal et al., 2014) , an introduction to the NTS 
will be provided in detail within this chapter.  
  
1.2 Gross anatomy of the spinal cord: segmental 
variation 
The mouse spinal cord is a near cylindrical shaped structure. Rostrally, it starts at the 
level of foramen magnum (extending from the inferior end of the hindbrain) and runs 
down to terminate at the inferior aspect of the vertebral column. The caudal end of the 
spinal cord, termed the conus medullaris, gives rise to a structure called the filum 
terminale; a thread of fibrous tissue originating from the pia and enclosed by arachnoid 
mater. Distally, the spinal cord is attached to the vertebral column by the filum 
terminale (Sengul and Watson, 2012). Commonly, there are 7 cervical, 13 thoracic, 6 
lumbar, 4 sacral and 28 caudal vertebrae in a mouse. This gives rise to a total of 34 
spinal cord segments, which comprise 8 cervical segments (C1 to C8), 13 thoracic 
segments (T1 to T13), 6 lumbar segments (L1 to L6), 4 sacral segments (S1 to S4) and 
3 coccygeal segments (Co1 to Co3) (Sengul et al., 2012, Sengul and Watson, 2012). 
The gross outline of the cord is not the same along its entirety. The width of the cord is 
greater in the cervical (C5-T1) and lumbosacral (L2-L6) enlargements, where increased 
numbers of motoneurones are located for the innervation of the forelimbs and 
hindlimbs respectively (Watson and Kayalioglu, 2009, Sengul and Watson, 2012, 
Sengul et al., 2012, Harrison et al., 2013).  
The spinal cord is primarily comprised of grey matter and white matter. For the most 
part, the grey matter is encased by the white matter (Watson and Kayalioglu, 2009). 
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The white matter predominantly contains axons and glial cells, while the grey matter 
mostly contains the cell bodies and processes of neurones and glial cells. In a 
transverse section, the grey matter appears to resemble a butterfly or the capital “H” in 
shape; consisting of two ventral (anterior) horns and two dorsal (posterior) horns, linked 
together (at each side) via intermediate grey matter. Commissural grey matter 
constitutes the cross connection between the two sides or uprights of the “H”. In two 
regions of the spinal cord, specifically the thoracic and upper lumbar areas, an area 
termed the intermediolateral horn (lateral horn) is present (Watson and Kayalioglu, 
2009, Snell, 2010) (see Figure 1.1).  
The gross morphology of transverse cord sections for each region in mice differs from 
one another. Segmental variations of the cervical, thoracic and lumbar cord regions will 
be described in due course as they are the regions of interest. The cervical cord has an 
oval transverse sectional profile. The ventral horns at the cervical enlargements (C5-
T1) contain a large number of motoneurone clusters which innervate the forelimbs and 
the axial muscles (Watson et al., 2009, Sengul and Watson, 2012, Sengul et al., 2012, 
Harrison et al., 2013, Allen Brain Atlas: Mouse Spinal Cord). Transverse sections from 
the thoracic region exhibit a round profile and are smaller in size than sections taken 
from either of the cervical and lumbar cord segments. The grey matter of the ventral 
and dorsal horns are slender in comparison to those in the cervical and lumbar regions. 
The ventral horn contains smaller clusters of motoneurones which innervate only the 
axial and intercostal muscles (Watson et al., 2009, Harrison et al., 2013, Allen Brain 
Atlas: Mouse Spinal Cord). The lateral horn is found throughout the thoracic cord and is 
where the sympathetic preganglionic neurones (SPNs) of the intermediolateral cell 
column (IML) are located (Petras and Cummings, 1972, Anderson et al., 2009, Watson 
and Kayalioglu, 2009, Sengul et al., 2012). The transverse section of the lumbar region 
has an oval profile similar to that of the cervical region but smaller in diameter and 
more rounded. The H-shaped grey matter in the lumbar cord sections is large, of which 
the ventral horns contain motoneurones clusters that innervate the hindlimbs and the 
axial muscles. This leads to the lumbosacral enlargement at L2-L6 segments (Watson 
et al., 2009, Sengul and Watson, 2012, Sengul et al., 2012, Harrison et al., 2013, Allen 
Brain Atlas: Mouse Spinal Cord). The lateral horns, containing SPNs of the IML, are 
also found in L1-L2 cord segments (Anderson et al., 2009, Sengul and Watson, 2012). 
Transverse sections taken from the sacral and coccygeal regions have a round profile, 
the diameter of which rapidly reduces as the cord progresses caudally (Watson et al., 
2009, Harrison et al., 2013, Allen Brain Atlas: Mouse Spinal Cord). The grey matter 
constitutes most of the cross-sectional area for both of these cord regions, with a much 
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smaller volume of white matter surrounding it (Watson et al., 2009, Allen Brain Atlas: 
Mouse Spinal Cord).   
Since our study only focuses on the distribution of neurones in the cervical, thoracic 
and lumbar cord segments, a diagram representing the segmental variation of these 
regions for transverse section is presented in Figure1.1.  
The spinal cord in mice, in similarity with that for humans and rats, receives its arterial 
supply from a single anterior spinal artery, two posterior spinal arteries, and radicular 
arteries (Lang-Lazdunski et al., 2000, Bilgen and Al-Hafez, 2006). The anterior spinal 
artery, which arises from a union of two branches originating from the two vertebral 
arteries (Lang-Lazdunski et al., 2000, Scremin, 2009, Sengul and Watson, 2012), 
descends caudally on the anterior surface of the cord to the conus medullaris. The 
anterior spinal artery is joined by anterior radicular arteries, which run transversely to 
enter the spinal canal via the intervertebral foraminae (Lang-Lazdunski et al., 2000, 
Scremin, 2009). The two posterior spinal arteries originate from the vertebral arteries 
(Sengul and Watson, 2012), and descend longitudinally on the posterior surface of the 
cord (Bilgen and Al-Hafez, 2006). They are joined by numerous posterior radicular 
arteries (Lang-Lazdunski et al., 2000, Scremin, 2009). The radicular arteries derive 
from various origins, including the vertebral, deep cervical, intercostals, sacral and 
hypogastric arteries (Lang-Lazdunski et al., 2000). The venous system of the cord 
reflects the arterial system. It includes three anterior spinal and three posterior spinal 
veins which are interconnected and drained by anterior and posterior radicular veins. 
The radicular veins drain into the internal vertebral venous plexus occupying the 
epidural space. The internal vertebral venous plexus additionally interconnects with the 
external vertebral venous plexus along the external vertebral surfaces (Scremin, 2009, 
Sengul and Watson, 2012, Farrar et al., 2015). 
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Figure 1.1:  Diagramatic representation of the segmental variations of 
the mouse cervical, thoracic and lumbar transverse cord sections 
(Figure adapted from Watson et al., 2009, Harrison et al., 2013, Allen Brain 
Atlas: Mouse Spinal Cord). VH: ventral horn; DH: dorsal horn; LH: lateral 
horn, FLMNs: forelimb motoneurones; HLMNs: hindlimb motoneurones; 
AxMNs: Axial motoneurones; Ico: intercostal motoneurones. 
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1.3 The laminae of Rexed 
The laminal organization of the spinal cord is defined based on the cytological features, 
cell body dimension, cell orientation and density of packing of the neurones present in 
the grey matter of the spinal cord. Accordingly the grey matter is classified into 10 
regions or laminae. These were first described by Rexed (Rexed, 1952) from their 
investigations of cat spinal cord utilising the toluidine blue staining technique and are 
briefly described below. With the exception of lamina X, which is located about the 
central canal, the numbering scheme used for the laminae relates to their dorsal to 
ventral order across the grey matter (see Figure 1.2). Since this study is concerned 
with investigating cell types within the laminae, with a particular focus on those in 
lamina X, a brief summary of the known cell-types in specific laminae are also 
described. 
 
Figure 1.2: The laminae of Rexed.  The lamination of the grey matter of 
the spinal cord can be organised into ten laminae based on morphology 
(shape and size) and cytoarchitectural arrangement. Figure adapted from 
Rexed, 1952.  
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Lamina I 
Lamina I is the most dorsal section of the grey matter in the dorsal horn. It occupies a 
narrow area lying parallel to the curvature of the dorsal horn. Within lamina I the cells 
possess different shapes (triangular and spindle) and sizes (small, medium and 
relatively large; the smallest are 5 µm x 8-10 µm and the largest are 15-25 µm x 30 µm, 
with the majority of neurones in the range 8-10 µm x 12-15 µm) and are loosely 
scattered (Rexed, 1952, Rexed, 1954). In mouse spinal cord, various cell shapes and 
sizes are also observed in lamina I, including large elongated, smaller triangular, 
multipolar and fusiform (Sengul and Watson, 2012). 
 
Lamina II  
Lamina II is thicker in appearance than lamina I (Rexed, 1952) and, due to the high 
density of its constituent cells, forms a distinct feature across the dorsal horn. Lamina II 
is also known as the substantia gelatinosa Rolandi. The cells in lamina II are small in 
size (ranging from 5 µm x 5 µm to 10 µm x 10 µm) (Rexed, 1952, Rexed, 1954).  
With regard to the mouse spinal cord, the neurones in lamina II are similarly small 
sized cells and possess either rounded or elongated shapes. Due to the lack of 
myelinated nerve fibres within the region, lamina II appears as a semi-transparent area. 
Lamina II can be divided into 2 zones, a ventral inner zone (lamina IIi) and a dorsal 
outer zone (lamina IIo). The neurones of the dorsal outer zone are smaller than those 
in the ventral inner zone and more crowded (Sengul and Watson, 2012). 
Lamina II interneurones are classified into islet, central, vertical, radial and medio-
lateral cells based on their morphology and the orientation of their process arborization 
(Grudt and Perl, 2002, Lu and Perl, 2003, Hantman et al., 2004, Lu and Perl, 2005). 
Islet cells possess dendrites and axons that extend more rostro-caudally than any other 
lamina II cell type. Central cells have a morphology similar to the islet cells, but with 
less extensive dendritic branching in the rostro-caudal axia. Vertical cells exhibit a 
dendritic arbour which, relatively, has a significant extension along the dorso-ventral 
orientation. Radial cells possess soma which are located adjacent to the border of 
lamina IIo and IIi. The medio-lateral cells possess dendrites that extend in the medio-
lateral orientation (Grudt and Perl, 2002).  
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Lamina III 
The cells in lamina III are relatively small in size (most cells are 7-8 µm x 10-12 µm in 
size, with the smallest being 5 µm x 7-8 µm and the largest approximately 10-12 µm x 
15-18 µm), although slightly larger than those comprising lamina II. Like laminae I and 
II, lamina III also curves laterally, however the degree of curvature in Lamina III is not 
as pronounced (Rexed, 1952).  
In relation to the mouse spinal cord a differentiating feature between lamina III and 
lamina II is that the former contains myelinated nerve fibres, while the latter is devoid of 
such fibres. A variety of cell shapes are observed within lamina III, including round, 
elongate, and spindle (Sengul and Watson, 2012). The majority of cells in the lamina 
have diameters ranging from 7 µm to 12 µm (Sengul et al., 2012). 
A large number of neurones in laminae I-III have axons that project within the spinal 
cord, and so are termed interneurones. Nearly all neurones in lamina II and the 
majority of those in laminae I and III are interneurones (Todd, 2010). Interneurones of 
the dorsal horn are either excitatory, using glutamate, or inhibitory, using GABA and/or 
glycine as their primary neurotransmitter. In rat approximately 25%, 30% and 40% of 
interneurones in laminae I, II and III respectively, contain GABA (Polgar et al., 2003, 
Todd, 2010). Moreover, for laminae I-III cells that contain glycine typically also contain 
GABA (Todd and Sullivan, 1990, Polgar et al., 2013). By contrast, while the majority of 
ChAT-IR neurones in lamina III are found to contain GABA (Todd, 1991, Mesnage et 
al., 2011), those neurones do not contain glycine (Todd, 1991). Projection neurones 
are primarily concentrated within lamina I plus scattered across laminae III – VI, with a 
limited number to be found  in lamina II (Todd, 2010). Many of the axons from the 
projection neurones in the dorsal horn project across the midline and ascend rostrally 
within the white matter, terminating in nuclei of the brainstem and thalamus which are 
involved in pain and temperature perception.  
 
Lamina IV 
A distinguishable feature between lamina IV and lamina III is that the former contains 
cells of various sizes (small – ranging between 7-9 µm x 10-12 µm – medium – 
generally 10-12 µm  x 15-18 µm – and large – 35 µm x 45 µm), while the latter 
generally contains cells that are of the smaller sizes (Rexed, 1952, Rexed, 1954). 
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With respect to the mouse, in appearance lamina IV is more substantial than laminae I-
III. However, the concentration of neurones within it is less. Moreover, only a limited 
number of large neurones are observed. Even so, a considerable variance in cell size 
is also apparent in lamina IV of mice, with the smallest being 7-10 µm in diameter and 
the largest being 35-45 µm (Sengul and Watson, 2012, Sengul et al., 2012).  
 
Lamina V 
In comparison to laminae I to IV, lamina V contains fewer cells but a greater 
abundance of nerve fibres; in fact the nerve bundles are both numerous and sizeable in 
the lateral region of lamina V (Rexed, 1952, Rexed, 1954). Lamina V can be divided 
into medial and lateral zones (Rexed, 1954). The cells of the medial zone tend to be 
medium in size (10-13 µm x 15-20 µm), while those of the lateral zone include a higher 
abundance of larger cells (up to 30 µm x 45 µm) in cat (Rexed, 1952, Rexed, 1954) .  
Similarly, in mouse the lateral part of lamina V also contains sizeable groups of nerve 
fibres and neurones which are large in size (diameters ranging from 30-45 µm) (Sengul 
and Watson, 2012, Sengul et al., 2012), while the medial part is absent of such fibre 
groups and consists of neurones that are relatively small to medium in size. Moreover, 
in mouse the shapes of the neurones found in lamina V are triangular, multipolar and 
spindle (Sengul and Watson, 2012). 
 
Lamina VI 
Lamina VI is located at the base of the dorsal horn (Rexed, 1954). It is comprised of 
medial and lateral zones. The medial zone contains cells that are relatively densely 
congregated and these are typically small (8 µm x 8 µm at a minimum) or medium (10-
12 µm x 12-15 µm) in size; the majority being in the medium range. By contrast, the 
cells of the lateral zone are generally less densely distributed and include cells of larger 
size (30 µm x 35 µm) exhibiting a star shape (Rexed, 1952, Rexed, 1954).   
In regard to the mouse spinal cord, the neurones found in this lamina possess 
elongated, spindle, triangular and multipolar shapes. Similar to cat, lamina VI in mouse 
is composed of a medial part whose form appears compact, and a lateral part whose 
form appears reticulated (Sengul and Watson, 2012). 
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GAD65 expressing inhibitory interneurones located in the medial portions of laminae V 
and VI are the origin of P boutons in lamina IX, which provide presynaptic inhibition of 
Ia afferent terminals (Hughes et al., 2005); where the term Ia indicates a primary 
muscle spindle afferent. 
 
Lamina VII 
Lamina VII covers an area in the middle part of the grey matter that was previously 
recognized as the zona intermedia (Rexed, 1952) and is alternatively termed as the 
intermediate grey (Sengul and Watson, 2012). The cells in lamina VII are typically 
medium in size (13-15 µm x 15-20 µm), although some can be relatively large in size 
(up to 40 µm x 50 µm), possess a star shape and are uniformly though not densely 
distributed, giving the lamina a homogeneous aspect (Rexed, 1952, Rexed, 1954).   
In the mouse spinal cord, the neurones (possessing multipolar, triangular and fusiform 
in shapes) of this lamina are likewise uniformly dispersed. Moreover, the lamina 
contains several nuclei that have been given specific names depending on their cord 
levels; from C1 to C4 there is the central cervical nucleus, from T1 to L2 there are the 
intermediolateral, intercalated and intermediomedial nuclei, from L1 to L2 there is the 
lumbar dorsal commissural nucleus, from L6 to S4 there is the sacral dorsal 
commissural nucleus, from S1 to S4 there is the sacral precerebellar nucleus, and from 
S1 to S2 there is the sacral parasympathetic nucleus (Sengul and Watson, 2012). 
Renshaw cells are found in lamina VII (Lagerback and Kellerth, 1985, Song et al., 
2006) and are glycinergic (Curtis et al., 1976). Renshaw cells receive excitatory 
innervation from motoneurones and then subsequently inhibit motoneurones plus also 
Ia inhibitory interneurones (Sapir et al., 2004). Ia inhibitory interneurones are located in 
lamina VII, particularly dorsal or dorsomedial to the motoneurones (Jankowska and 
Lindstrom, 1972). 
 
Lamina VIII 
In the thoracic cord region lamina VIII occupies an area which encompasses both the 
base and the core of the ventral horn. However in other regions, due to the presence of 
increased numbers of motoneurones within the ventral horn, lamina VIII is only found in 
the medial half of the ventral horn. Lamina VIII contains cells of various sizes (for cats 
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the range spans from the smallest at 10 µm x 10 µm to the largest at 50 µm x 60 µm, 
and while there is no particularly dominant size present, an appreciable number of cells 
exhibit sizes in the range 10-15 µm x 15-20 µm) and as a result seems heterogeneous 
in feature in the spinal cord of both cats (Rexed, 1952) and mice (Sengul and Watson, 
2012). 
With respect to mouse spinal cord the large cells in lamina VIII closely resemble 
motoneurones in form. Furthermore, a large proportion of neurones in the lamina 
notably possess dendrites which exhibit a dorsoventral orientation. The commissural 
fibres from some of the neurones in the lamina are contralateral projecting fibres, since 
they extend to the ventral horn on the opposite side (Sengul and Watson, 2012). 
Commissural interneurones have been observed within laminae VI, VII and VIII, and 
are either excitatory using glutamate, or inhibitory using glycine. These interneurones 
may excite or inhibit contralateral motoneurones in the ventral horn (Bannatyne et al., 
2003). 
 
Lamina IX 
Lamina IX contains large sized motoneurones (Rexed, 1952, Heise and Kayalioglu, 
2009a), the most commonly observed size appearing to be around 30 µm x 40 µm. In 
some spinal cord segments two distinct groups of motoneurones are discerned, 
corresponding to medial and lateral cell columns (Rexed, 1952, Rexed, 1954).  
Mouse lamina IX contains α-motoneurones (involved in the innervation of skeletal 
muscles and which are relatively large (Weber et al., 1997, Sengul and Watson, 
2012)), possessing diameters of more than 30 µm (Wootz et al., 2013), and γ-
motoneurones (involved in the innervation of muscle spindles), which are relatively 
smaller in size. Whereas most alpha motoneurones receive direct input from Ia-derived 
proprioceptive sensory afferents, gamma motoneurones do not receive such direct 
input (Friese et al., 2009). In addition, interneurones and a limited quantity of β-
motoneurones can also be found in the lamina (Sengul and Watson, 2012).  It should 
be noted that the designation of motoneuron classification based on size in the 
literature is inconsistent, with different groups utilising diameter, cross-sectional area or 
estimated volume (Weber et al., 1997, d'Errico et al., 2013). 
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Lamina X 
Lamina X, also termed area X or the central grey of the spinal cord (Rexed, 1952, 
Rexed, 1954, Watson and Kayalioglu, 2009, Heise and Kayalioglu, 2009a, Deuchars, 
2015), is the area surrounding the central canal containing the grey commissures and 
the substantia gelatinosa centralis. The abundance of nerve fibres in the lamina is 
relatively low (Rexed, 1954).  
The neurones found in lamina X of mice are triangular, multipolar and spindle shaped; 
the lamina contains two named nuclei, these being the paraependymal part of the 
intercalated nucleus (central autonomic area (CAA)) plus the cholinergic central canal 
cluster neurones (Sengul and Watson, 2012).  
In rats, lamina X contains large cells of 40-50 µm in diameter as well as smaller cells 
possessing diameters of  20-30 µm (Nicholas et al., 1999). For mice, cells within lamina 
X are reported to typically range about two diameters, 7 µm  and 20 µm, while the 
ependymal cells which line the central canal are indicated as being 6-7 µm in diameter 
(Fornai et al., 2014). 
 
1.4 The arborisaton of primary afferent inputs in 
various laminae 
Primary afferent fibres of various modalities arborise in the dorsal horn laminae.  
Generally, the majority of the large myelinated cutaneous (Aβ) afferents are low-
threshold mechanoreceptors which respond to touch or hair movement, while most of 
the finely myelinated (Aδ) and unmyelinated (C) afferent fibres convey nociceptive or 
thermoreceptive information (Todd, 2010, Abraira and Ginty, 2013).  
The primary afferent axons of mechanoreceptors involved in the detection of the 
discriminative touch and tactile perception (such as pressure, vibration, stretch of the 
skin and hair deflection air) can be categorised based on the morphology of the 
peripheral mechanosensory end organs that they innervate (Luo et al., 2009). 
Conduction velocity, which is a property of fibre size and degree of myelination, plus 
physiological properties are also used to categorise the primary afferent axons (Luo et 
al., 2009, Todd, 2010). The majority of the primary afferents of mechanoreceptors are 
low-threshold large diameter fibres (Luo et al., 2009). Although Woolf and Fitzgerald 
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mapped the termination of Aβ low-threshold afferents in laminae III and IV (Woolf and 
Fitzgerald, 1986),  the arborisation of myelinated low-threshold mechanoreceptive 
afferent fibres responding to touch or hair movement can be observed to terminate in 
an area which spans from laminae IIi to VI (LaMotte, 1977, Todd, 2010). Myelinated Aδ 
hair afferent fibres terminate in lamina III with extensions into laminae IIi and IV (Light 
and Perl, 1979, Djouhri, 2016). Mechanoreceptors can be further categorised into two 
groups dependent upon the rate of their adaptation to sustained mechanical stimuli. 
These two groups are the rapidly adapting (RA) and slowly adapting (SA) 
mechanoreceptors (Brown and Iggo, 1967, Luo et al., 2009). The RA 
mechanoreceptors are reported to terminate in laminae III to V (Luo et al., 2009), 
similarly, the axon arborisation of SA mechanorectors are to be found in laminae III and 
IV, plus the dorsal part of lamina V (Brown et al., 1978). Ia muscle spindle afferents are 
found to terminate in various laminae; including V, VI, VII and IX with the largest 
distribution in lamina IX (Ishizuka et al., 1979). GABAergic neurones in laminae V and 
VI have been identified as the source of ventral horn P boutons that form axo-axonic 
synapse with Ia afferent terminals involved in motor output regulation (Maxwell et al., 
1990, Hughes et al., 2005). These GABAergic P boutons can be distinguished from 
other GABAergic terminals in the ventral horn by their strong expression of the GAD65 
isoform, which is in contrast to the majority of GABAergic terminals in the ventral horn 
that possess strong GAD67 and low GAD65 immunoreactivity (Hughes et al., 2005). 
Aδ and C afferents fibres, which can be nociceptive or thermoreceptive, predominantly 
terminate in lamina I and II (Todd, 2010). Aδ nociceptive afferents have additionally 
been observed in laminae I and V (Light and Perl, 1979, Djouhri, 2016). Nociceptive C 
afferent fibres can be divided into 2 neurochemical subgroups, those that express 
neuropeptides and those that are devoid of neuropeptides, peptidergic and 
nonpeptidergic respectively (Hunt and Rossi, 1985, Todd, 2010). The peptidergic 
afferents predominantly terminate in lamina I and IIo, while non-peptidergic afferents 
largely terminate in lamina IIi (Hunt and Rossi, 1985). 
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1.5 Development of the various neuronal populations 
in the spinal cord with a focus on those that 
develop within the ventral neural tube 
An alternative way to describe neuronal cell types within the spinal cord is through the 
application of knowledge in relation to spinal cord development and cell differentiation. 
This section will discuss the neuronal types that develop within the spinal cord, 
focusing on those that generate within the ventral neural tube. 
The nervous system of vertebrates develops from what is termed the neural plate 
(Pituello, 1997) and starts with the plate induction (Tanabe and Jessell, 1996); the plate 
subsequently folds during maturation to form the neural tube. Determination of cell 
patterning in the CNS is largely dependent on where a given induced neural cell is 
located relative to a network formed by two signalling systems, one of which operates 
along the anteroposterior axis of the neural tube, while the other acts along the 
dorsoventral axis (originally the mediolateral axis of the neural plate) (Simon et al., 
1995, Tanabe and Jessell, 1996); the nature of the inductive signal experienced by the 
precursor cells from the signalling systems being dependent on where the cells are 
situated in relation to the network axes (Roelink et al., 1995, Simon et al., 1995). 
Signals from the anteroposterior axis give rise to the various sections of the neural 
tube, while those relating to the dorsoventral axis generate the various cell types within 
each section (Simon et al., 1995, Tanabe and Jessell, 1996).  
During the initial stages of spinal cord development, the ventral neural tube produces 
floor plate cells (around the ventral midline), motoneurones (about ventrolateral 
locations) and ventral interneurones (from locations that are more dorsal) (Tanabe and 
Jessell, 1996). With particular regard to ventral interneurones four classes have been 
identified to derive from the neural tube corresponding to types V0, V1, V2 and V3 
(Ericson et al., 1997a, Ericson et al., 1997b, Jessell, 2000, Briscoe and Ericson, 
2001)(see Figure 1.3). During cell development a protein termed sonic hedgehog has 
been shown to be strongly expressed in the notochord and floor plate cells; discernible 
through immunohistochemistry (Roelink et al., 1995). Sonic hedgehog facilitates 
notochord and floor plate signalling events to induce cell differentiation in the ventral 
neural tube (Roelink et al., 1995, Ericson et al., 1997b). This has been confirmed via 
the incubation of stage 10 ventral neural tube/floor plate explants with an antibody 
raised against sonic hedgehog (Ericson et al., 1997b). In comparison to the control 
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explants, those grown in the presence of the anti-sonic hedgehog antibody generated 
<3 motoneurones, while in the control the number totalled ~250 motoneurones. Ventral 
interneurones were also discerned to be greatly affected by the presence of the anti-
sonic hedgehog antibody with ~10 V1 and V2 interneurones generated in the test 
explants compared to ~60 V1 and ~100 V2 in the control (Ericson et al., 1997b). 
Ericson et al. (Ericson et al., 1997b) additionally demonstrated the concentration 
gradient dependence of different ventral cell types on sonic hedgehog using 
applications of the sonic hedgehog N-terminus recombinant protein (Shh-N) on in vitro 
stage 10 chick intermediate neural plate explants. In the absence of the recombinant 
protein the explanted tissue failed to produce both interneurones of types V1 and V2, 
or indeed motoneurones.  The amount of sonic hedgehog required for signal induction 
of the ventral cell types located in different locations is varied. For example, induction 
of V1 interneurones requires a lower concentration of sonic hedgehog than is 
necessary for V2 interneurones (by around a factor of 2), while the sonic hedgehog 
concentration required for motoneurone induction is greater than that for V2 
interneurones (by approximately a further factor of 2). This suggests that cell types 
generated at more ventral locations apparently require higher levels of sonic hedgehog 
for their formation.  
Neuronal cells in the ventral spinal cord also express a variety of homeodomain 
transcription factors. These factors have subsequently been used not only as an 
alternative way to identify neuronal subtype (Roelink et al., 1995, Ericson et al., 1997a, 
Ericson et al., 1997b) but also as an aid in establishing the sources of extrinsic and 
intrinsic signals that affect the diversity of such neurones (Jessell, 2000, Pierani et al., 
2001). 
The development of the dorsal neural tube is dependent upon dorsalising signals from 
the roof plate, particularly from bone morphogenetic proteins (BMP) (Helms and 
Johnson, 2003, Lu et al., 2015) and what are termed Wnts (members of Wingless 
+MMTV integrants, Int  family) (Lu et al., 2015). Eight dorsal horn neuronal subtypes 
have been identified, termed dI1- dI6, dILA and dILB (Gross et al., 2002, Muller et al., 
2002, Helms and Johnson, 2003, Caspary and Anderson, 2003, Wilson and Maden, 
2005, Xu et al., 2013, Lu et al., 2015). These neurones can be distinguished from one 
another via the homeodomain transcription factors which they express (Caspary and 
Anderson, 2003, Helms and Johnson, 2003). Since the neurones of interest to this 
study are located in the area generated from the ventral neural tube, only the locations 
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of ventral interneuronal subtypes (V0-V3) and motoneurones during embryonic and 
postnatal developments have been represented in Figure 1.3. 
 
 
Figure 1.3: The location of ventral interneurone subtypes (V0-V3) and 
motoneurones (MN) during embryonic and postnatal development 
(Figures adapted from Grossmann et al., 2010).  
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1.6 Neurochemical classification of spinal neurons 
(laminae I-X): with focus on ACh and GABA 
1.6.1 The synthesis of acetylcholine (ACh) and GABA 
1.6.1.1 ACh: Synthesis and Immunohistochemical markers  
The first suggestion that nerves might release substances that were either the same as 
or acted similar to drugs which were being used in a given experiment came from Elliott 
in 1904 (Elliott, 1904). However, it was not until Loewi published results on experiments 
with isolated frog hearts in 1921 (Loewi, 1921) – using what was subsequently 
established to be ACh -- that such was confirmed; as outlined in Dale’s address to the 
Physiological Society in 1935 (Dale, 1935). Following the isolation and identification of 
ACh from ergot by Ewins (Ewins, 1914), Dale subsequently identified the similarity of 
the effect of ACh to both muscarine and certain divisions of the autonomic nervous 
system (Dale, 1914). 
The process of ACh biosynthesis requires choline (Lipton and Barron, 1946).  It is 
initiated by the uptake of extracellular choline into the nerve terminals of cholinergic 
neurones via a high-affinity system that is dependent on sodium (Yamamura and 
Snyder, 1972, Yamamura and Snyder, 1973). In addition to choline, the synthesis 
process also requires an acetyl group (attached to a coenzyme). Although initial 
studies were unable to establish the source of the acetyl group (Lipton and Barron, 
1946, Nachmansohn and Berman, 1946) later work proved to be more successful at 
identifying the compound as acetyl coenzyme A (acetyl-CoA); with Lipmann having 
been the first to name the source as coenzyme A (Lipmann, 1953). Biosynthesis of 
ACh from choline and acetyl-CoA subsequently occurs within the cytoplasm of 
neuronal nerve terminals (Feldberg and Vogt, 1948, Roghani et al., 1994, Usdin et al., 
1995), and is facilitated by the key enzyme currently known as choline 
acetyltransferase (ChAT) (Perry et al., 1978, Erickson et al., 1994); this enzyme 
originally being termed as choline acetylase (Nachmansohn and Machado, 1943).The 
manufactured ACh is subsequently packed into synaptic vesicles via a vesicular 
acetylcholine transporter (VAChT) (Erickson et al., 1994, Roghani et al., 1994)(see 
Figure 1.4).  
The neurotransmission activity of ACh typically terminates at the synaptic cleft, where it 
is hydrolysed by the enzyme acetylcholinesterase (AChE) (originally known as choline 
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esterase) (Stedman and Stedman, 1937, Marnay and Nachmansohn, 1937) into 
acetate and choline (Fagerlund and Eriksson, 2009). 
The most reliable method for localising cholinergic neurones histochemically has 
proved to be via the use of antisera raised against ChAT (Bradford, 1986) which has 
been widely used by many researchers in the field (Barber et al., 1984, Ruggiero et al., 
1990, Stornetta et al., 2013, Gotts et al., 2015). 
Because ACh is packed into synaptic vesicles by VAChT, antisera raised against 
VAChT has also been used as a marker to label cholinergic neurones and their 
processes, particularly their nerve terminals (Arvidsson et al., 1997, Maeda et al., 
2004).  Another marker for cholinergic neurones in the CNS is the ACh hydrolysing 
enzyme, AChE, however, its use is unreliable since AChE has been observed to be 
present in some non-cholinergic cells (Wallace, 1981, Eckenstein and Sofroniew, 
1983). 
 
 
Figure 1.4:  Illustration summarising the various stages in the 
biochemistry for the synthesis of Ach. Figure based on information in 
Zimmermann, 2008. 
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1.6.1.2 GABA: Synthesis, Immunohistochemical markers and In Situ 
Hybridization (ISH) 
Aside from the neurotransmitter glycine (Kish et al., 1989), GABA is a major inhibitory 
neurotransmitter in the CNS (Krnjevic and Schwartz, 1967, Iversen and Kelly, 1975, 
Clark et al., 1992, Liu et al., 1993, Gadea and Lopez-Colome, 2001); more than  40 % 
of the inhibitory synapses occurring in the brain use GABA (Bowery and Smart, 2006). 
Neurones using GABA are generally found to be linked to local circuits across the CNS 
(Benes and Berretta, 2001, Briatore et al., 2010, Watanabe et al., 2015, Lin et al., 
2015, Voytenko et al., 2015).  
The main precursor  to GABA synthesis is glutamate, which is catalysed by the enzyme 
glutamic acid decarboxylase (GAD) to produce GABA (Costa et al., 1979). According to 
the history of its discovery, GABA was first reportedly identified in the brain of various 
animals and humans in 1950 (Roberts and Frankel, 1950, Awapara et al., 1950, 
Udenfriend, 1950). The results from an experiment carried out by Roberts and Frankel 
(Roberts and Frankel, 1950) suggested glutamic acid as being a likely precursor of 
GABA, since increased levels of GABA were observed in every instance when 
homogenate containing mouse brain had been incubated with glutamic acid. The 
authors also hypothesized that the enzyme responsible for GABA synthesis in bacteria 
and plants via decarboxylation of glutamic acid, GAD, could also be responsible for its 
occurrence in the brains of mammals. GAD was subsequently reported to be present in 
the brain tissue of rats shortly thereafter (Wingo and Awapara, 1950); in the brain it is 
now established that there are two major isoforms of GAD, these being GAD67 (GAD1) 
and GAD65 (GAD2) (Bradford, 1986, Erlander et al., 1991). Transportation of GABA 
into synaptic vesicles requires the actions of a vesicular inhibitory amino acid 
transporter (VIAAT), and occurs in a manner that is ATP dependent (Hell et al., 1988, 
Kish et al., 1989, Fykse et al., 1989, Hell et al., 1990, Hell et al., 1991, McIntire et al., 
1997, Sagne et al., 1997, Chessler et al., 2002)(see Figure 1.5). 
With respect to GABA removal from the synaptic cleft, high-affinity GABA transporters 
(known as GATs), dependent on Na+, can be found in both neurones and glia (Schon 
and Kelly, 1975, Clark et al., 1992, Liu et al., 1993, Borden et al., 1994). There are 3 
subtypes of GAT expressed in the CNS. The predominant forms are GAT1 and GAT3, 
which are primarily found at the neuronal nerve terminals and glial processes, 
respectively (Radian et al., 1990, Ikegaki et al., 1994, Itouji et al., 1996, Su et al., 
2015). GAT2 is also expressed in the CNS, but only to a limited extent, seemingly in 
leptomeninges and blood vessels (Lopez-Corcuera et al., 1992, Ikegaki et al., 1994, 
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Zhou et al., 2012). GABA degradation then requires the combined action of 
mitochondrial enzymes, specifically GABA transaminase and succinic semialdehyde 
dehydrogenase (Bouche et al., 2003).  
 
 
Figure 1.5:  Illustration summarising the various stages in the 
biochemistry for the synthesis of GABA. Figure based on information in 
Brekke et al., 2015. 
 
In the 1970s-1980s, GABAergic neurones in rat and mice had been detected utilising 
immunohistochemistry (IHC) for GABA (Davidoff and Schulze, 1988, Kosaka et al., 
1988, Caffe et al., 1996) or GAD (not specific to any particular GAD isoform) (Ruggiero 
et al., 1985, Kosaka et al., 1988, Gritti et al., 1993, Belin et al., 1983, Caffe et al., 1996, 
Meeley et al., 1985). 
However, the GAD enzyme seems to be concentrated in nerve terminals compared to 
cell bodies. Therefore, the labelling of GABAergic neurone cell bodies has proven to be 
a challenge. To overcome this problem, some studies have avoided use of a 
permeabilizing agent and utilised  enzymatic visualisation to boost the low signal 
intensity (Fong et al., 2005), or injected colchicine (Kosaka et al., 1988, Meeley et al., 
1985) into studied animals which disrupts axoplasmic transport and leads to 
accumulation of GAD in cell bodies (Ribak et al., 1978, Whatley et al., 1994, Sardella et 
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al., 2011). Additionally, ISH for GAD67 and/or GAD65 has been utilised by studies 
investigating the distribution of GABAergic neurones (Stornetta and Guyenet, 1999, 
Tillakaratne et al., 2000, Tillakaratne et al., 2002, Fong et al., 2005, Deuchars et al., 
2005, Edwards et al., 2007, Trifonov et al., 2012). 
 
1.6.2 ACh and GABA receptor subunits 
The effects of neurotransmitters such as ACh and GABA are mediated by the protein 
structures they bind to. These effectors of neurotransmitter action undergo 
conformational changes upon agonist binding resulting in an effect that is either direct 
or indirect.  Based on their structure and function, such effectors, which are generally 
termed as receptors, can be placed into two broad classes.  The first class directly 
mediates the flow of ions into the cell when bound by an agonist and is called a ligand 
gated ion channel (LGIC) (Miller and Smart, 2010).  The second class triggers a 
cascade of intracellular signalling which modulates the activity of ion channels (Audet 
and Bouvier, 2012). The effects of the latter are determined by the type of G-protein 
they are associated with and are known as G-protein coupled receptors (GPCRs) 
(Caulfield and Birdsall, 1998, Alexander et al., 2015a).  Both these classes of receptor 
have their own subdivisions and variations; for the purpose of this thesis those 
appropriate to ACh and GABA will be addressed below. 
As a receptor class, LGIC has several subdivisions that can be defined according to 
receptor structure homology.  In the case of ACh and GABA, they belong to the same 
subdivision, the Cys-loop ligand gated ion channel superfamily, that are characterised 
by the existence of a disulphide-bridged loop in the extracellular domain (Miller and 
Smart, 2010). GPCRs are often referred to as 7TM receptors due to their possessing 7 
hydrophobic regions identified as being transmembrane (TM) domains (Alexander et 
al., 2015a). 
 
1.6.2.1 Receptor structure of nicotinic acetylcholine receptor:  the 
prototypical receptor for the Cys-loop ligand gated ion channel 
superfamily 
The nicotinic acetylcholine receptor (nAChR) belongs to the Cys-loop superfamily of 
LGICs (Miller and Smart, 2010). This member has its structure resolved due to the rich 
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source of these receptors found in the electric organ of Torpedo marmorata (Unwin et 
al., 1988, Unwin, 2005).  Each functional receptor is a pentameric structure consisting 
of 5 individually coded subunits, arranged in a ring-like configuration (Miller and Smart, 
2010, Unwin, 2013).  Each subunit is a single protein containing 4 hydrophobic regions 
(M1 to M4) that pass through the cell membrane with the second transmembrane 
region (M2) forming the channel pore and gate (Unwin et al., 1988, Miller and Smart, 
2010, Unwin, 2013)(see Figure 1.6a and 1.6b).  The ion channel is selective for Na+ 
and K+ ions, plus also limited amounts of Ca2+ ions which varies according to the 
subunits present (Unwin, 2013). 
 
 
Figure 1.6:  Structure of the nicotinic acetylcholine receptor. Figure 
based on information in Unwin, 2013.  
A) Diagramatic representation of top down view of a nicotinic acetylcholine 
receptor with identified subunits.  
B) Side view of an individual nicotinic acetylcholine receptor subunit 
illustrated as a ribbon diagram with key features labelled.   
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1.6.2.2 Receptor stoichiometry and pharmacology of nicotinic 
acetylcholine receptors 
Of the 17 gene encoded functional nAChR subunits that have been identified, 16 can 
be found in mammals; the α8 subunit expression being restricted to avian species 
(Lukas et al., 1999, Alexander et al., 2015b).  The subunits fall within 5 families (α, β, γ, 
δ and ε), with the largest being the α family which is distinguishable from the other 
subunit forms through its having two tandem cysteine residues located near the ACh 
binding site (Alexander et al., 2015b).  The stoichiometry of functional channels is 
dependent upon their anatomical expression. For example, in adult animals the 
somatic neuromuscular junction contains hetero-oligomeric channels with a conserved 
assembly of (α1)2β1δε.  In contrast, both embryonic and denervated skeletal muscle 
contain nAChR assembled from (α1)2β1γδ (Alexander et al., 2015b).  Most functional 
nAChRs are hetero-oligomeric combinations of α and β subunits. Occasionally, a third 
subunit is present which leads to a modification of the channels biophysical or 
pharmacological properties (Alexander et al., 2015b).  Some α-subunits (α7-9) can 
form functional homomeric channels with distinct pharmacological properties 
(Alexander et al., 2015b).  The ACh binding site forms at the interface of the α subunit 
(the principal component) and a neighbouring subunit (the complementary component), 
with two binding sites per receptor, the individual affinities of which are determined by 
the constituent subunits (Sine and Engel, 2006, Alexander et al., 2015b). 
Experiments by Dale (1914) functionally described the agonist action of ACh in 
comparative terms to muscarine and nicotine. Ultimately this lead to the two classes of 
ACh receptor being defined according to their prototypical selective agonist: muscarinic 
and nicotinic, respectively (Dale, 1914), although the potent effect of ACh is transient 
due to its rapid hydrolysis by cholinesterase (Dale, 1914, Brucke, 1937).  nAChRs can 
be divided into two classes  (Gotti et al., 2006)  depending on their sensitivity to the 
snake venom, α-bungarotoxin (Changeux et al., 1970).  Those channels sensitive to 
this toxin include α7, α8 and α9 homo-pentameric arrangements as well as hetero-
pentameric α7α8 and α9α10 combinations (Gotti et al., 2006).  Insensitivity to α-
bungarotoxin is exhibited by hetero-pentameric receptors which are combinations of 
subunits α2-α6 and β2-4. The use of nonselective agonists for functional assays 
include nicotine, 1,1-dimethyl-4-phenylpiperazinium (DMPP), epibatidine and ACh 
(Gotti et al., 2006, Alexander et al., 2015b).  Antagonists of nAChR such as 
tubocurarine and pancuronium are potent neuromuscular blockers with a long history of 
clinical use during surgery (Wenningmann and Dilger, 2001).  More selective nAChR 
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antagonists are available and provide a useful tool in discerning the roles of different 
receptor subtypes in physiological processes (see review by Alexander et al. 2015b) 
(Rousseau et al., 2005, Alexander et al., 2015b).  In contrast to ligands that bind at the 
classic ACh binding site (also referred to as the orthosteric binding site), more recent 
advances have led to the discovery of receptor modulators that bind at alternative sites 
to that used by ACh, termed allosteric sites (Chatzidaki and Millar, 2015).  The ligands 
binding at these alternative sites can potentiate (positive allosteric modulator) the 
effects of orthosteric ligand binding or inhibit (negative allosteric modulator) thus acting 
as a non-competitive antagonist. 
 
1.6.2.3 Receptor structure of GABAA receptor 
Schofield et al., (Schofield et al., 1987) suggested on the basis of sequence homology 
that GABAA receptors and nAChRs belonged to the same superfamily of ligand gated 
ion channels.  This was the beginning of the Cys-loop ligand-gated ion channel 
superfamily to which glycine and 5-hydroxytryptamine type 3 (5-HT3) receptors also 
belong (Miller and Smart, 2010).  Having the same ultrastructural composition as the 
nAChR, GABAA receptors are a pentameric arrangement of individually coded subunits 
(each subunit containing 4 transmembrane domains) (Alexander et al., 2015b)(see 
Figure 1.7). To date for mammals, there have been 19 GABAA receptor genes 
identified collected into the subunit groups α1-6, β1-3, γ1-3, π, δ, ε, θ and ρ1-3 
accordingly (Collingridge et al., 2009, Alexander et al., 2015b).  All functional GABAA 
receptor assemblies are anion selective channels, which under most physiological 
conditions leads to hyperpolarisation of the cell membrane potential through an influx of 
Cl- (Olsen and Sieghart, 2008).  The effect of GABAA receptor activation is therefore 
inhibitory in most scenarios. By contrast, in the immature brain a higher quantity of 
Na+/K+/Cl- cotransporters are present, which control intracellular Cl- concentrations and 
effectively act to drive Cl- into the neurones, resulting in higher Cl- concentrations within 
the cell compared to outside (Plotkin et al., 1997). In this latter situation, activation of 
the GABAA receptors results in depolarization of the postsynaptic cells and excitation 
(Mueller et al., 1983, Gaiarsa et al., 1995), since Cl- passes out of the cell via the 
receptor so making the inside of the cell less negatively charged (Plotkin et al., 1997). 
This also happens in some mature sensory neurones (Price et al., 2006).  The channel 
pore is formed by the second transmembrane (M2) region of each subunit, the 
structural features of which define the channel gate and ion selectivity filter (Olsen and 
Sieghart, 2008, Miller and Smart, 2010). 
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1.6.2.4 Receptor stoichiometry and pharmacology of GABAA receptors 
Most GABAA receptors are heteropentameric constructs of stoichiometry 2α, 2β and 1γ; 
in respect of which variants contain a single α subtype, a single β subtype and the γ 
subunit may be substituted with either a  π, δ, ε or θ subunit  (Olsen and Sieghart, 
2008, Alexander et al., 2015b).  The stoichiometric subunit arrangement of 2α.2β.1γ is 
supported by recombinant receptor studies of the most common hetero-oligomer, 
α1β2γ2, which conclude that the functional receptor is an arrangement of (α1)2(β2)2γ2 
(Chang et al., 1996, Collingridge et al., 2009, Alexander et al., 2015b).  The ρ subunit 
generally does not co-assemble to form heteropentamers but instead forms 
homopentameric channels (Bormann, 2000, Alexander et al., 2015b).  Initially identified 
and characterised by their unique pharmacology, these channels were originally 
termed “GABAC”, however use of this term has subsequently been discouraged, since 
on the basis of sequence homology, structure, and functionality, they are more 
appropriately classified as GABAA subunits (Milligan et al., 2004, Olsen and Sieghart, 
2008). 
The GABA binding site is found at the interface of the α and β subunits (β+α-) (see 
Figure 1.7c) with two binding sites present in the typical αβγ heteropentameric channel 
(Smith and Olsen, 1995, Ramerstorfer et al., 2011).  This is also the site of action for 
the classical GABAA competitive antagonist, bicuculline (Bormann, 2000, Alexander et 
al., 2015b).  Observations of bicuculline insensitive responses to GABA led to the 
discovery of GABA ρ receptors; although, despite their insensitivity to bicuculline, 
barbiturates and lack of modulation by benzodiazepines, GABA ρ receptors are still 
sensitive to neurosteroids and picrotoxin like other GABAA receptors (Olsen and 
Sieghart, 2008). 
Benzodiazepines (BZs) are important modulators of relevance to the vast majority of 
GABAA receptors with continuing clinical application (Rudolph and Knoflach, 2011).  As 
allosteric modulators of GABAA receptors, BZs do not activate the channel opening 
directly but instead potentiate the actions of GABA when it binds to its orthosteric site.  
The BZ-binding site is located at the interface between the γ and α subunit extracellular 
domains (α+γ-), in a region containing a conserved histidine residue (see Figure 1.7c) 
(Rudolph and Knoflach, 2011, Ramerstorfer et al., 2011); though the absence of this 
histidine residue in α4 and α6 subunits renders the GABAA receptors containing them 
insensitive to BZs. As a result, studies into the contribution different α subunits make to 
the pharmacological effects observed with BZ administration have been facilitated 
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through the adoption of point mutation experiments involving the histidine residue 
(Rudolph and Knoflach, 2011). 
 
 
Figure 1.7:  Diagramatic representation of the GABAA receptor and its 
binding sites. 
A)  Each subunit is a single protein with 4 transmembrane spanning regions 
(TM1-4), a large extracellular N-terminus domain, and also an intracellular 
loop linking the M3 and M4 parts. Diagram based on information in 
Bormann, 2000. 
B)  The arrangement of each subunit within the pentameric receptor, with 
the channel pore being formed from the alignment of the M2 regions. 
Diagram based on information in Bormann, 2000.  
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Figure 1.7 (continued): 
C) The two orthosteric GABA binding sites are located on the interface 
between α and β subunits (β+α-).  The allosteric benzodiazepine (BZ) 
binding site is located at the interface between the γ and α subunits (α+γ-) 
with the conserved histidine residues required for BZ activity found on the 
extracellular domain of the α subunit (with the exceptions of α4 and α6). 
Diagram based on information in Rudolph and Knoflach, 2011. 
 
1.6.2.5 Receptor structure of GPCRs: Muscarinic acetylcholine receptor 
Dale’s initial observations of the effects of ACh were compared to the actions of 
muscarine, a description that has continued to this day to define the family of receptors 
that mediate the non-nicotinic actions of ACh. Only upon blockade of muscarine with 
atropine were the “nicotine-like” actions of ACh revealed (Dale, 1914). The muscarinic 
acetylcholine receptor (mAChR) belongs to the Class A, rhodopsin-like family of 
GPCRs. GPCRs are comprised of single polypeptide chains with 7 hydrophobic 
regions which form transmembrane domains (TM1 to TM7); giving rise to their 
alternative terminology as “7TM receptors” (Alexander et al., 2015a).   They possess 
an extracellular N-terminus,  3 extracellular loops (ECL1-ECL3) and 3 intracellular 
loops (ICL1-ICL3) which link the TM domains (Audet and Bouvier, 2012, Alexander et 
al., 2015a), plus a C-terminus containing an eighth helix (H8) which lies parallel to the 
cell membrane intracellularly (see Figure 1.8) (Moreira, 2014).  Operating as part of a 
transduction unit, the GPCR binds with a soluble signal before activating a 
heterotrimeric (αβγ) G protein, which subsequently leads to the modulation of an 
effector that may be in the form of an enzyme or an ion channel (Audet and Bouvier, 
2012, Moreira, 2014).  The G protein is bound to the intracellular surface of the GPCR, 
with the regions TM3/ICL2, TM5/ICL3 and ICL3/TM6, plus also the C-terminus, being 
of particular importance to this process (Kaye et al., 2011, Moreira, 2014). 
 
1.6.2.6 Receptor subtypes and pharmacology of muscarinc 
acetylcholine receptors  
The genes for 5 muscarinic acetylcholine receptors have been discovered and are 
referred to as M1-5 in accordance with NC-IUPHAR  recommendations (NC-IUPHAR :  
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Figure 1.8:  Structure of the muscaric acetylcholine receptor 
A) Sequence homology and G-protein coupling on muscarinic 
acetylcholine receptor. Diagram based on information in Kruse et al., 
2012. 
B) Illustration of the topological organisation of GPCRs showing conserved 
structural features.  Also illustrated are the G protein dependent and G 
protein independent signalling. Diagram based on information in Audet 
and Bouvier, 2012. 
 
The International Union of Basic and Clinical Pharmacology Committee on Receptor 
Nomenclature and Drug Classification) (Caulfield and Birdsall, 1998).  These 5 
receptors divide into two groups based on the G protein that they preferentially couple 
with; the M1/M3/M5 receptors acting through Gq/11, while the M2/M4 receptors act through 
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Gi/o (Caulfield and Birdsall, 1998).  This preference correlates with differences between 
the ICL3 regions in each of the two groups, which suggests that the structural 
sequence of the ICL3 region is likely an important determinant in the selective coupling 
of G protein subtypes to the receptor (Caulfield and Birdsall, 1998, Moreira, 2014). 
The M1/M3/M5 receptors activate phospholipase Cβ via Gq/11 to bring about increases in 
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (Caulfield, 1993, Caulfield 
and Birdsall, 1998).  The increase in IP3 leads to a rise in [Ca2+]i via release of the ion 
from IP3-sensitive intracellular stores, whilst the increase in DAG is believed to bring 
about protein kinase C (PKC) activation. Conversely, the M2/M4 receptors act to inhibit 
adenylyl cyclase (AC) via their coupled G protein, so reducing intracellular cAMP levels 
and counteracting the effects of Gs-coupled GPCRs such as β-adrenoceptors 
(Caulfield, 1993). 
There are no subtype selective agonists for muscarinic receptors. As a result the 
physiological effects from the action of such agonist are determined by the type of 
tissue in which the action occurs (Caulfield and Birdsall, 1998).  Broad acting agonists 
for mAChRs include carbachol and bethanechol.  In contrast, some muscarinic 
receptor antagonists do demonstrate receptor selectivity, such as biperidin (M1), 
tripitramine (M2) and ML381 (M5) (Alexander et al., 2015a). 
 
1.6.2.7 Receptor structure and pharmacology of GABAB receptors 
First reported as a bicuculline-insensitive, baclofen-sensitive GABA receptor (Bowery 
et al., 1981), GABAB receptors have since been cloned (Kaupmann et al., 1997) and 
were the first GPCR to be identified as a heterodimer (Marshall et al., 1999, Alexander 
et al., 2015a)(see Figure 1.9). They are classified as belonging to the metabotropic 
glutamate family of GPCRs (Class C), share the 7TM structure common to all GPCRs 
and utilise the Gi/o protein subunit for signal transduction (Bowery et al., 2002, 
Alexander et al., 2015a).  In their native heterodimeric form, GABAB1 and GABAB2 
allosterically couple, mutually enhancing the affinity of the former for agonists and the 
ability of the latter to couple to G proteins (Alexander et al., 2015a). Transduction 
through the pertussis toxin sensitive Gi/o protein leads to inhibition of adenylate cyclase 
and a reduction in intracellular cAMP.  Presynaptic GABAB activation reduces Ca2+ 
conductance through P/Q- and N-type voltage gated calcium channels.  Postsynaptic 
effects of GABAB activation include an increase in K+ conductance, plus possibly also 
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the induction of Ca2+ spiking in thalamocortical neurones upon their being subject to 
long-duration hyperpolarisation (Bowery et al., 2002).  
 
 
Figure 1.9:  Schematic representation of the GABAB heterodimeric 
receptor. Figure based on information in Marshall et al., 1999. 
 
The first specific agonist reported for GABAB was the β-p-chlorophenyl GABA 
derivative, baclofen (Bowery et al., 1981).  Since then, additional equally effective 
specific agonists have been developed, including CGP 44532  (Alexander et al., 
2015a).  The first selective antagonists for GABAB were phaclofen, saclofen and 2-
hydroxysaclofen, however their expressed affinity for GABAB was low. Subsequent 
research into selective antagonists included development of an agonist capable of 
crossing the blood-brain barrier, CGP35348 (Bowery et al., 2002). 
 
31  
 
1.6.3 The laminar and segmental distribution of cells that express 
GABA and cells that express ACh, with particular emphasis on 
thoracic regions  
In the spinal cord five major groups of cholinergic neurones have been identified in rat 
by Barber et al. utilising IHC for ChAT. These are ventral horn motoneurones, 
sympathetic preganglionic and parasympathetic preganglionic neurones, partition 
neurones in the intermediate grey matter, central canal cluster cells, plus dorsal horn 
neurones (Barber et al., 1984).  The identifications by Barber et al. (1984) are 
consistent with the observations of Eckenstein and Thoenen, who localised the 
cholinergic neurones in the CNS through the use of ChAT antibodies (Eckenstein and 
Thoenen, 1982, Eckenstein and Thoenen, 1983)(see Figure 1.10). 
 
 
Figure 1.10:  Diagramatic distribution of cholinergic neurones in the 
thoracic transverse cord sections of rats utilising IHC for ChAT. 
Sympathetic cholinergic preganglionic neurones are found in four locations, 
specifically  the principal intermediolateral nucleus (IMLp), the intercalated 
nucleus (IC), the central autonomic area (CAA) and the funicular 
intermediolateral nucleus (MILf). The dorsal horn (DH) and ventral horn 
(VH) also contain cholinergic neurones. Figure based on information in 
Barber et al., 1984 and Eckenstein and Thoenen, 1982. 
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Within this section only three groups of cholinergic neurones will be the subject of 
discussion; specifically those of the motoneurones, SPNs (though the parasympathetic 
preganglionic neurones will not be the subject of further discussion in this thesis 
because they are not present in the thoracic spinal cord) and the dorsal horn neurones. 
While the groups relating to partition neurones in lamina VII and central canal cluster 
cells in lamina X are located in the areas of our interest, they are not pertinent and so 
are discussed separately in section 1.6.4 
It is well established that ACh is used in motor circuits by somatic motoneurones in the 
ventral horn of the spinal cord (Barber et al., 1984, Johann et al., 2011). Somatic 
motoneurones innervate the voluntary skeletal muscles of the neck, trunk and limbs. 
They mainly consist of two types, specifically α-motoneurones and γ-motoneurones.   
α-motoneurones are the main population and innervate the skeletal muscle extrafusal 
fibres. γ-motoneurones are of lower abundance and innervate the intrafusal muscle 
fibres belonging to muscle spindles (McHanwell and Watson, 2009) . 
Regarding SPNs, four sub-groups of ChAT immunoreactive (ChAT-IR) neurones are 
reported (Barber et al., 1984)(Figure 1.10). The major group is in the principal 
intermediolateral nucleus (IMLp) (Heise and Kayalioglu, 2009b) of the lateral horn, 
which extends from the first segment of thoracic cord to upper lumbar segments 
(Barber et al., 1984, McHanwell and Watson, 2009). The second group of ChAT-IR 
neurones are found dorsal to the central canal (Barber et al., 1984, Seddik et al., 2007, 
Anderson et al., 2009), in an area termed the central autonomic area (also known as 
CA (Barber et al., 1984) or CAA (Deuchars et al., 2005)). The third group of ChAT-IR 
neurones are found in the area between CAA and IMLp, termed the intercalated 
nucleus (Barber et al., 1984, Anderson et al., 2009). The last group has been termed 
the funicular intermediolateral nucleus (IMLf (Heise and Kayalioglu, 2009b)) and is 
located lateral to the IMLp within the white matter of the lateral funiculus (Barber et al., 
1984, Anderson et al., 2009).  
In 1996, Bordey et al. (Bordey et al., 1996a) utilised electrophysiology to study 
neurones in lamina X of the thoracolumbar cord dorsal to the central canal. These 
neurones were identified as SPNs in CAA based on observations made in respect to 
their morphology and location. In the study, application of 1,1-dimethyl-4-phenyl-
piperazinium (DMPP), a selective nAChR agonist, gave rise to a direct depolarization 
of CAA neurones, so suggesting nicotinic excitation of these neurones could influence 
sympathetic outflow. Given their results, plus other (Barber et al., 1984) observations of 
cholinergic neurone populations within lamina X, Bordey et al. concluded that 
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interneurones in lamina X might be potential candidates for the source of cholinergic 
input to the CAA SPNs (Bordey et al., 1996a), much like they are for intermediomedial 
nucleus (IMM) SPNs as reported by Borges and Iversen (Borges and Iversen, 1986). 
The distribution of ChAT immunoreactivity in rat spinal cord has been subject to study 
utilising peroxidase anti-peroxidase IHC for ChAT (Barber et al., 1984). Results 
indicated that in some horizontal sections, for the region adjacent to the ependymal 
layer (ventral to the central canal being the most frequently observed location), the 
presence of ChAT-IR varicosities could be discerned, stemming from central canal 
cluster cells. Furthermore, ChAT-IR fibres possessing a terminal-like appearance were 
observed in the central grey matter in proximity to non-ChAT immunoreactive (ChAT-
IR) cells of the ependymal layer.  
It has been suggested that dorsal horn cholinergic neurones are involved in the 
moderation of sensory circuits, particularly nociceptive transmission (Mesnage et al., 
2011, Pawlowski et al., 2013). When treating mice with an antisense 
oligodeoxynucleotide (AS-ODN) against ChAT (a technique in which the sequence 
constituting the AS-ODN effectively binds to the mRNA to prevent the subsequent 
expression of ChAT and so block the process of genetic information transfer from DNA 
to protein (Dias and Stein, 2002)), ChAT levels in the dorsal horn decreases; though 
the levels of ChAT in motoneurones are seemingly unaffected. As a result of the 
reduced amount of ACh produced in the region, a substantial drop in nociceptive 
thresholds can be discerned in paw pressure and thermal paw withdrawal tests for the 
mice (Matsumoto et al., 2007). In addition, in keeping with an inhibitory cholinergic role, 
approximately 94-95% of the dorsal horn cholinergic neurones are immunoreactive for 
GABA (Todd, 1991, Mesnage et al., 2011). 
Barber’s group have also reported on extensive studies into the presence of 
GABAergic neurones within the rat spinal cord, finding that such neurones can be 
found throughout most of the spinal cord grey matter. They were present in all laminae 
of Rexed, including laminae I to VIII and X, except for lamina IX. Small sized 
GABAergic neurones were observed in lamina I – III, while larger GABAergic neurones 
were additionally apparent in laminae located more ventrally (see Figure 1.11) (Barber 
et al., 1982). In addition, some GAD-IR or GABA-IR neurones in three major groups or 
areas within the spinal cord also expressed ChAT immunoreactivity; these being 
central canal cluster cells, partition cells and the dorsal horn (Kosaka et al., 1988). A 
novel subgroup of GABAergic interneurones within the CAA of the thoracic cord were 
shown by Deuchars et al. (Deuchars et al., 2005) to have a role in the inhibitory control 
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of SPNs of the IML. In 2007 Al-Mosawie et al. reported on the subtypes of V2-derived 
interneurones in the spinal cord of adult mice, with reference to their location and 
possible neurochemistry (Al-Mosawie et al., 2007). During development, without the 
presence of Islet-1 (Isl1) the cell fate of V2 interneurones was dependent upon LIM 
homeobox 3 (Lhx3) transcription factor expression (Ericson et al., 1997b, Zhou et al., 
2000, Karunaratne et al., 2002). YFP expression in the double-transgenic offspring of 
Lhx3cre/+ x thy1-loxP-stop-loxP-YFP mice was used to mark postnatal interneurones 
which were V2-derived; while intraperitoneal injection (IP) of Fluorogold was used to 
label the motoneurones. Spinal cord sections (from the cervical, thoracic, lumbar and 
sacral cord levels) were then used to quantify the distribution of V2-derived 
interneurones. Al-Mosawie et al. found that approximately 88% of all YFP+ V2-derived 
neurones were interneurones (approximately 12% were motoneurones).  For all the 
examined cord levels, V2-derived interneurones predominantly resided in lamina VII, 
though some neurones could also be discerned in laminae V, VI and X. Using 
fluorescent ISH for vesicular glutamate transporter 2 (VGLUT2), it was discerned that 
an appreciable portion (in excess of 50% from the observed sections of 2 animals) of 
YFP+ V2-derived interneurones were glutamatergic. Moreover, on studying the co-
labelled YFP and VGLUT2 terminals via IHC, results suggested that projections from 
the glutamatergic V2-derived interneurones mainly traverse to the ventral horn, 
particularly at the lumbar cord levels.  In addition, Al-Mosawie et al. found that some 
YFP+ boutons exhibited co-expression for the neuronal glycine transporter 2 (GlyT2) or 
GABA synthesising enzymes (GAD65 or GAD67), suggesting that V2-derived 
interneurones could also be glycinergic or GABAergic. The YFP+/GlyT2 
immunoreactive (YFP+/GlyT2-IR) boutons were found predominantly in the dorsal horn 
plus laminae IX and X. The YFP +/GAD67-IR boutons were discerned in the dorsal 
spinal cord, and the YFP +/GAD65-IR boutons were observed throughout the grey 
matter of the spinal cord.  
Given the literature reports on the discovery of GABAergic and cholinergic neurones 
within lamina X and/or its adjacent laminae, a discussion detailing the findings from 
such studies in relation to GABAergic and cholinergic interneurones is provided in 
section 1.6.4. 
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Figure 1.11:  The distribution of GAD-IR neurones in the lumbar spinal 
cord of rats. Figure based on information in Barber et al., 1982. 
 
1.6.4 Identified cell types and reported cholinergic and GABAergic 
receptor mediated effects in lamina X and adjacent regions 
As previously mentioned, lamina X contains central canal cluster cells which are 
cholinergic as well as cholinergic SPNs  in the CAA (Barber et al., 1984). However, 
further cell types, in relation to functionality and neurochemistry, have also been 
discovered and reported within lamina X and its adjacent regions. These neurones will 
be described here (see Figure 1.12). 
The role of lamina X cholinergic interneurones in the modulation of motor circuitry was 
indicated since they are the source of the C bouton (terminal) input onto motoneurones 
in the ventral horn. In 1972, McLaughlin reported that the origin of cholinergic C 
boutons may stem from such interneurones in the spinal cord since the number of 
cholinergic C boutons projecting to the motoneurones in the ventral horn did not 
decrease after spinal transection (McLaughlin, 1972). However, the specific location of 
these neurones remained unidentified. In 2007 Miles et al. (Miles et al., 2007) indicated 
that for mice in which ChAT promoter controlled expression of GFP, all motoneurones 
of the lumbar spinal cord expressed GFP, but C boutons and some groups of 
cholinergic interneurones (in the dorsal horn, lamina VII and lamina X) did not; 
therefore suggesting that C boutons possibly originate from cholinergic interneurone 
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Figure 1.12:  Locations of cell types and cholinergic receptor 
mediated effects reported in lamina X and its adjacent regions based 
on literature. 
 
groups. Miles and his colleagues extended their investigations to transgenic mice in 
which yellow fluorescent protein (YFP) expression had been controlled by the 
transcription factor Dbx1, termed Dbx1-YFP mice (where Dbx is a developmentally 
defined V0 interneuronal marker) (Jessell, 2000). In the mouse line C boutons were 
found to be positive for YFP. On applying immunohistochemical analysis to the lumbar 
spinal cord sections of the Dbx1-YFP mice, it was determined that C boutons exhibited 
a profile of ChAT+/YFP+/NOS- (where NOS is nitric oxide synthase) and that the 
interneurones with such a profile were largely located lateral to the central canal (in 
lamina X and the medial section of lamina VII). These neurones giving rise to C 
boutons are termed as medial partition neurones. Moreover, upon investigating C 
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bouton functionality through the application of electrophysiology in relation to 
motoneurone response, results indicated that M2 receptor activation increases 
motoneurone activity (Miles et al., 2007, Wilson et al., 2004, Muennich and Fyffe, 
2004). 
With regard to autonomic control, ACh plays a significant role in cardiovascular 
regulation, as evidenced by studies involving anaesthetised rats, where injecting ACh 
into the IML of the thoracic cord resulted in increased heart rate (McKitrick and 
Calaresu, 1991). However, in seeming contrast to the results from rats, initial 
experiments using microelectrophoretic application of ACh to SPNs in anaesthetised 
cats failed to produce a response (Coote et al., 1981). The weak effect of ACh was 
specifically remarked upon by Gibson & Logan (Gibson and Logan, 1995) in their rat 
thoracolumbar spinal cord slice experiments, which they suggested may due to rapid 
metabolism of ACh by endogenous cholinesterase.  By instead using the enzyme-
resistant ACh analogue carbachol, hyperpolarising responses in SPNs were 
subsequently observed and attributed to M2 muscarinic receptor activation. 
Unexpectedly, in the presence of a complete muscarinic receptor blockade by atropine, 
no nicotinic response to carbachol was observed, leading the authors to theorise that 
the two receptor types could be differentially expressed by SPNs dependent upon their 
target organ.   
In addition to studies on SPNs in the IML, the effects of ACh on other autonomic nuclei 
in the spinal cord have also been performed, particularly in respect of the CAA. Bordey 
et al. (Bordey et al., 1996a) observed that all thoracolumbar lamina X neurones in the 
region dorsal to the central canal, which corresponds to the CAA, depolarised in 
response to application of nAChR agonist, DMPP.  In addition to this direct 
depolarisation, their results also suggested that increased presynaptic glutamate 
release was involved in facilitating excitatory transmission onto these cells. Further 
evidence of nAChR on SPNs in the CAA was provided by Bradaia et al. when they 
pharmacologically identified α7-containing receptors on these cells. Using choline (10 
mM) as a selective α7 nAChR agonist (Papke et al., 1996, Bradaia et al., 2005)  in 
combination with selective α7 nAChR antagonists α bungarotoxin (α-BgT, 50 nM) and 
strychnine (1 µM), the subunit composition of CAA SPN nAChRs were investigated. 
Choline-induced inward currents were highly sensitive to α-BgT and strychnine. They 
were also apparently insensitive to dihydro-β-erythoidine (DHβE, 1 µM), which is a non-
α7 nAChR antagonist. Conversely the inward currents produced upon application of 
the broad nicotinic agonist, DMPP (100 µM), were not significantly affected by α-BgT 
38  
 
and strychnine but were blocked by the non-α7 nAChR antagonist, DHβE. The partial 
recovery of choline-induced inward currents from α-BgT blockade also suggests that 
these receptors may not be homomeric α7 but heteromeric nAChRs, thus indicating a 
role for these receptors in fast cholinergic transmission (Bradaia et al., 2005). Members 
of the same group later demonstrated that presynaptic non α7 nAChR activation on 
GABAergic terminals innervating SPNs in the CAA plays a role in facilitating inhibitory 
transmission (Seddik et al., 2006). 
As well as SPNs in lamina X, non-SPN neurones are also present (Bordey et al., 
1996b). Bordey et al. (Bordey et al., 1996b) undertook whole-cell patch-clamp 
recording on thoracolumbar spinal cord slices from neonate rats. Comparing the 
location of these lamina X neurones, situated at a more dorsal location to the central 
canal, with the location of the previously discerned SPNs, predominantly in the ventral 
part of the dorsal commissure (Hosoya et al., 1994) and also in the pericanal region, 
indicated that these neurones were not SPNs. Application of DMPP depolarised the 
neurones, which suggested that the neurones possessed nAChRs. The source of their 
cholinergic input is unknown. 
In 2005 Deuchars et al. reported a newly identified group of GABAergic interneurones 
in the CAA of the rat thoracic spinal cord. Employing trans-synaptic labelling via 
injection of the pseudorabies virus (PRV) into the rat adrenal gland, in combination with 
ISH for GAD67 mRNA, some infected neurones observed dorsal and lateral to the 
central canal (in the CAA) were also identified as being GABAergic, since they 
expressed mRNA encoding for GAD67. This suggested that these particular 
GABAergic neurones in the CAA were presympathetic neurones. Utilising 
electrophysiology, stimulation of the CAA in the region containing these GABAergic 
interneurones produced monosynaptic IPSPs in SPNs. Subsequent bicuculline 
antagonism of these IPSPs indicated that they were mediated via activation of GABAA 
receptors. Moreover, upon glutamate microinjection into the CAA, to activate neuronal 
cell bodies, the degree of hyperpolarization observed was found to greatly diminish on 
application of bicuculline. In combination, the results from the study suggested these 
GABAergic interneurones in the CAA play a direct role in the inhibitory regulation of 
SPNs (Deuchars et al., 2005). 
Kosaka et al. (Kosaka et al., 1988) investigated the co-expression of ChAT and GAD 
(or GABA) in the adult rat cervical spinal cord. The experiment involved 
intracerebroventricular injection of colchicine into the animal one day prior to perfusion. 
Utilising peroxidise-antiperoxidase IHC for ChAT, GAD or GABA, one of the two paired 
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surfaces from adjacent sections (40 µm thick) was incubated with ChAT antibody while 
the other paired surface was incubated with GAD (or GABA) antibody. The approach 
taken therefore allowed for the observation of co-localisation in individual cell bodies 
which as a result of the sectioning process had been cleaved, and so were present in 
adjacent slices. Co-expression of ChAT and GAD (or GABA) was found in central canal 
cluster cells and partition cells; at a level of 37%, corresponding to 18 of the 49 ChAT-
IR neurones examined. In addition, co-expression was also observed in the dorsal horn 
(10 co-localised neurones among the 16 examined ChAT-IR neurones). A similar 
observation was reported by Todd, where 94% of ChAT-IR neurones within lamina III 
were also immunoreactive to GABA (Todd, 1991). 
There is little evidence that cholinergic innervation of the spinal cord is supraspinal. In 
1991, Sherriff et al. (Sherriff et al., 1991) investigated the possible existence of a 
cholinergic projection from the brainstem to the spinal cord. In their study, rats were 
injected with retrograde tracers (Horseradish Peroxidase (HRP), wheat germ 
agglutinin-conjugated HRP (WGA-HRP) or true blue) into the lumbar enlargement, or in 
one instance into the mid thoracic spinal cord. The brain and spinal cord sections were 
subsequently processed according to IHC protocols in order to visualise the tracers 
(through the use of tetramethylbenzidine and cobalt intensified diaminobenzidine 
(DAB)) and also cholinergic neurones (utilising IHC for ChAT). Although they did 
observe the presence of descending projections from the brainstem to the spinal cord 
none of these labelled cells were cholinergic, so indicating that cholinergic innervation 
to the spinal cord is from within the spinal cord itself. Sheriff and Henderson (Sherriff 
and Henderson, 1994) extended the investigation by studying sources of spinal 
cholinergic neurones innervating the rat spinal cord through the use of retrograde 
tracing methods, via True blue or cholera toxin subunit B (CTB) injection into the spinal 
cord at the level of first lumbar vertebra, in combination with IHC for ChAT and CTB. 
The presence of neurones exhibiting ChAT and tracer double labelling was only 
observed in sections up to 6 segments rostrally and caudally distant from the injection 
site. These double labelled neurones were identified as being partition cells 
(predominantly belonging to the medial group) and central canal cluster cells; with each 
50 µm thick spinal cord section containing a few double labelled neurones from each 
group. Based on the evidence from their study Sheriff and Henderson determined that 
some cholinergic partition and central canal cluster cells contribute short range 
intersegmental propriospinal projections. 
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A neuronal group in lamina X that could be a potential source of ascending projections 
to the brainstem was investigated by Nahin et al. (Nahin et al., 1983). Rats were 
injected with HRP as a retrograde tracer into several regions of the medulla, pons and 
midbrain. While injections into all parts of the brainstem resulted in neurones within 
lamina X being retrogradely labelled, so suggesting that lamina X neurones give rise to 
long ascending projections across all subdivisions of the brainstem, those applied 
specifically into the paramedian medullar and/or pontine reticular formation generated 
the largest number of labelled lamina X neurones (mainly on the side contralateral to 
that of the injection site). However, Nahin et al. did not investigate the neurochemistry 
of the studied neuronal population.  
Retrograde tracer Fluorogold and/or CTB was injected into the cerebellum of mice. The 
cerebellar and spinal cord sections were subsequently processed using IHC to observe 
spinal neurones which projected to the cerebellum. The results suggested that the 
central cervical nucleus, located lateral to the central canal, and other scattered 
neurones within laminae VII (at all spinal cord levels) sent projections to the cerebellum 
(Sengul et al., 2015). However, the neurochemistry of these cerebellar projecting 
neurones was not investigated. 
 
1.6.4.1 Inputs to lamina X and its adjacent regions 
In order to understand neuronal circuits and their function, a knowledge of the possible 
associated inputs and outputs for these circuits within the regions of interest is 
important.  To reveal this aspect a number of research investigations have been 
undertaken utilising various techniques including IHC, tracing studies and 
electrophysiology. This section will describe the evidence of possible inputs reported 
within lamina X plus adjacent regions in the spinal cord of various species. 
The distribution of punctate GAD-IR structures, presumed to be terminals, has been 
reported in the rat lumbosacral spinal cord using peroxidase IHC (McLaughlin et al., 
1975). According to the light microscopic analysis, moderate accumulation of GAD-IR 
puncta was observed in laminae VII and lamina X. Puncta located in the ventral horn 
and the dorsal horn were additionally revealed by electron microscopy to correspond to 
GAD-IR synaptic terminals. Although the puncta observed within laminae VII and X 
were not investigated under an electron microscope, it may be suggested that the 
puncta found in these laminae also correspond to GAD-IR terminals which make 
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contact with local neurones within these regions. A similar finding was reported in 
monkey lumbar cord where peroxidase anti-peroxidase IHC for GABA revealed that 
lamina X contained a moderate concentration of GABA-IR fibres and terminals (Carlton 
and Hayes, 1990). 
Neurones in the lateral hypothalamic area (LHA) that are immunoreactive to melanin-
concentrating hormone (MCH), plus the projections from such neurones into the rat 
spinal cord, have been the subject of past investigation (Bittencourt and Elias, 1998). In 
the study, one group of rats were injected at the thoracic cord level with the retrograde 
tracer diamidino yellow. To improve neurone immunostaining these animals were also 
injected with colchicine 20-25 days after tracer injection and 48 hours before perfusion. 
Adjacent serial sections of forebrain, brainstem and spinal cord were then stained 
using IHC for the retrograde tracer and MCH. A second group of rats were injected with 
Phaseolus vulgaris leucoagglutinin (PHA-L), an anterograde tracer, into either their 
LHA or zona incerta; since MCH and neuropeptide EI generally co-localise within 
neurones of these regions (Bittencourt et al., 1992), the purpose of this group was to 
confirm both the distribution of co-localised MCH and neuropeptide EI projecting 
neurones and determine the terminal projections of such neurones into the spinal cord. 
Both MCH and neuropeptide EI are processed from a precursor which is also 
responsible for producing a hormone that affects adaptive changes of pigmentation. 
Results from the study showed that large numbers of MCH-IR terminals project into 
lamina X, predominantly around the central canal, from the LHA at all spinal cord 
levels. This suggests that lamina X is enriched by MCH innervations from descending 
projection neurones in the LHA. Moreover, since co-localisation between MCH and 
neuropeptide EI was observed to be prevalent in neurones of the LHA, Bittencourt and 
Elias proposed that the MCH-IR terminals projecting to the spinal cord from the LHA 
were also likely to be immunoreactive for neuropeptide EI (Bittencourt and Elias, 1998) 
Major contributions of serotonergic (5-HT or 5-hydroxytryptamine) projections to the 
spinal cord arise from the raphe nuclei, particularly from the nucleus raphe magnus, the 
nucleus raphe pallidus and the nucleus raphe obscurus (Ballion et al., 2002). According 
to a study on mice, utilising both immunoperoxidase and immunofluorescence 
techniques to localise serotonin (Ballion et al., 2002), at zero days postnatal the dorsal 
region of the peri-ependymal area of the spinal cord possessed commissural 5-HT-IR 
fibres (5-HT), while at 10 days postnatal the region received high levels of 5-HT 
innervation. In adult rat, the distribution of descending serotonergic fibres projecting to 
the spinal cord has been investigated utilising peroxidise antiperoxidase IHC (Newton 
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and Hamill, 1989). The whole spinal cord from C1 to the conus medullaris was 
examined for the presence of 5-HT-IR terminals. Results indicated that large amounts 
of 5-HT-IR fibres were present in both laminae VII and X (particularly in the dorsal 
commissural nucleus). The authors additionally noted that the areas within lamina VII 
and X that possessed most of the 5-HT-IR fibres also contained SPNs.  Ten days after 
transection of the spinal cord (at the junction of T4-T5) a significant decrease in 
serotonergic descending fibres was discerned caudal to the transection, in the IMLp, 
intercalated nucleus and dorsal commissural nucleus. Furthermore, results obtained 
from spinal cord hemisection indicated that laminae VII and X received innervation from 
both crossed and uncrossed descending serotonergic projections. 
An investigation into the co-localisation of serotonin (5-HT) with nine individual 
substances within the axons of adult rat spinal cord has further suggested that these 5-
HT pathways are neurochemically heterogeneous. Markers tested were GAD and eight 
neuropeptides (specifically calcitonin, gene-related peptide, dynorphin, enkephalin, 
galanin, neuropeptide Y, neurotensin, substance P and somatostantin) (Maxwell et al., 
1996). In the study fluorescent IHC in combination with confocal microscopy was used 
to examine the L4 spinal cord segments. The results indicated that a moderate level of 
co-localisation between serotonin and substance P was present within axon terminals 
in lamina X. Furthermore, the only other substances for which serotonin co-localisation 
could be discerned within lamina X axon terminals were dynorphin and galanin, both in 
limited numbers. Therefore they may be a small subgroup of serotonergic inputs with 
potentially different functions. 
An investigation into dopaminergic distributions across all regions of the spinal cord (for 
rats, cats and monkeys) revealed that lamina X received considerable dopaminergic 
innervation, though essentially confined to the area encircling the central canal plus a 
region spreading out in an apparently dorsolateral direction (Holstege et al., 1996).  
Met-Enkephalin, substance P and somatostatin synaptic terminals were also 
investigated in the cervical cord lamina X region of monkey utilising electron 
microscopy in combination with IHC (LaMotte and Shapiro, 1991). Met-enkephalin 
terminals were largely observed lateral to the central canal. Similarly, substance P 
terminals were also predominantly observed lateral to the central canal and in the 
dorsal commissural nucleus, though some terminals could additionally be found dorsal 
and ventral to the pericanal region. Relative to Met-enkephalin and substance P 
terminals, the number of observed somatostatin terminals in lamina X was more 
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limited, with the majority of those discerned being lateral to the central canal and along 
the dorsal commissure. 
Utilising PHA-L (an anterograde tracer) injection into the locus coeruleus nucleus of rat 
spinal cord in combination with IHC for PHA-L and dopamine-β-hydroxylase (Clark and 
Proudfit, 1991), noradrenergic projections from the locus coeruleus were predominantly 
observed to terminate in lamina X (particularly in the area adjacent to the central canal) 
and lamina VII (ipsilateral side to the injection site).  
The existence of a monosynaptic pathway between SPNs and cells in the raphe 
pallidus and/or caudal raphe magnus of rat has been ultrastructurally studied (Bacon et 
al., 1990). PHA-L retrograde tracer was injected into the raphe pallidus and the raphe 
magnus. The adrenal gland was later injected unilaterally with cholera B chain 
conjugated to HRP (CB-HRP), which subsequently retrogradely labelled SPNs in the 
IMLp, IMLf and a few in the intercalated nucleus  on the ipsilateral site, predominantly 
in T7-T11 cord segments.  Synaptic contacts between the retrogradely labelled SPNs 
and PHA-L containing terminals were observed, suggesting the presence of a 
monosynaptic pathway between these SPNs and cells in the raphe pallidus and/or the 
caudal raphe magnus.  
Cholinergic V0-derived interneurones, of interest due to their location in close proximity 
to the central canal, were studied through the use of transgenic mice, IHC and 
electrophysiology (Zagoraiou et al., 2009). Focusing on Pitx2 positive V0 interneurones 
in the upper lumbar spinal cord levels, synaptic inputs to transgenically labelled 
neurones (Pitx2::Cre;Thy1.Isl.YFP) were investigated via immunofluorescence. Their 
results indicated the presence of strong synaptic input (based on the numbers of 
boutons in close apposition to somata) from VGLUT2 and GAD67 containing neurones; 
each contributing more than 50 boutons per cholinergic V0 soma. Suggested sources 
of the glutamatergic input included interneurones (Alvarez et al., 2004) and descending 
projections (Du Beau et al., 2012). Some serotonergic (20 boutons per soma) inputs 
were detected and attributed to serotonergic innervation from the brainstem (Ballion et 
al., 2002). In addition a few VGLUT1 (vesicular glutamate transporter 1) (approximately 
10 boutons per soma) inputs were observed, likely originating from primary afferents 
(Alvarez et al., 2004) and/or the corticospinal tract (Du Beau et al., 2012). 
Electrophysiological recordings from the hemisected spinal cords of 
Pitx2::Cre;Thy1.Isl.YFP mice subjected to a rhythmogenic drug cocktail (NMDA 5 µM, 
5-HT 10 µM, dopamine 50 µM) showed most fluorescent protein-labelled V0 
interneurones to be tonically active, with a small number showing distinct bursting 
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activity. Among the tonically active fluorescent protein-labelled neurones, while they 
lack intrinsic rhythmic activity, most (80%) increased their firing rate in phase with 
motor burst activity. Under voltage clamp conditions, while inhibitory postsynaptic 
currents (IPSCs) were detected throughout the motor burst cycle, barrages of 
excitatory postsynaptic currents (EPSCs) in phase with ventral root bursts were also 
observed. Indirect input from sensory afferents was additionally demonstrated. The 
study concluded that the rhythmic activity exhibited by Pitx2+ V0 interneurones was 
largely dependent on local excitatory interneurone inputs (Zagoraiou et al., 2009).   
 
1.6.4.2 Output from lamina X and its adjacent regions 
A background knowledge of projections from the area of interest is important in order to 
understand the circuits involved within the region. This section will describe studies 
carried out to investigate possible projections from lamina X and its adjacent regions to 
various CNS areas. 
The connection between spinal cord neurones and both the midbrain periaqueductal 
grey and the medullary reticular formation were studied in rat using fluorescent 
retrograde tracers, Fast Blue plus either Nuclear yellow or Diamidino yellow 
dihydrochloride. Injections made into the periaqueductal grey (Fast Blue) and the 
medullary reticular formation (one of the two yellow dyes), gave rise to double labelled 
neurones in instances where neurones provided projections to both regions. Laminae 
VII and X contained prominent levels of the observed double labelled neurones, so 
indicating that some neurones within these laminae provide ascending projections to 
both the periaqueductal grey and the medullary reticular formation (Pechura and Liu, 
1986). 
In rats which had been injected into various areas of the brain with a gold complex 
retrograde tracer made of WGA-apohorseradish peroxidase conjugate coupled to 
colloidal gold, neurones situated close to the CAA (dorsal commissural nucleus) of 
lamina X were discerned to project to the nucleus of tractus solitarius (NTS) and the 
parabrachial area via the spinosolitary and spinoparabrachial tracts respectively. In 
addition neurones in lamina VII of the lower thoracic and upper lumbar cord were 
observed to project to the hypothalamus and amygdala. Furthermore, investigations 
were also undertaken using c-fos immunohistochemistry as a marker to label active 
spinal neurones activated by noxious visceral stimulation via acidified (acetic acid) IP 
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injection. Results suggested that spinal neurones which contributed to the 
spinoparabrachial and spinosolitary tracts might play a major role in visceronociceptive 
transmission. A limited number of such neurones were discerned to be in lamina X at 
the thoracolumbar junction (Menetrey and de Pommery, 1991).  
Another site of projection from neurones in lamina X is to the ventral horn of the spinal 
cord. Medial partition neurones, interneurones located lateral to the central canal within 
lamina X and the medial section of lamina VII, have been reported to be the neuronal 
source of cholinergic C boutons which project to motoneurones in the ventral horn 
(Miles et al., 2007). Details on the experimental procedures involved to establish this 
determination are described within section 1.6.4.  
One target for the efferent projections from lamina X neurones is within lamina X itself. 
According to the study by Barber et al. on rat spinal cord sections, involving the 
application of peroxidase anti-peroxidase immunohistochemical techniques for ChAT 
(Barber et al., 1984), such local projections have been identified in relation to the 
neuronal origins for some ChAT-IR varicosities observed in the region adjacent to the 
ependymal layer (ventral to the central canal being the most frequently observed 
location). In these instances the ChAT-IR varicosities were seen to extend from central 
canal cluster cells.  
As mentioned previously, evidence also exists that lamina X interneurones target SPNs 
in the IML (Deuchars et al., 2005) (see section 1.6.4). 
 
1.7 The Autonomic nervous system with particular 
emphasis on sympathetic nervous system 
Homeostasis is strongly influenced by the autonomic nervous system. Cardiac muscle, 
smooth muscle and glands are governed by the efferent (motor) aspect of the 
autonomic nervous system. However, in addition there is also an afferent aspect to the 
autonomic nervous system. The afferent system is concerned with the feedback of 
sensory information from receptors present in the organs to the CNS. Such information 
is then integrated by various neuronal pathways in the CNS to influence the autonomic 
motor outflow (Loewy, 1990a, Deuchars and Lall, 2015).  
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The autonomic nervous system was first described by Langley (Langley, 1921). In the 
body, the autonomic nervous system can be split into three components. These are the 
sympathetic, parasympathetic and enteric nervous system. Various internal organs are 
controlled through the joint, but opposing, actions of the sympathetic and 
parasympathetic components. For instance, activation of sympathetic fibres in the heart 
causes tachycardia, whereas bradycardia occurs as a result of parasympathetic fibres 
being stimulated (Loewy, 1990a). Further effects of the sympathetic nervous system 
include pupillary dilation, vasoconstriction of blood vessels, sweat secretion, 
piloerection, bronchial dilation, plus relaxation of the bladder wall muscle and 
contraction of the internal sphincter, while those of the parasympathetic nervous 
system include pupillary constriction, vasodilation, bronchial constriction, plus 
contraction of the bladder wall muscle and inhibition of the internal sphincter (Purves, 
2008). By contrast, glandular secretion and motility in the gut are controlled by a group 
of neurones in the gut wall which is termed the enteric nervous system (Loewy, 1990a). 
The efferents of the sympathetic nervous system arise from the spinal cord and 
innervate ganglionic cells in the sympathetic chains which in turn project to the thoracic 
viscera (including lung and heart), various abdominopelvic viscera, the muscles in 
vascular walls, hair follicles and sweat glands (Snell, 2010). Its activation gives rise to 
responses which are associated with “Fright, fight and flight”, causing the heart, blood 
vessels, airways and liver to work in such ways as to result in increased cardiac output, 
changes to blood flow, increased lung airflow and raised concentrations of blood 
glucose respectively. These changes contribute to increasing the chances of survival 
when subjects are placed in stressful situations (Longstaff, 2005). 
The efferents of the parasympathetic nervous system arise from brainstem nuclei and 
the sacral spinal grey matter (Snell, 2010, Longstaff, 2005). Activation of the 
parasympathetic nervous system is associated with the body being in a “rest and 
digest” condition. It is involved in the stimulation of exocrine gland secretion and 
anabolic processes (Longstaff, 2005).  
The enteric nervous system is located exclusively outside the CNS. It consists of both 
the myenteric and the submucosal plexus, which lie within the gut wall. The enteric 
nervous system primarily regulates the rhythm and coordination of the gut contraction 
(Langley, 1921, Kingsley, 2000). 
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1.7.1 Sympathetic nervous system 
1.7.1.1 Location of the sympathetic preganglionic cell column 
In mice, lamina VII contains the sympathetic preganglionic cell columns, including the 
intermediolateral nucleus (forming two IMLs) – which constitutes the lateral horn 
(Anderson et al., 2009, Sengul et al., 2012) – and the intercalated nucleus. The IML is 
situated at the lateral border of lamina VII, between the first thoracic and second 
lumbar segments (T1-L2) (Anderson et al., 2009, Sengul and Watson, 2012). By 
comparison for the majority of mammalian species the IML is to be found between the 
C8 and L3 segments (Strack et al., 1988, Deuchars and Lall, 2015). In addition to the 
IML and the intercalated nucleus, detailed studies within these segments have 
indicated that sympathetic preganglionic neurones (SPNs) also reside in the lateral 
funiculus and the central autonomic nucleus (Barber et al., 1984, Deuchars and Lall, 
2015). 
  
1.7.1.2 Anatomical organisation of the sympathetic nervous system 
The axons of SPNs exit the spinal cord via the ventral nerve roots and then travel to 
the sympathetic chain, which lies along both sides of the vertebral column. From the 
sympathetic chain, there are three possible modes of distribution for these 
preganglionic axons. Firstly, they may form a synapse, using ACh as their 
neurotransmitter, onto sympathetic postganglionic neurones within the sympathetic 
chain. The postganglionic axons then travel out of the sympathetic chain to reach the 
thoracic spinal nerves, at which point they subsequently accompany the spinal nerves 
to reach smooth muscle within the vascular walls, sweat glands and arrector pili 
muscles. Secondly, after leaving the spinal cord the preganglionic axons of SPNs may 
travel rostrally within the sympathetic chain to synapse onto sympathetic postganglionic 
neurones in the cervical segments of the chain. The postganglionic axons then leave 
the sympathetic chain and distribute to the cervical spinal nerves.  
Several axons of SPNs also travel caudally within the sympathetic chain to synapse 
with sympathetic postganglionic neurones in the lower lumbar and sacral regions of the 
chain. The postganglionic axons from these neurones then travel to join the lumbar, 
sacral and coccygeal spinal nerves. Thirdly, the preganglionic axons of SPNs travel to 
the sympathetic chain and then leave the chain without synapsing with any ganglionic 
neurones. These preganglionic axons then travel to synapse with postganglionic 
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neurones which are located outside the sympathetic chain (such as prevertebral 
ganglion). After synapsing, the postganglionic axons subsequently travel to the glands 
and smooth muscle of the viscera. A limited number of preganglionic axons of SPNs 
also reach the adrenal medulla of the adrenal gland. Cells in the adrenal medulla are 
considered to be modified sympathetic neurones involved in adrenaline and 
noradrenaline secretion (Snell, 2010, Deuchars and Lall, 2015)(see Figure 1.13). In an 
alternative to the local reflex pathway, some central axons from the dorsal root ganglia 
neurones connect to ascending neurones which in turn send axons to make links with 
regions in higher centres which are responsible for the modulation of autonomic, limbic 
and endocrine functions (Snell, 2010, Deuchars and Lall, 2015). 
 
 
Figure 1.13:  Anatomical organisation of the sympathetic nervous 
system (Figure adapted from Loewy, 1990a, Deuchars and Lall, 2015). 
SPNs: sympathetic preganglionic neurones; DRG: dorsal root ganglion; 
SPGN: sympathetic postganglionic neurone. 
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Sympathetic outflow from the spinal cord originates from SPNs, the last common 
central pathway of the sympathetic nervous system and interface between the CNS 
and peripheral nervous system (Deuchars, 2007). SPNs receive supraspinal inputs 
from various regions of the brain including paraventricular hypothalamic nucleus, A5 
noradrenergic cell groups, caudal raphe region, rostral ventrolateral medulla, and 
ventromedial medulla (Strack et al., 1989a, Strack et al., 1989b, Deuchars, 2007). 
Some circuits utilise interneurones in order to establish contact onto SPNs.  The 
locations of interneurones controlling sympathetic activity in laminae V, VII, X, and the 
IML (Strack et al., 1989a, Cabot et al., 1994, Deuchars, 2007) have only been 
established in the last few decades but details pertaining to their role and 
neurochemistry is still not well reported.  Along with supraspinal innervation, 
sympathetic interneurones additionally receive innervation from local afferent 
pathways; each innervation path playing a crucial role in the maintenance of 
sympathetic outflow (Deuchars, 2007). The contribution of motoneurones to the 
modulation of sympathetic activity may be mediated by an undefined population of 
interneurones. Chizh et al. (1998) suggested that sympathomotor coordination could 
occur through a common central pattern generator projecting to both the somatic 
motoneurones and sympathetic neurones however they could only demonstrate 
unidirectional integration of activity from motorneurons to SPNs (Chizh et al., 1998). 
 
1.7.2 Parasympathetic nervous system 
1.7.2.1 Locations of parasympathetic preganglionic neurones  
The cells that give rise to parasympathetic preganglionic axons have their origins within 
both the brainstem and also the sacral spinal grey matter (Snell, 2010, Longstaff, 
2005); an aspect termed craniosacral outflow.  
Several cranial nerves originate from brainstem parasympathetic nuclei. These are the 
oculomotor nerve (via the Edinger-Westphal nucleus), the facial nerve (via the superior 
salivary nucleus and lacrimatory nucleus), the glossopharyngeal nerve (via the inferior 
salivatory nucleus) and the vagus nerve (via the dorsal vagal nucleus) (Snell, 2010). As 
regards the spinal cord of mice, preganglionic parasympathetic neurones are located in 
the L6-S1 cord segments (Anderson et al., 2009). 
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1.7.2.2 Anatomical organisation of the parasympathetic nervous system 
The cells that give rise to the afferent fibres of the parasympathetic system have their 
origins in both cranial nerve sensory ganglia and also the sacral dorsal root ganglia. 
The afferent fibres related to these cells extend from the viscera. Central axons then 
pass into the CNS where they establish an afferent element to a local reflex arc or 
ascend to make connections with higher centres associated with the autonomic 
nervous system (Snell, 2010). 
The preganglionic axons leave the brainstem and spinal cord via their associated 
cranial nerves and ventral spinal nerve roots respectively. The preganglionic axons 
target visceral structures, establishing synapses with neurones in peripheral ganglia 
that are in close proximity to their target structure; the neurotransmitter associated with 
these synapses being ACh (Snell, 2010). 
 
1.8 Nucleus of tractus solitarius (NTS) 
1.8.1 Gross Morphology of the NTS 
The NTS is constituted from an assortment of neurones in the dorsomedial medulla, 
and stretches from the lower end of the facial motor nucleus to the lower end of the 
pyramidal decussation (Ciriello, 1994). Afferent projections from the facial (CN VII), 
glossopharyngeal (CN IX) and vagus (CN X) nerves  (Torvik, 1956, Kalia and 
Mesulam, 1980, Loewy, 1990b) constitute a bundle of nerve fibres termed the solitary 
tract, which in turn is encircled by the group of neurones comprising the NTS (see 
Figure 1.14). 
At the rostral level the NTS appears as two columns situated alongside the fourth 
ventricle. The two columns subsequently unite to establish a single component at the 
level inferior to obex (Ciriello, 1994) – the obex is the lower border of the fourth 
ventricle (Burt, 1993). The NTS is generally divided into three regions, defined by their 
location relative to the area postrema, which are termed rostral, intermediate and 
caudal (Loewy, 1990b) (see Figure 1.15). 
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Figure 1.14:  Diagram of a transvese section of mouse medulla 
oblongata at the level of the area postrema showing the location of 
the NTS. Afferent projections from the facial (CN VII), glossopharyngeal 
(CN IX) and vagus (CN X) nerves (Torvik, 1956, Kalia and Mesulam, 1980, 
Loewy, 1990b) constitute a bundle of nerve fibres termed the solitary tract 
(ST). The neurones comprising the NTS subnuclei surround the solitary 
tract (Figure adapted from Ciriello, 1994, Okada et al., 2008, Ganchrow et 
al., 2014, Allen Brain Atlas: Mouse Brain). 
NTS subnuclei; com: commissural subnucleus; ce: central subnucleus; dl: 
dorsolateral subnucleus; dm: dorsomedial subnucleus; lat: lateral 
subnucleus; m: medial subnucleus; v: ventral subnucleus; vl: ventrolateral 
subnucleus. 
Other structures; AP: area postrema; CC: central canal; Cu: cuneate 
nucleus; Gr: gracile nucleus; X: dorsal vagal nucleus; XII: hypoglossal 
nucleus. 
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Figure 1.15:  Morphology and sub-regions of the NTS. Rostrally, the 
NTS (marked in blue) appears as two columns situated alongside the fourth 
ventricle (IV). These two columns subsequently unite to establish a single 
component at the level inferior to obex (Ciriello, 1994). The intermediate 
NTS region lies in the same plane and adjacent to the area postrema (AP), 
whereas the rostral and caudal NTS regions respectively lie rostral and 
caudal to this plane (Figure adapted from Loewy, 1990b). 
 
1.8.2 Functions of the NTS: why it is important to study? 
Afferent information to the NTS comes from baroreceptors, chemoreceptors, cardiac 
receptors, gastrointestinal and pulmonary receptors plus also the gustatory sense 
(Kalia et al., 1984, Altschuler et al., 1989, Loewy, 1990b)(see Figure 1.16). The NTS is 
therefore a primary integration location for the autonomic nervous system (Loewy, 
1990b).  
To form reflex pathways efferent outputs from the NTS are subsequently sent via 
mono- or multi-synaptic pathways to vagal or SPNs, which control target structures. In 
contrast, the integrative function involves more complex alterations. Information from 
the NTS makes several connections with various systems in the brainstem and 
forebrain so that the autonomic, neuroendocrine and behavioural response is regulated 
within a range that still maintains homeostasis (Loewy, 1990b). 
Determining the constituent cell types in the NTS is therefore important for a full 
understanding of the circuits involved in central autonomic control. Two of the major 
neurotransmitters in the NTS are GABA (Walberg and Ottersen, 1992, Fong et al., 
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2005) and ACh (Tago et al., 1989, Ruggiero et al., 1990), but their co-localisation has 
not been reported. 
 
 
Figure 1.16:  The projection of afferent information from various 
visceral receptors to the NTS (Figure adapted from Loewy and Burton, 
1978, Loewy, 1990b).  
 
1.8.3 The subdivision of the NTS  
The NTS is very heterogeneous in neuronal types. For over half of a century, numbers 
of researchers have actively attempted to classify the NTS neurones into subdivisions. 
In general, most of these subnuclei are named after their location relative to the solitary 
tract (Ciriello, 1994). 
A simple system used to categorise the NTS neurones into two major groups based on 
cytoarchitectural aspects was described by Torvik, whose best observations were 
obtained upon application of the silver impregnation method. According to his study the 
NTS could be divided into two regions, the medial and the lateral; the boundary 
between the two regions being located somewhat medial to the solitary tract.  The 
medial group was defined by a uniform yellow appearance and contained heavily 
crowded neurones plus a few delicate intrinsic nerve fibres, similar to the substantia 
gelatinosa of the spinal dorsal horn. In contrast, the lateral group possessed large 
numbers of nerve fibres plus neurones which were more sparsely distributed (Torvik, 
1956). Kalia and Sullivan (Kalia and Sullivan, 1982) extended the number of defined 
NTS subdivisions to six, specifically the medial, intermediate, ventral, ventrolateral, 
interstitial and commissural subnuclei, based on results obtained utilising the Nissl-
stain technique on rat brainstem sections. Results from other research studies have 
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indicated even more NTS subdivisions including dorsolateral, dorsal (Kalia et al., 1984) 
and subnucleus gelatinosus (Kalia and Mesulam, 1980). The subnucleus gelatinosus is 
a subgroup situated in proximity to the area postrema, and is comprised of neurones 
which exhibit a gelatinous appearance due to the total absence of myelinated nerve 
fibres (Kalia and Mesulam, 1980). In addition, Ross et al. carried out a study on rats to 
observe the efferent projections from the NTS to the rostral regions of the ventrolateral 
medulla (Ross et al., 1985). From their study, the subnucleus centralis (or the central 
subnucleus) is named and described as a roughly circular grouping of cells located 
medial to the ventral part of the solitary tract within the middle third of the NTS column. 
The locations of the various NTS subnuclei are shown in Chapter 4. 
 
1.8.4 Afferent inputs of NTS subnuclei 
A single subnucleus of the NTS may obtain afferent inputs (see Table 1.1) from more 
than one specific organ (Baptista et al., 2005). 
In addition to receiving afferent inputs from various organs, the NTS neurones also 
receive inputs from the area postrema (Loewy, 1990b); which is classified as a 
circumventricular organ since the endothelial cells in the capillaries of the area 
postrema are fenestrated, enabling substances such as proteins to cross the blood 
brain barrier (van der Kooy and Koda, 1983, Wuchert et al., 2008). The area postrema 
is a significant component in circuits involved in autonomic regulation, for example, it 
receives afferent inputs from the hypothalamic paraventricular nucleus (PVN), lateral 
parabrachial nucleus (PBN), the NTS (Shapiro and Miselis, 1985) and vagus nerve 
(Contreras et al., 1982) and projects to the PBN, the dorsal motor nucleus of the vagus, 
the NTS (van der Kooy and Koda, 1983, Shapiro and Miselis, 1985) and the nucleus 
ambiguus (Shapiro and Miselis, 1985). Other CNS areas involved in autonomic 
integration similarly provide projections to the NTS, including the hypothalamus 
(Geerling et al., 2010) and the amygdala (Saha, 2005). 
The NTS is innervated by projections from spinal neurones (Menetrey and Basbaum, 
1987). Neurones in lamina I have been observed to project to the NTS through the 
application of tracing methods (Gamboa-Esteves et al., 2001a, Gamboa-Esteves et al., 
2001b, Gamboa-Esteves et al., 2001c). Moreover, by utilising Fluorogold injections into 
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Table 1.1:  A summary of afferent input to NTS subnuclei  
NTS subnucleus Afferent input 
Commissural  Cardiac afferent (Kalia et al., 1984) 
Central  Oesophagus (Altschuler et al., 1989, Baptista et al., 2005) 
Dorsolateral Baroreceptor and chemoreceptor       (Kalia et al., 1984) 
Dorsal Baroreceptor and chemoreceptor       (Kalia et al., 1984) 
Subnucleus gelatinosus 
(also term parvocellular NTS or subpostrema NTS (Loewy, 1990b)) 
Stomach (Altschuler et al., 1989) 
 
Intermediate  Palate, pharynx (Altschuler et al., 1989) 
Major respiratory nucleus (Kalia et al., 1984) 
Tracheal afferent (Kalia et al., 1984) 
Interstitial Palate, pharynx (Altschuler et al., 1989),  
Major respiratory nucleus (Kalia et al., 1984) 
Laryngeal afferent  (Kalia et al., 1984) 
Medial  Gastrointestinal afferents (Kalia et al., 1984) 
Ventral  Major respiratory nucleus (Kalia et al., 1984) 
Pulmonary afferent (Kalia et al., 1984) 
Ventrolateral Major respiratory nucleus (Kalia et al., 1984) 
Pulmonary afferent (Kalia et al., 1984) 
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the NTS of rats in combination with substance P receptor IHC, Guan et al. observed 
that some trigeminal and spinal substance P receptor expressing neurones sent 
projections to the NTS; those neurones that did so were primarily located in lamina I of 
the spinal cord. The observations made from such studies suggest that lamina I spinal 
neurones projecting to the NTS may therefore be involved in the regulation of somatic 
and also visceral nociceptive information, individually or in combination (Guan et al., 
1998). As previously mentioned (see Section 1.6.4.2), in rats, neurones in the 
superficial layers of the dorsal horn (Menetrey and de Pommery, 1991) as well as 
neurones situated close to the CAA of lamina X have been discerned to project to the 
NTS, via the spinosolitary tract . Besides laminae I and X, projections to the NTS also 
arise from neurones in other areas of the spinal cord, including lamina V, the lateral 
spinal nucleus of the dorsolateral funiculus, and the autonomic cell columns of both the 
thoracic and sacral regions (Menetrey and Basbaum, 1987)(see Figure 1.17). 
 
 
Figure 1.17:  Ascending projections from the spinal cord to the NTS 
based on literature. 
 
1.8.5 Efferent projections and central autonomic connections of the 
NTS 
Studies have been carried out utilising both tracing methods and/or IHC to investigate 
projections from the NTS to the spinal cord.  
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Through the application of an autoradiographic anterograde axonal transport technique 
(involving injections directly into the NTS) and a retrograde HRP technique (involving 
injections into several regions including the parabrachial region in the pons, the inferior 
olivary complex, ventrolateral portions of the reticular formation, the ambiguus complex 
and the spinal cord), neurones from various subnuclei of the NTS of cats were 
observed to project to the spinal cord. These NTS subnuclei include the intermediate, 
ventrolateral, commissural and medial subnuclei (Loewy and Burton, 1978). Injection of 
CTB into laminae I-III of the C4-C7 spinal cord segments of rats caused retrograde 
labelling that indicated that the commissural subnucleus of the NTS sends descending 
projections to the superficial laminae of the dorsal horn (Tavares and Lima, 1994). In 
cats, retrograde tracing using fluorescent tracers revealed that the targeting of thoracic 
levels by projections from respiratory related neurones in the ventrolateral subnucleus 
of the NTS was entirely contralateral, while for cervical levels the targeting was 
predominantly contralateral (Portillo et al., 1986).  
Following bilateral injection of WGA-HRP into the midcervical cord of rats (Mtui et al., 
1993), labelled NTS neurones were primarily observed at caudal NTS levels in an area 
ventral to the solitary tract (within ventral and ventrolateral subnuclei). Moreover, for 
levels which were caudal to the obex, labelled neurones were discerned in the 
intermediate division. Similarly, upon injection of WGA-HRP into the upper thoracic 
cord of rats, NTS neurones in an area located close to the ventral border of the solitary 
tract were retrogradely labelled, although seemingly only at the level of the area 
postrema. Subsequent unilateral iontophoretic injection of the anterograde tracer 
PHA-L into the caudal NTS, in combination with IHC, showed decussation of labelled 
NTS axons in lamina X, plus also projection of labelled NTS axons to the ventral horn, 
lamina VII and superficial lamina of the dorsal horn.  
Pre-proglucagon (PPG) neurones are to be found predominantly in the NTS and the 
reticular formation of the medulla. Research using transgenic mice (where YFP had 
been expressed under control of a glucagon promoter) along with IHC techniques, 
produced results which suggested that PPG neurones in the NTS and the reticular 
formation contribute abundant projections to SPNs and interneurones in the spinal 
cord. Since the densest PPG innervation was discerned to project to SPNs, it was 
subsequently indicated that such connections may be involved in the modulation of 
sympathetic function (Llewellyn-Smith et al., 2015).  
Based on the literature, neurones from various NTS subnuclei (including intermediate, 
ventrolateral, ventral, commissural and medial subnuclei) send supraspinal projections 
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to the spinal cord. Nearly all the areas within the spinal cord, including the dorsal horn, 
ventral horn, lamina VII and lamina X, receive projections from the NTS. In addition, 
SPNs and interneurones in the spinal cord are innervated by projections from the NTS. 
Apart from sending projections to the spinal cord (Loewy and Burton, 1978)(see Table 
1.2), the NTS also sends projections to various important nuclei in the brainstem and 
forebrain regions which are related to the regulation of autonomic and endocrine 
functions (Loewy and Burton, 1978, Ross et al., 1985, Loewy, 1990b) (see Figure 
1.18). 
 
 
Figure 1.18:  Diagram showing the efferent projections from NTS to 
the central autonomic network of the brain (Figure adapted from Loewy, 
1990b). 
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Table 1.2:  A summary of efferent projections from NTS subnuclei to 
the spinal cord and brainstem regions  
NTS Subnucleus Efferent projection  
Commissural Nucleus reticularis rostroventrolateralis (RVL) (Ross et al., 1985) 
Parabrachial nuclei & Kölliker-Fuse nuclei (Loewy and Burton, 1978) 
Cervical spinal cord (Loewy and Burton, 1978) 
Thoracic spinal cord (Loewy and Burton, 1978) 
Lumbar & sacral spinal cord (Loewy and Burton, 1978) 
Central Retrofacial nucleus and nucleus ambiguus (Ross et al., 1985) 
Dorsal  RVL (Ross et al., 1985) 
Intermediate RVL (Ross et al., 1985)  
Cervical spinal cord (Loewy and Burton, 1978) 
Thoracic spinal cord (Loewy and Burton, 1978) 
Lumbar & sacral spinal cord (Loewy and Burton, 1978) 
Interstitial RVL (Ross et al., 1985) 
Lateral Medial accessory olive (Loewy and Burton, 1978) 
Medial Parabrachial nuclei & Kölliker-Fuse nuclei (Loewy and Burton, 1978) 
Parvocellular Parabrachial nuclei & Kölliker-Fuse nuclei (Loewy and Burton, 1978) 
Ventral RVL (Ross et al., 1985) 
Ventrolateral RVL (Ross et al., 1985) 
Cervical spinal cord (Loewy and Burton, 1978) 
Thoracic spinal cord (Loewy and Burton, 1978) 
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1.9 Summary  
GABAergic and cholinergic interneurones play an important role in modulating afferent 
and efferent neurones within the spinal cord, particularly in lamina X, and within the 
NTS of the medulla oblongata. The co-localisation of these two neurotransmitters 
within a population of interneurones could represent an important subgroup of 
interneurones that may function to integrate different systems or provide antagonistic 
feedback within a single system. 
 
1.10 Aim   
The neurotransmitters GABA and ACh play important functional roles in various 
pathways of the spinal cord.  GABAergic and cholinergic interneurones have been 
reported to play a crucial role in sensory (Maxwell et al., 1990, Todd, 1991, Mesnage et 
al., 2011), motor (Miles et al., 2007, Al-Mosawie et al., 2007) and autonomic circuits 
(Bordey et al., 1996a, Deuchars et al., 2005). Some sources of cholinergic and 
GABAergic inputs which modulate these circuits are still unknown. Some neurones in 
various CNS regions including cerebral cortex, basal forebrain, retina (Kosaka et al., 
1988), laterodorsal, pedunculopontine tegmental nuclei (Jia et al., 2003), the NTS, area 
postrema, reticular formation and lateral paragigantocellular nucleus (Gotts et al., 
2015) are reported to co-express ChAT and GABA or GAD. In the spinal cord the 
dorsal horn (Kosaka et al., 1988, Todd, 1991, Mesnage et al., 2011) and lamina X 
cervical cord (Kosaka et al., 1988) are observed to contain neurones co-expressing 
ChAT and GABA (or GAD). It is suggested that lamina X and adjacent regions may 
contain many unidentified interneurones which may have a key involvement in several 
pathways (Barber et al., 1984, Strack et al., 1989a, Sherriff and Henderson, 1994, 
Bordey et al., 1996a, Deuchars, 2007).  Indeed, newly identified interneurones in 
lamina X and VII have been increasingly reported over the last decade (Deuchars et 
al., 2005, Miles et al., 2007, Al-Mosawie et al., 2007, Zagoraiou et al., 2009). Therefore 
lamina X is an attractive area for the observation of new neuronal subgroups. Since 
ACh and GABA play crucial roles in numerous circuits of the spinal cord, this study 
focuses on the presence of a neuronal group in lamina X and adjacent regions that 
potentially uses both ACh and GABA. 
The aim of this study is to determine the spatial distribution of ACh/GABA co-
localisation within neurones of lamina X and lamina VII, with a particular focus on the 
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thoracic spinal cord, because evidence suggests that these areas are heterogeneous 
in cell type. There is also evidence to suggest that SPNs and various neuronal groups 
in the spinal cord are modulated through cholinergic and GABAergic receptors. The 
source of these cholinergic and GABAergic inputs are not well established, and so 
could potentially arise from the projections of ACh/GABA co-localised neurones located 
within lamina X and VII. Other cord regions including the cervical and lumbar and 
various areas within the medulla oblongata focusing on the NTS will also be 
investigated for the co-localisation. Building upon initial observations from Kosaka 
(Kosaka et al., 1988) in relation to the cervical spinal cord, we wish to deduce the 
distribution of ChAT/GAD67-GFP co-localised neurones throughout the spinal cord and 
regions of the medulla oblongata. In order to investigate ChAT/GAD67-GFP co-
localised neurones, GAD67-GFP knock-in mice (Tamamaki et al., 2003) will be used in 
combination with IHC. A thorough knowledge regarding the distribution of these co-
localised neurones will aid the necessary physiological studies needed to elucidate 
their role. To this end determination of the inputs and outputs of these cells will be 
made utilising IHC and/or juxtacellular labelling under electrophysiological conditions.  
 
1.11 Hypothesis 
The ChAT/GAD67-GFP co-localised neurones form a subgroup within the spinal cord 
with a distinct spatial distribution that may correspond to the role they perform in the 
modulation of neurones within the spinal cord. A study performed by Chizh et al., 
(1998) demonstrated the ability of sympathetic outflow to synchronise with somatic 
motor output independent of supraspinal structures; as determined via the tested 
animals having been bisected at the upper thoracic level, which meant that responses 
were not influenced by supraspinal levels  (Chizh et al., 1998).  In discussing the 
theoretical explanations for their observations, Chizh et al. suggested that only a 
subgroup of each neuronal population were coupled, sharing inputs from the same 
central pattern generator or oscillator.  Given the apparent unidirectional nature of the 
coupling between somatic motor outflow and associated sympathetic activity (whereas 
sympathetic outflow seemingly does not correlate to associated somatic motor outflow), 
shared input from a common source seems unlikely and the cellular pathways 
underlying this relationship remain unresolved. There is a possibility that ChAT/GAD 
co-localised neurones have a role in autonomic-efferent modulation. The co-
localisation also extends rostrally, plus reaches the medulla oblongata region. 
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This study is an important first step in the identification and characterisation of a 
subgroup of interneurones within the spinal cord.  Co-localisation of ChAT and GABA 
(or GAD) in central canal cluster cells in cervical spinal cord sections of the rat has 
been demonstrated (Kosaka et al., 1988).  Here a population of ChAT/GAD67-GFP co-
expressing neurones located ventral to the central canal in cervical, thoracic and 
lumbar regions of the spinal cord was described.  A detailed description of the 
anatomical location of these neurones is necessary so that physiological studies to 
determine their role can be performed.  A thorough understanding of the physiological 
role and pharmacological properties of ChAT/GAD67-GFP co-expressing neurones 
may then establish their viable potential as a therapeutic target. 
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2 General Methods 
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The experiments in this thesis have utilised neuroanatomical techniques for 
investigating the organisation and morphology of ChAT-IR, GAD67-GFP-IR and 
ChAT/GAD67-GFP co-localised neurones within the spinal cord and medulla 
oblongata. The chemistry, possible projections and synaptic inputs of these neurones 
have also been explored. The investigative techniques utilised for the work involved 
retrograde tracing via Fluorogold injection, IHC and electrophysiology.  
This chapter defines the basic methodology, plus the technical considerations and all 
the preparative procedures applied for the experiments encompassed by this thesis. 
Supplemental details to these basic methods are provided in the relevant chapters.     
 
2.1 Animals  
The animal work detailed in this thesis has been carried out in line with the Animals 
(Scientific Procedures) Act 1986 and the ethical standards set out by the University of 
Leeds Ethical Review Committee by individuals with UK Home Office approval. 
The Animals were kept in a 12 hour light/dark cycle with free access to food and water.  
They were phenotyped at P1-4 days and weaned at P19-21 days.  No more than 5 
animals were housed per cage.  Animal stocks were maintained by harem breeding 
using wild type C57/BL6 mates with one male and two females.  
Due to difficulty in localising the labelled cell bodies of GABAergic neurones using GAD 
or GABA antibodies (Fong et al., 2005, Zhao et al., 2013) without colchicine injection 
(Barber et al., 1982, Kosaka et al., 1988), GAD67-GFP knock-in mice expressing green 
fluorescent protein (GFP) under control of the endogenous promoter for GAD67  
(Tamamaki et al., 2003) were used in this study. The details of GAD67-GFP knock-in 
mice and their suitability over other transgenic mouse lines are discussed in section 
2.1.1.  
Wild type mice (C57BL/6) were also used in this study. 
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2.1.1 Transgenic mice  
The details of relevant transgenic mice and the reason for choosing GAD67-GFP 
knock-in mice over other mice lines are discussed below. 
In GIN (GFP-expressing inhibitory neurones) mice (Oliva et al., 2000), the selective 
expression of GAD67-EGFP in a subpopulation of GAD67-IR neurones has been 
demonstrated. The authors took advantage of this to investigate the distribution of a 
somatostatin-expressing subpopulation of GABAergic interneurones in the 
hippocampus. However, the absence of expression in other brain areas, particularly the 
cerebellum, striatum and hypothalamus, effectively limits the use of this line for other 
studies. 
An alternative strategy which has been used is to couple GFP expression with GAD65 
expression, to produce GAD65-GFP mice. However, for this transgenic mouse line, 
while it is expected that GABAergic neurones in many regions of brain (such as the 
hippocampus and neocortex) will express GFP (Lopez-Bendito et al., 2004), it appears 
that during development only low numbers of GAD65-GFP cells are positive for GABA; 
around 50% of GAD65-GFP cells in this mouse line indicate the presence of GABA 
during the embryonic period, increasing to approximately 70% at 21 days postnatal. 
Therefore, this mouse line appears to have limitations in regards to its viability for 
studies into GABAergic neurones during development.  
In recent years, transgenic mice in which a green fluorescent protein (GFP) expressed 
under control of a GAD67 promoter (GAD67-GFP knock-in mice) (Tamamaki et al., 
2003) have become widely used to study the structures and functions associated with 
the GABAergic system in the CNS  (Edwards et al., 2014, Gotts et al., 2015). 
According to Tamamaki et al., within various regions of the CNS the distribution of GFP 
positive cell bodies (detected from IHC) in this transgenic mouse line is comparable to 
that of the GAD67 signals (obtained from ISH). Furthermore, non-GAD67 cells 
demonstrate no ectopic expression of GFP, while cells which are positive for GAD67 
always exhibit GFP expression (Tamamaki et al., 2003).  
 
66  
 
2.1.2 Validation of GAD67-GFP knock in mice in the spinal cord 
2.1.2.1 Preparation of animals 
Three GAD67-GFP knock-in mice (males) were perfused with 100 ml of 2% 
glutaraldehyde in 4% paraformaldehyde (PFA) in 0.1% phosphate buffer (PB), and 
then postfixed with 4% PFA overnight. Cervical, thoracic and lumbar cords of the mice 
were sectioned transversely at 20 µm with a vibrating microtome (Leica VT1000S, UK) 
and cryostat. Since preliminary data suggested that the staining apparent in the 
cryostat sections was not as good as that observed for tissue sectioned using the 
microtome, cryosectioning was subsequently avoided in this study. To detect GAD67 
the use of Triton X-100 and ethanol as permeablising agents was not included in the 
protocols since our preliminary data demonstrated that these reduced the number of 
GAD67-IR cell bodies labelled. The IHC protocol used was as follows: 
 
2.1.2.2 Double labelling IHC for GAD67 and GFP 
The sections were incubated in 1% bovine serum albumin (BSA) blocking serum 
(Molecular Probes) (10 mg of BSA/10ml of phosphate buffer saline (PBS; 0.876% 
NaCl, 0.02% KCl in 0.1 M PB, pH 7.2) for thirty minutes and then washed with PBS. 
Next, the sections were simultaneously incubated with the GFP and GAD67 primary 
antibodies diluted in 1% BSA in PBS for 4 nights, following which they were rinsed with 
PBS before being incubated in biotinylated horse anti-mouse (see Table 2.1) overnight. 
After being rinsed with PBS the sections were incubated in Alexa Fluor ® 488 and 
Streptavidin Alexa Fluor ® 555 (see Table 2.1) for 1-2 hours. Subsequent to a final 
rinse with PBS the sections were mounted. 
Since only the cells on the surface of the tissue section were labelled, a single plane of 
image was taken under a confocal microscope. Images were acquired of three sections 
each at the cervical, thoracic and lumbar cord levels for all test animals (n = 3 animals) 
and the degree of co-localisation between GAD67 and GFP within the cell bodies 
noted. 
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Table 2.1:  Combinations of antibodies used for double labelling for 
GAD67 and GFP IHC. 
Target 
Marker 
Primary Secondary Tertiary 
Antibody Conc Source Antibody Conc Source Antibody Conc Source 
GAD67 Mouse 
anti- 
GAD67 
1:500 Chemicon 
International 
Biotinylated 
hourse anti- 
mouse 
1 : 
500 
Vector 
Laboratories 
Streptavidin 
Alexa Fluor  
® 555 
1 : 
1000 
Invitrogen 
GFP Rabbit 
anti-GFP 
1: 
1000 
Invitrogen Alexa Fluor 
® 488 
donkey 
anti-rabbit 
1: 
1000 
Invitrogen    
 
Co-localisation of GFP and GAD67 can be observed (Figure 2.1) in cells throughout 
the spinal grey matter particularly in the areas known to contain GABAergic neurones, 
particularly the dorsal horn (Figure 2.1 B), lamina VII (Figure 2.1 C) and lamina X 
(Figure 2.1 D). Since lamina X is the main focus of our study, validation of GAD67-GFP 
knock-in mice with respect to their use in lamina X spinal cord research has additionally 
been carried out in this study since it has not previously been reported in literature. 
Results indicate that in lamina X, 100% of GAD-IR cells of the cervical, thoracic and 
lumbar cords contain GFP, while 76.19%, 84.57% and 85.79% of the GFP positive 
cells of the cervical, thoracic and lumbar cords respectively are GAD67-IR. This 
suggests that GFP positive cells in the spinal cord are GAD67-IR cells; with the fact 
that not all GFP positive cells are observed as GAD67-IR being likely due to the 
difficulty of using IHC for GAD67 in order to obtain exact numbers of labelled GAD67-
IR cell bodies (Fong et al., 2005). 
Our preliminary data suggested that using Triton X-100 and cryosectioning decreased 
the efficiency of GAD67-IR soma labelling; a finding consistent with other studies (Fong 
et al., 2005, Zhao et al., 2013). However, since Triton X-100 was not used in our study, 
the extent of antibody penetration was therefore limited to the surface of the tissue 
sections, and so only cells on the surface were labelled. It is well known that 
GABAergic neurones are difficult to detect. Other improved immunohistochemical 
approach has been introduced to mitigate the difficulty of GAD/GABA immunostaining. 
These include the use of fixative agents which contain high concentrations of 
glutaraldehyde (0.5-2.5%), which preserves GAD/GABA immunoreactivity by switfly 
binding GAD/GABA to the cell (Zhao et al., 2013), plus colchicine injections, which can 
enhance cell body labelling of GABAergic neurones as it blocks axonal transport of  
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Figure 2.1:  The co-localisation of GAD67 and GFP in cells within the 
grey matter of lumbar spinal cord. Confocal images show the co-
localisation of GAD67 and GFP immunoreactivity within the cells of the 
dorsal horn (Bi to Biii), lamina VII (Ci to Ciii) and lamina X (Di to Diii). Few 
co-localised cells are present in the ventral horn and none were observed 
in this section (Ai to Aiii). Cells which exhibit co-localisation are indicated by 
arrows. 
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GAD/GABA. Despite these improved methods, insufficient numbers of labelled cell 
bodies were still observed (Zhao et al., 2013). 
Given the above observations, the GAD67-GFP knock-in mouse line was accepted to 
constitute a suitable animal group for the research described in this text, where the 
intention was to observe the labelled cell bodies of GAD67-IR neurones in the lamina X 
of the spinal cord. 
 
2.2 Tracing techniques 
To observe the connections between neurones and other structures (both within the 
CNS and outside of the CNS) procedures involving the introduction of chemicals or 
agents into the brain areas have been developed, which are now termed tracing 
techniques. Depending on the direction that these chemicals are transported, the 
tracing techniques can be categorised into two types; retrograde tracing and 
anterograde tracing (Purves, 2008).  
Retrograde tracing is utilised to investigate connections from their terminations to their 
neuronal points of origin, and is achieved via the tracing agents first being absorbed by 
axons and terminals in proximity to the injection site and then transported toward the 
cell body. Conversely, anterograde tracing is used to trace connections from their 
neuronal points of origin to their terminations, and is achieved through the tracing 
agents first being absorbed by the cell bodies of neurones and then transported to the 
axon terminals of those neurones (Purves, 2008).  
 
2.3 Retrograde labelling of motoneurones and 
preganglionic neurones 
Work undertaken by Ambalavanar and Morris previously found that when injecting 
animals subcutaneously (into the right vibrissal pad and the middle of the back) or 
intravascularly (into the right carotid artery and right femoral vein), Fluorogold was 
absorbed into the nerve terminals located in the periphery and then transported 
retrogradely to their cell bodies. Their results indicated that this technique facilitated 
retrograde labelling of motoneurones, autonomic nervous system preganglionic 
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neurones, plus also pituitary projecting neurones of the hypothalamus (Ambalavanar 
and Morris, 1989). Fluorogold can also be taken up into axons indirectly from IP 
injection via endocytosis at nerve terminals (Catapano et al., 2008) and may also be 
visualised without using IHC. Fluorogold has been widely used to distinguish 
motoneurones and autonomic motoneurones from interneurones in the CNS (Anderson 
and Edwards, 1994, Deuchars et al., 2001, Brooke et al., 2002, Al-Mosawie et al., 
2007, Llewellyn-Smith et al., 2015). 
In this study, Fluorogold injections were selected to be used, via the retrograde tracing 
method, to distinguish motoneurones and SPNs from interneurones.  The major 
disadvantage to the use of Fluorogold is that it is non specific to a particular group of 
neurones; readily diffusing from the injection site, Fluorogold will be endocytosed by 
any neurones whose terminals it makes contact with (Catapano et al., 2008). However, 
this is not a limitation in this study as the IP injection results only in labelling of CNS 
neurones with axons that project to the periphery and not neurones intrinsic to the 
CNS. 
 
2.4 Immunohistochemistry (IHC) 
Although often used interchangeably, the terms immunohistochemistry (IHC) and 
immunocytochemistry (ICC) refer to the application of similar techniques to different 
preparations. Both techniques make use of the explicit attraction that exists between an 
antigen and a relevant antibody (Polak and Van Noorden, 2003). In the case of ICC, 
antibodies are used to detect antigens on isolated cells devoid of the extracellular 
matrices and architecture found in vivo, such as in cultured cell monolayers.  
Immunohistochemistry refers to the same process but applied to sections of tissue and 
the cells within (Matos et al., 2010). 
From the early 1940s until mid-1950s, Coons and his collaborators played a critical role 
in developing knowledge concerning the use of IHC. Most notably, they pioneered the 
procedure of labelling antibodies with fluorescent dyes and subsequently using these 
labelled antibodies to locate the presence of antigens within selected tissue sections;  
the results from such applications being visualised via fluorescent microscopy (Coons 
et al., 1941, Coons and Kaplan, 1950, Coons et al., 1955). 
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The development of enzyme-linked antibodies opened up the technique to those 
laboratories lacking fluorescent microscopes and so helped to popularise the use of 
IHC (Nakane and Pierce, 1966, Matos et al., 2010).  The use of diaminobenzidine to 
produce an electron dense precipitate for use in electron microscopy (Singer, 1959, 
Matos et al., 2010), peroxidase anti-peroxidase (PAP) (Sternberger et al., 1970) and 
alkaline phosphatase-antialkaline phosphatase (APAAP) (Mason and Sammons, 1978) 
further broadened the application of IHC (Matos et al., 2010).  Additional advances led 
to antigen retrieval methods (Huang et al., 1976), and systems for labelling cells in 
fresh samples such as avidin-biotin-complex (ABC) (Hsu and Raine, 1981, Matos et al., 
2010). 
 
2.5 Preparation of animals 
2.5.1 Retrograde tracing utilising Fluorogold injection  
Three adult GAD67-GFP knock-in mice (4-6 weeks in age, approximately 30 grams in 
weight, both sexes), plus three GAD67-GFP knock-in young mice (7-14 days in age, 
both sexes) used for quantitative analysis, were intraperitoneally injected with 
Fluorogold (0.1 ml of 1% Fluorogold per adult animal and 0.05 ml of 1% Fluorogold for 
the young mice).  
 
2.5.2 Perfusion and fixation 
One to three days after the Fluorogold injection, the mice were anaesthetised with an 
IP injection of 60 mg/kg sodium pentobarbitone. The depth of anaesthesia was 
assessed by the pinch reflex. When the pinch reflex was absent the ribcage was 
opened to expose the heart. The right atrium was cut and 100 ml of 4% PFA in 0.1M 
PB for the adult mice, or 50 ml of 4% PFA in 0.1M PB for the young mice, then 
perfused through the left ventricle. After the perfusion, the skulls and vertebral columns 
were dissected and the brainstem and spinal cords removed and then postfixed with 
4% PFA for up to 24 hours. The tissues were subsequently kept in PB.  
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2.5.3 Tissue sectioning 
The meninges were carefully removed using fine forceps and spinal cords and 
brainstems sectioned transversely or sagittally at  30 µm to 50 µm with a vibrating 
microtome (Leica VT1000S, UK), and free floating sections collected in 0.1 M PB.  
 
2.5.4 Gelatin embedding for IHC on longitudinal sections  
In instances where the tissue was fragile and needed support, or sagittal sections were 
required, gelatin embedding was required. 10% gelatin in 50 ml of deionised water was 
placed on a hot plate stirrer until the gelatin melted. The gelatin solution was then left to 
cool until it was warm but not yet set. The spinal cord was then embedded by the 
gelatin using a 35 mm tissue culture dish. The culture dish sat upon a copper plate 
previously cooled in a -20 C freezer.  Once the gelatine had begun to show signs of 
setting the dish was transferred to a freezer to expedite the process, but using caution 
to avoid any freezing of the tissue. Once set, the block of gelatine surrounding the cord 
was excised and then postfixed with 0.2% - 1% glutaraldehyde in 4% PFA for up to 24 
hours before sectioning was undertaken via a vibrating microtome. 
 
2.6 Antigen retrieval  
Cross-linking of proteins can occur when using fixative agents.  This may prevent 
antibodies from binding to the antigenic sites. In formaldehyde fixed tissue, the use of 
high temperature, pH and suitable solutions (Shi et al., 1997) can be used as an aid to 
the antigen retrieval process. While experimenting to determine the optimal conditions 
for immunostaining we explored the use of antigen retrieval using 10 mM sodium 
citrate. Tissue was incubated with sodium citrate in 80 °C water for thirty minutes prior 
to primary antibody incubation. However it was found that the procedure compromised 
the GFP immunoreactivity. As a result is was decided to not use this protocol for the 
subsequent investigations.  
An alternative fixative which produces a stronger reaction with better tissue 
preservation than formaldehyde is glutaraldehyde. However it also possesses many of 
the disadvantages that are seen with formaldehyde but more accentuated due to its 
increased reactivity.  This includes loss of antigenicity due to cross-linking; which can 
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be overcome by diluting it in another fixative, such as formaldehyde. In this situation 
the more rapid action of formaldehyde initiates the fixation process, stabilising the 
molecules, and thus gives time for the relatively slowly diffusing glutaraldehyde to 
strengthen the reaction (Stradleigh and Ishida, 2015). 
 
2.7 Fluorescence IHC 
The first time each antibody was used (see Table 2.2), the optimal concentration for its 
use was determined by performing serial dilutions of the antibody in PBS containing 
0.1% - 0.3% Triton X-100 (Sigma) (to increase cell permeability) and 5% donkey serum 
(blocking for non-specific immunoreactivity) at 4 °C for a minimum of 18 hours. The 
sections were washed with PBS for 3 x 10 minutes before application of a suitable 
Alexa Fluor secondary antibody (1:1000, 1-3 hours, room temperature). This was 
followed by further 3 x 10 minutes PBS washes.  
For double labelling fluorescent IHC, tissue sections were incubated as previously 
described but with both primary antibodies simultaneously.  After repeated washing of 
the tissue in PBS solution the sections were then incubated in Alexa Fluor secondary 
antibodies diluted in PBS (see Table 2.3) for 1-3 hours before being washed with PBS 
for 3 x 10 minutes. 
For triple labelling, tissue sections were simultaneously incubated with all three primary 
antibodies following the method described for single labelling.  After repeated washes 
in PBS solution the sections were incubated in biotinylated antibody (see Table 2.3) for 
either 4 hours (dilution; 1:200) or overnight (dilution; 1:500) prior to being washed with 
PBS again for 3 x 10 minutes. Subsequently, the sections were incubated with 
streptavidin-conjugated fluorophore and secondary antibodies (see Table 2.3) for one 
to three hours before being washed with PBS for 3 x 10 minutes.  
Once the washes post secondary antibody incubation were complete the tissue 
sections were mounted as described in Section 2.9.  
Due to the difficulty of GAD detection in cell bodies, the use of GAD67 antibody 
required special consideration to facilitate effective immunostaining, as discussed 
below. 
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Table 2.2:  Determination of optimal primary antibody concentration 
and characterisation of primary antibodies used. 
Antibody Immunogen Manufacturer and 
details 
Concentration Ref/control 
Goat anti-ChAT Human placental 
enzyme 
Millipore Cat# 
AB144P-1ML, 
RRID:AB_262156, 
polyclonal antibody 
1:500 (Chapman et al., 2013) 
 
Rabbit anti-GFP GFP isolated directly 
from Aequorea 
Victoria 
Invitrogen Cat# 
A11122, 
RRID:AB_221569, 
polyclonal antibody 
1:1000 (Chapman et al., 2013) 
 
Mouse anti GFP GFP isolated directly 
from Aequorea 
Victoria 
Invitrogen Cat# 
A11120, 
RRID:AB_221568, 
monoclonal antibody 
 
1:1000 The labelling was only 
observed in cells that 
expressed GFP 
Mouse anti-GAD67 Recombinant GAD67 
protein 
Chemicon 
International Cat# 
MAB5406, 
RRID:AB_2278725, 
monoclonal antibody 
1:500 (Chapman et al., 2013) 
 
Rabbit anti-GABA GABA-BSA Sigma Cat# A2052, 
RRID:AB_477652, 
polyclonal antibody 
1:500 Staining reveals 
identical patterns to 
those previously 
documented (Kosaka et 
al., 1988, Todd 1991) 
Mouse anti-NOS1 
(nNOS) 
Amino acids 2-300 of 
NOS1 of human 
origin 
Santa Cruz 
Biotechnology, Inc 
Cat# sc-5302, 
RRID:AB_626757, 
monoclonal antibody 
1:250 Staining reveals 
identical patterns to 
those previously 
documented (Wiedner et 
al., 1995) 
Guinea pig anti-
VGLUT1 
Synthetic peptide 
from rat VGLUT1 
protein 
Millipore Cat# 
AB5905, 
RRID:AB_2301751, 
polyclonal antibody 
1:30,000 Staining reveals 
identical patterns to 
those previously 
documented (Todd et 
al., 2003) 
Guinea pig anti-
VGLUT 2 
Synthetic peptide 
from rat VGLUT2 
protein 
Millipore Cat# 
AB2251, 
RRID:AB_1587626, 
polyclonal antibody 
1:10,000 Staining reveals 
identical patterns to 
those previously 
documented (Todd et 
al., 2003) 
Guinea pig anti-
GlyT2 
Synthetic peptide 
from the carboxy 
terminus as 
predicted from 
cloned rat GlyT2 
Millipore Cat# 
AB1773, 
RRID:AB_90953), 
raised in guinea pig, 
polyclonal antibody 
1:15,000 Staining reveals 
identical patterns to 
those previously 
documented (Jursky and 
Nelson, 1995) 
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Table 2.3:  Determination of optimal secondary antibody and 
conjugate concentrations. 
Antibody Manufacturer and details Concentration 
Alexa Fluor ® 555 
donkey anti-goat 
Invitrogen 1: 1000 
Alexa Fluor ® 488 
donkey anti-rabbit 
Invitrogen 1: 1000 
Alexa Fluor ® 488 
donkey anti-mouse 
Invitrogen 1: 1000 
Alexa Fluor ® 555 
donkey anti-rabbit 
Invitrogen 1: 1000 
Streptavidin Alexa 
Fluor ® 555 
Life Technologies 1: 1000 
Streptavidin pacific 
blue 
Invitrogen 1: 1000 
Biotinylated donkey 
anti- goat 
Jackson Immuno-Research Laboratories 1:200 for 4 hrs 
or  
1:500 overnight 
Biotinylated donkey 
anti- rabbit 
Jackson Immuno-Research Laboratories 1:200 for 4 hrs 
or  
1:500 overnight 
Biotinylated horse 
anti- mouse 
Vector Laboratories 1:200 for 4 hrs 
or  
1:500 overnight 
Biotinylated donkey 
anti- guinea pig 
Jackson Immuno-Research Laboratories 1:200 for 4 hrs 
or  
1:500 overnight 
ExtrAvidin® 
Peroxidase (EAP) 
Sigma 1 : 1500 for IHC 
 
1 : 250 for cell recovery 
DAB solution Sigma 5 mg in 10 ml in Tris buffer with 0.01% 
H2O2 
DAB SK-4100 Vector Laboratories 5 ml of distilled water containing buffer 
solution    (2 drops), DAB  (4 drops) and 
H2O2 (2 drops) 
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The spinal cord was sectioned using a vibrating microtome as it resulted in better 
staining for labelled GAD67-IR cell bodies than those sectioned using cryosectioning, 
per our preliminary data. Initially spinal cord sections were washed for 3 x 10 minutes 
in PBS before a 30 minute incubation with 50% ethanol to permeabilise the tissue 
(Fong et al., 2005) . However, our results suggested that this method provided lower 
numbers of labelled GAD67-IR cell bodies in comparison to sections which had been 
prepared without incorporating ethanol incubation. Consequently the use of ethanol 
incubation was subsequently avoided. Sections were incubated in primary antibody 
using the protocol described in section 2.1.2.2  The use of Triton X-100 was avoided at 
all stages since it reduced the cell body labelling (Fong et al., 2005). 
 
2.8 Peroxidase IHC 
Peroxidase cytochemistry was first introduced by Graham and Karnovsky (Graham and 
Karnovsky, 1966). For the purposes of the studies in this thesis the following procedure 
was followed: 
To provide a permanent reaction product, tissue sections were incubated with 1% H2O2 
for thirty minutes to quench endogenous peroxidase. The sections were washed three 
times with PBS before being incubated in primary antibody for a minimum of 18 hours 
at 4 °C (in PBS containing 0.1% - 0.3% Triton X-100). The sections were washed three 
times with PBS before being incubated in biotinylated antibody overnight at 4 °C. The 
sections were then washed three times with PBS before being incubated in ExtrAvidin® 
Peroxidase (EAP; 1:1500 in PBS, Sigma) overnight at 4 °C. Next, one of two options 
for continued tissue preparation was selected. The first option was to wash the sections 
three times with PBS prior to incubation in diaminobenzidine (DAB) solution (Sigma) (5 
mg in 10 ml in Tris buffer with 0.01% H2O2) for ten minutes in a dark cold room at 4 °C. 
The reaction was subsequently precipitated through the continued addition of 1% H2O2 
until brown colour labelling was observed. To halt the reaction the sections were then 
washed with Tris twice (10 minutes each). In the second option, the sections were 
washed three times with PBS before being incubated at room temperature in DAB 
solution using peroxidase substrate kit (DAB SK-4100, Vector Laboratories; 5 ml of 
distilled water containing buffer solution (2 drops), DAB (4 drops) and H2O2 (2 
drops))(see Table 2.3) until brown colour labelling occurred. The final concentration of 
H2O2 in the reaction mixture was 0.01%. To stop the reaction, the sections were 
washed with deionised water and then kept in PBS. Details on peroxidise IHC in 
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relation to cell recovery for juxtacellular labelling will not be mentioned here but will be 
detailed in Chapter 3.  
 
2.9 Preparation of sections for viewing under the 
fluorescence, confocal and light microscope 
For viewing under a fluorescence and/or confocal microscope, the sections were air 
dried on glass slides (Academy Science Limited) and mounted under a coverslip 
(Scientific Laboratory Supplies) using Vectashield mounting medium (Vector 
laboratories, UK). The edges of the coverslips were sealed by applying nail varnish to 
prevent evaporation of the mounting medium.  
For viewing sections that had been processed using peroxidase IHC under a light 
microscope, the sections were air dried on gelatinised glass slides overnight. The 
tissue sections were then dehydrated through an ethanol concentration series of 50%, 
70%, 95%, 100% and 100% for two to five minutes at each stage. Finally, the sections 
were cleared through xylene and mounted in DPX under a coverslip (BDH Laboratory 
Supplies, UK).  
 
2.10 Image capture 
A Nikon Eclipse E600 microscope equipped with epifluorescence and a Q-Imaging 
Micropublishing 5.0 camera was used, with the images being visualised and captured 
using Acquis image capture software (Acquis Images Capture system, Synoptics, UK).  
Some tissue sections from fluorescence IHC were selected to be alternatively 
visualised and captured using a confocal microscope (Zeiss LSM 510 Meta Confocal 
Microscope) in conjunction with Zen software.  
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2.11 Image manipulation and figure making 
A combination of confocal and epifluorescent microscopy was used to study the data, 
selection being dependent upon the desired objectives. For gross counting and initial 
observations epifluorescent microscopy was sufficient and readily available. Some 
situations required higher resolution images however, such as when a precise 
determination of co-localisation was necessary, or there was close apposition, or 
methodological considerations led to sub-optimal staining. In these instances, confocal 
microscopy was used.  
Fluorescent images in Figures 3.4, 3.11, 3.12, 4.3, 4.6, 4.8 and 4.9 B were obtained 
using epifluorescent microscopy. All other fluorescent images were obtained via 
confocal microscopy. The captured images were only adjusted minimally for brightness 
and contrast and then labelled using CorelDraw x5 and x6 software. 
 
2.12 Quantification of co-localisation 
2.12.1 Spinal cord study 
ChAT-IR and/or GAD67-GFP-IR neurones in lamina X, VII, ventral horn, dorsal horn 
and lateral horn of the adult (n =3) and young mice (n = 3) were manually quantified 
from both sides of the cord across 50 µm thick sections under an epiflorescence 
microscope. Each area was identified by its location based on literature reports (Rexed, 
1952, Rexed, 1954, Watson and Kayalioglu, 2009, Sengul and Watson, 2012, Sengul 
et al., 2012, Allen Brain Atlas: Mouse Spinal Cord), as depicted in Figure 1.1 and 1.2.  
To avoid double counting cells in adult animals, every sixth consecutive section (50 µm 
thick) was counted for each region of the spinal cord, with a total of ten sections per 
region.  Across 3 animals this gave a total of 30 sections each for the cervical, thoracic 
and lumbar regions.  Due to the decreased volume of tissue in young animals, every 
third consecutive section (50 µm thick) was counted with a total of 5 sections per 
region.  This gave a total of 15 sections for each region across 3 animals.  Cells were 
counted by eye using epifluoresence microscopy, so allowing for adjustment of the 
plane of focus in order to ensure all positively labelled cells in the section (both sides) 
were accounted for.  Data was collated in a Microsoft Excel spreadsheet for statistical 
analysis.  Pooled data for each section area of a region was used to determine the 
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mean number of positive cells per section in each respective region across all 3 
animals.  This was repeated for all areas to give the mean values (± SEM, standard 
error of the mean) of positively labelled neurones in relation to each marker (ChAT and 
GAD67-GFP) within laminae X and VII, plus the ventral horn, dorsal horn and lateral 
horn for the cervical, thoracic and lumbar regions.  Where co-localised neurones were 
observed, the proportion of co-localisation was expressed as a percentage of the 
ChAT-IR and GAD67-GFP-IR population separately. N is used to represent the number 
of neurones counted and n is used to indicate the number of animals used. The 
number of sections counted is depicted as nsc. Comparison of the relative abundance 
of each neurochemically-defined population in lamina X between juvenile and adult 
mice was conducted using Student’s t-test via SPSS. 
Neuronal morphology, determined by soma shape and soma size, was measured using 
the pictures taken from sections with double labelling IHC. The width (X-axis diameter) 
and length (Y-axis diameter) of somata from a two dimensional perspective were 
measured using CorelDraw x6 software.  The cross sectional area of neuronal soma 
were then estimated based on the cells being oval (using the average value of the X-
and Y-axia diameters).  
 
2.12.2 NTS and medulla oblongata study 
ChAT-IR and/or GAD67-GFP-IR neurones in the NTS of adult mice (n = 3) were 
manually quantified from both sides of the NTS column across 50 µm thick sections 
under an epiflorescence microscope. Each subnucleus was identified by its location 
based on literature reports (Ciriello, 1994, Poole et al., 2007, Okada et al., 2008, 
Ganchrow et al., 2014) (see Figure 4.1). 
From each animal, every sixth consecutive section was studied to avoid the risk of 
double counting the same neurones in adjacent sections. Six sections were counted in 
total (from each animal); two each representative of the caudal, intermediate and 
rostral regions of the NTS, and if a section to be investigated was damaged, it was 
substituted in the analysis by an adjacent section. Due to the limited distribution of the 
central subnucleus in the NTS, ChAT-IR, GAD67-GFP-IR and nNOS-IR neurones in 
this area were counted in four sections, from every third consecutive serial section (30 
µm thick) from one animal. Data was collated in a Microsoft Excel spreadsheet for 
statistical analysis. Pooled data for each subnucleus of the NTS was used to determine 
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the mean number of positive cells per section across all 3 animals.  This was repeated 
for all subnuclei to give the mean values (± SEM) of positively labelled neurones in 
relation to each marker (ChAT and GAD67-GFP) within each subnucleus of the NTS. 
Comparison of the relative abundance of each neurochemically-defined population 
between NTS and area postrema was conducted using Student’s t-test via SPSS. 
In an attempt to quantify the intensity of ChAT staining within the NTS neurones ChAT 
immunoreactivity in the NTS was compared against that observed in the dorsal vagal 
nucleus for the same section of a wild type mouse using DAB staining. The detail of 
DAB IHC protocol was described in section 2.8 using DAB solution (Sigma). The value 
obtained from ImageJ software relates only to lightness not darkness. In order to 
measure darkness, it would have been necessary to convert the captured image to a 
negative of itself, so that light features became dark and dark features became light. As 
such it was decided not to convert the images, but instead to measure the lightness of 
neurones in the original image. Consequently, when comparing the intensity of staining 
between NTS and dorsal vagal neurones the relative lightness level was reported, 
based on measurements taken from isolated neurones. By being specific to the 
staining of selected cells, the approach taken therefore eliminated several possible 
sources of measurement error, including those that may arise from differences in 
background staining, and also from multiple cells or processes passing through the 
measured region. 
The numbers of neurones containing ChAT and/or GAD67-GFP in other areas of the 
medulla oblongata, including the area postrema, reticular formation, dorsal vagal 
nucleus, hypoglossal nucleus and nucleus ambiguus were manually quantified using 
the same approach as for the NTS. Specifically, from 3 mice using 50 µm thick sections 
and an epiflorescent microscpe, with every sixth consecultive section being examined; 
the total number of sections examined per animal being dependent on the size of the 
area, for instance 2 sections per animal for the area postrema and 6 sections per 
animal for the reticular formation. Each area was identified by its location based on 
reports in the literature (VanderHorst and Ulfhake, 2006, Allen Brain Atlas: Mouse 
Brain) (see section 4.3). 
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3 Neurones expressing ChAT and GAD67-GFP 
in mouse spinal cord focusing on           
lamina X and VII 
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3.1 Introduction 
A full understanding of the functions of the CNS requires a detailed understanding of 
neuronal circuitry. One way in which specific neuronal subgroups can be studied in 
relation to their location and potential function is to utilise neurochemical identification 
of particular subgroups.  In this chapter, we focus on the existence of a subgroup of 
neurones in the spinal cord which potentially utilise both ACh and GABA, located in 
lamina X.  
The neurotransmitters GABA and ACh play important functional roles in the spinal 
cord.  GABAergic inhibitory interneurons are critical components of local circuits and 
play significant roles in the dorsal horn and ventral horn (Todd and Maxwell, 2000).  
Neurons containing immunoreactivity for GABA or the synthesizing enzyme GAD are 
found in the dorsal horn of the rat and mouse (Kaduri et al., 1987, Todd and McKenzie, 
1989, Polgar et al., 2013) with scattered soma in other layers, particularly lamina X 
surrounding the spinal cord and cerebrospinal fluid contacting neurones in the 
ependymal layer surrounding the central canal (Kaduri et al., 1987). 
The possibility that neurones can co-release both ACh and GABA originated from 
anatomical studies showing ChAT-IR neurones that also contain GAD (or GABA) in the 
rat retina, cerebral cortex and basal forebrain (Kosaka et al., 1988), the cat laterodorsal 
and pedunculopontine tegmental nuclei (Jia et al., 2003), ChAT immunoreactivity has 
also been observed in GAD67-GFP-IR neurones in the mouse brainstem in the NTS, 
area postrema, reticular formation and lateral paragigantocellular nucleus (Gotts et al., 
2015).  In situ hybridisation studies have shown mRNA for both GAD and ChAT is 
present in cell bodies of the globus pallidus and nucleus basalis of the mouse basal 
forebrain (Granger et al., 2016).  
Functional studies have since determined that ACh and GABA are co-released from 
starburst amacrine cells in the rabbit retina (Lee et al., 2010), from a population of 
globus pallidus cells projecting to the mouse cerebral cortex (Saunders et al., 2015a) 
and from neurons in the mouse forebrain (Saunders et al., 2015b). For a review see 
Granger et al. 2016. 
In the rat spinal cord, a population of ChAT-IR or ChAT-GFP containing cells that also 
contain GABA or GAD have been observed in lamina III of the dorsal horn (Kosaka et 
al., 1988, Todd, 1991, Mesnage et al., 2011) where they display morphological and 
electrophysiological characteristics consistent with interneurones (Mesnage et al., 
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2011).  In addition, ChAT and GABA (or GAD) immunoreactivity are co-localised in a 
population of cells surrounding the rat central canal, studied only at the cervical level 
(Kosaka et al., 1988).  
Sources of cholinergic and GABAergic mediated effects on various pathways in the 
spinal cord are yet to be fully defined. The origin of thes cholinergic and GABAergic 
inputs may arise from lamina X neurones since evidence suggests that lamina X 
contains a heterogeneous population of neurones and may contain many unidentified 
interneurones which provide the source of cholinergic and GABAergic modulation of 
several pathways (see section 1.6.4). Therefore this study focuses on the presence of 
a neuronal group in lamina X and adjacent regions that potentially uses both ACh and 
GABA. 
 
3.2 Aim 
The aim of this study is to investigate the existence of co-localisation between ACh and 
GABA within the cervical, thoracic and lumbar spinal cord regions. Adult and young 
GAD67-GFP knock-in mice (Tamamaki et al., 2003) are used in combination with IHC. 
The locations of ChAT/GAD67-GFP co-localised neurones are also determined so that 
further investigations into the projections and functions of such neurones can be 
considered utilising juxtacellular labelling from extracellular electrodes in spinal cord 
slices. Moreover, inputs to the co-localised neurones are explored in order to gain a 
better understanding into their possible functions. 
 
3.3 Methods  
The methods in this chapter are divided into 4 subsections based on the purpose of the 
experiment conducted, as follows: 
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3.3.1 Looking for evidence of ChAT and GAD67-GFP co-localisation in 
the adult and neonatal spinal cords of mice 
For the study of ChAT/GAD67-GFP co-localisation defined by this section, adult (4-6 
weeks, n = 3) or young (7-14 days postnatal, n = 3) GAD67-GFP knock-in mice of 
either sex (Tamamaki et al., 2003) were used. To distinguish motoneurones and SPNs 
from interneurones in the spinal cord, the mice were intraperitoneally injected with 
Fluorogold (Ambalavanar and Morris, 1989, Anderson and Edwards, 1994).  
Immunohistochemistry was performed as described previously (see section 2.7), using 
the combinations of antibodies depicted in Table 3.1. Details regarding the appropriate 
control and characterization of antibodies used are described in chapter 2 (see Table 
2.2). Quantification of co-localisation was performed in laminae X and VII, with the 
laminae being identified based on the information indicated in the Allen mouse spinal 
cord atlas (http://mousespinal.brain-map.org/) and literature (Rexed, 1952, Rexed, 
1954, Watson and Kayalioglu, 2009) (see Figure 1.1 and 1.2).  Other areas in the 
spinal cord including the ventral horn, dorsal horn and lateral horn were also 
investigated for the presence of co-localisation. The experimental, quantification and 
analytical methods used are detailed in section 2.12.1).  
 
Table 3.1:  Combinations of antibodies used for quantification of co-
localisation study 
Target 
Marker 
Primary Secondary 
Antibody Conc Source Antibody Conc Source 
ChAT Goat anti- 
ChAT 
1:500 Millipore Alexa Fluor 
® 555 
donkey 
anti- goat 
1 : 
1000 
Invitrogen 
GFP Rabbit 
anti-GFP 
1: 
1000 
Invitrogen Alexa Fluor 
® 488 
donkey 
anti-rabbit 
1: 
1000 
Invitrogen 
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3.3.2 Looking at the pattern of intersegmental expression of ChAT-IR 
and GAD67-GFP-IR cells in lamina X of adult and neonatal mouse 
spinal cords 
The number of ChAT-IR, GAD67-GFP-IR plus ChAT/GAD67-GFP co-localised 
neurones present in the cervical, thoracic and lumbar cord regions of both adult (n = 3) 
and young mice (n = 3) were determined using the methodology indicated in section 
3.3.1 and 2.12.1.  
Since the connection between co-localised neurones and SPNs was of interest, plus 
given the fact that the thoracic cord region contains the majority of SPNs, the location 
of co-localised neurones in lamina X of the thoracic cord region was explored to 
establish the optimal area for subsequent juxtacellular labelling experiments. In order to 
observe neurones exhibiting ChAT/GAD67-GFP co-localisation, sagittal and transverse 
serial sections of the spinal cords were examined, as per the methodology indicated in 
the following sub-sections:  
 
3.3.2.1 Reconstruction of the location of ChAT/GAD67-GFP co-localised 
neurones 
3.3.2.1.1 Transverse serial sections 
The upper thoracic cord (approximately T2-T4) of a GAD67-GFP knock-in adult mouse 
was sectioned serially and transversely at 50 µm, following which the sections were 
processed for IHC for ChAT and GAD67-GFP as above (Table 3.1). Pictures of serial 
sections around the central canal regions were taken to observe co-localisation. The 
location of co-localisation was then three-dimensionally reconstructed using 
Reconstruct software version 1.1.0.0 (SynapseWeb, 1999).   
 
3.3.2.1.2 Sagittal serial sections 
Nearly the whole thoracic spinal cord (approximately from T1 to T12) of a GAD67-GFP 
knock-in adult mouse was embedded in 10% gelatin and then postfixed with 1% 
glutaraldehyde in 4% PFA overnight (see section 2.5.4). The embedded cord was then 
sectioned serially and sagittally at 50 µm and processed using IHC for ChAT and 
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GAD67-GFP (see Table 3.1). The location of ChAT/GAD67-GFP co-localised neurones 
in relation to the central canal region throughout the studied thoracic spinal cord was 
observed and mapped using camera lucida. The locations were then reconstructed 
using CorelDraw x6 software.  
Reconstruct software version 1.1.0.0 was not selected for reconstructing the co-
localised neurone locations in the sagittal sections because the whole length of the T1-
T12 cord section under investigation was too large for the required level of microscope 
magnification. Therefore, the camera lucida approach was selected. In addition, since 
the sagittal and transverse planes provided sufficient information on where the majority 
of co-localised neurones were located, it was not necessary to extend the study to 
investigate the horizontal sections.  
 
3.3.3 Morphological analysis of cells that express ChAT and GAD67-
GFP in neonatal spinal cords using juxtacellular labelling  
3.3.3.1 Animal and tissue preparation 
Forty three GAD67-GFP knock-in mice, of both sexes and 7-14 days postnatal, were 
used. The mice were anaesthetised with an IP injection of 60 mg/kg sodium 
pentobarbitone. The depth of anaesthesia was assessed by the pinch reflex and when 
it was absent the ribcage was opened to expose the heart. The right atrium was cut 
and 20 ml of ice-cold sucrose artificial cerebrospinal fluid (Sucrose aCSF, composition 
in mM; Sucrose (217), NaHCO3 (26), KCl (3), MgSO4 (2), NaH2PO4 (2.5), CaCl2 (2), 
glucose (10)) perfused into the left ventricle. After the perfusion, the animals were 
decapitated and the vertebral columns were dissected. The spinal cords were removed 
from the animals and placed in ice-cold sucrose aCSF under continual oxygenation 
(95% O2, 5% CO2). The meninges were carefully removed using fine forceps. A 5% 
solution of agar in aCSF (composition in mM; NaCl (124), NaHCO3 (26), KCl (3), 
MgSO4 (2), NaH2PO4 (2.5), CaCl2 (2), glucose (10) pH7.4) was heated to boiling point. 
When the agar solution cooled down, the thoracic and upper lumbar spinal cord was 
embedded in the agar and then placed on ice until it was set. The embedded spinal 
cords were cut at 300 µm using Integraslice 7550 PSDS (Campden Instruments) and 
maintained in oxygenated ice-cold sucrose aCSF throughout the cutting process. The 
slices were transferred to a holding chamber where they were left to equilibrate in 
oxygenated aCSF for approximately one hour prior to patching. 
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3.3.3.2 Patch electrode preparation and tracer agents 
Borosilicate glass tubes (1.20 mm outside diameter, 0.94 mm internal diameter and 10 
cm in length, model no G120TF-4, Warner Instruments) were pulled by a micropipette 
puller (model P-97, Sutter Instrument CO, USA) to form the patch electrodes. These 
pulled electrodes had a tip diameter of approximately 2-3 µm and a resistance of 5-7 
MΩ. The electrodes were filled with intracellular solution (pH 7.2, 295 mOsm, 
composition in mM; K-gluconate (110), EGTA (11), MgCl2 (2), CaCl2 (0.1), HEPES 
(10), Na2ATP (2), NaGTP (0.03) using a Microfill (World Precision Instruments, UK)). 
To enable cell recovery, neurobiotin (1-2%, Vector Laboratories, UK) and/or rhodamine 
(2%, Invitrogen) were added into the intracellular solution. 
 
3.3.3.3 Juxtacellular labelling  
Spinal cord slices were placed in a chamber with a constant flow of oxygenated aCSF; 
the flow rate of 3-5 ml per minute being provided via a peristaltic pump.  
To visualise neurones, an upright microscope (Zeiss Axioskop, Germany) equipped 
with infrared DIC/phrase contrast, epifluorescence and a CCD camera was used with 
Q-Capture Pro7 software.  
A chloride silver wire was placed into the barrel of the patch clamp electrode, which 
was subsequently mounted onto an electrode holder (Warner Instrument Corp, USA). 
pCLAMP version 10.2 (Molecular Devices) was used as the data acquisition package. 
Master 8 (AMP instruments, Israel) was used to set the time and duration of applied 
current. 
The central canal of the spinal cord was placed in the centre of the field of view at x2.5 
and then x10 magnification. Any neurones situated ventral to the central canal that 
were positive for GFP (being visualised under epifluorescence) were then viewed more 
closely at x60 magnification, since these were the neuronal targets of the study. Prior 
to the electrode being placed into the bath solution containing the spinal cord slice, a 
positive pressure was applied using a 5 ml syringe to prevent debris build up in the tip 
of the electrode. The electrode was positioned above the slice using the coarse control 
of manipulator (Luigs & Neumann, Germany). The slice was then viewed again at x10 
magnification under infrared DIC while the electrode was lowered towards the region 
containing the neurone of interest. Next, the target neurone was viewed at x60 
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magnification and placed in the centre of the field of view. Finally, the electrode was 
visualised at x60 magnification and its tip placed in the centre of the field of view just 
above the slice.  
In current-clamp mode, the electrode resistance was removed from the recording by 
adjusting the series resistance dial until the voltage response to a 250 pA pulse 
became zero. An electrode resistance of between 5 and 7 MΩ was required and the 
offset moved to zero. A positive pressure was applied before moving the electrode to 
the surface of the neurone using the fine controls of the manipulator (Luigs & 
Neumann, Germany). When the electrode was close enough to the neurone a dimple 
was observed on the surface of the neurone. 
To establish a seal, the amplifier was switched to voltage clamp mode and a -25 mV 
pulse was applied (20 ms, 5 Hz). The positive pressure was removed and as the seal 
formed the current response to the voltage pulse decreased in accordance to Ohm’s 
law.  A constant holding voltage of -60 mV was applied. When the seal resistance 
increased the current reading was observed until a current of approximately 20 pA - 30 
pA was observed, which indicated that the seal resistance was nearly 3 GΩ. A small 
amount of negative pressure was essential to help create the seal.  
The holding potential and current pulse were decreased in I=0 mode. A small amount 
of holding potential was left on and a current pulse of -50 pA was set to stabilise the 
neurone. The mode was then switched back to current clamp. 
To observe extracellular action potentials a small positive current was applied (0.01 to 
0.03 nA) to the cell membrane of the neurones (see Figure 3.1). When an action 
potential was discerned, a higher positive current of 0.3 to 2.0 nA was then applied to 
the cell membrane (200 ms ON and 200 ms OFF) for at least 20 minutes to label the 
neurones (Pinault, 1996, Joshi and Hawken, 2006) . The time and duration of the 
applied current were set using a Master 8. 
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Figure 3.1:  Diagrammatic representation of extracellular action 
potential upon application of a positive current (between 0.01 to 0.03 
nA) to the cell membrane of a neurone.  
 
3.3.3.4 Fluorescence IHC for ChAT, GAD67-GFP and neurobiotin 
following juxtacellular labelling. 
Following juxtacellular labelling, electrodes were carefully removed from the filled 
neurones while applying a gentle positive pressure. The spinal cord slice (300 µm 
thick) was fixed overnight using a solution of 0.25% glutaraldehyde in 4% PFA. 
Following fixation, the sections were washed in 0.2 M PB and then incubated for up to 
a week in solutions of PBS containing 0.05% of thimerosal and 1.5-2% Triton X-100 
plus combinations of antibodies as detailed in Table 3.2.  
 
3.3.3.5 Peroxidase IHC 
Following the triple labelling fluorescent IHC to detect ChAT, GAD67-GFP and 
neurobiotin, the 300 µm thick spinal cord slices containing the labelled neurones were 
further processed using peroxidase IHC to provide a permanent reaction product and 
to study their morphology and possible projections. The details of the DAB IHC 
procedure involved was as described in section 2.8 using DAB SK-4100 from Vector 
Laboratories, with the only difference being that the EAP step incorporated PBS 
containing 0.3% Triton X-100 and 1:250 of ExtrAvidin Peroxidase (EAP, Sigma).  
 
200 ms
200 ms
0.01-0.03 nA
100 ms
50 mV
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Table 3.2:  Combinations of antibodies used for IHC following 
juxtacellular labelling. 
Target 
Marker 
Primary Secondary Tertiary 
Antibody Conc Source Antibody Conc Source Antibody Conc Source 
ChAT Goat anti- 
ChAT 
1:500 Millipore Alexa 
Fluor ® 
555 
donkey 
anti-goat 
1 : 
1000 
Invitrogen    
GFP Rabbit 
anti-GFP 
1: 
1000 
Invitrogen Alexa 
Fluor ® 
488 
donkey 
anti-rabbit 
1: 
1000 
Invitrogen    
Neurobiotin 
tracer 
  Vector 
Laboratories 
   Streptavidin 
pacific blue  
1: 
1000 
Invitrogen 
 
3.3.3.6 Morphology study using camera lucida 
For morphological studies, the cell body and processes of DAB-labelled neurones were 
observed and drawn using camera lucida in conjunction with the Nikon Eclipse E600 
microscope. 
 
3.3.4 Assessment of neurochemically-defined afferent inputs on to 
ChAT/GAD67-GFP co-localised neurones in lamina X  
For assessment of the neurochemically-defined afferent inputs onto ChAT/GAD67-GFP 
co-localised neurones in lamina X, 2 GAD67-GFP adult mice (females) were used. 
Immunohistochemistry was performed as described previously (see section 2.7), using 
the combinations of antibodies detailed in Tables 3.3 and 3.4.  The numbers of 
VGLUT1-IR, VGLUT2-IR, GlyT2-IR and GAD67-IR boutons observed in close proximity 
to the cell body of a co-localised neurone in lamina X were established, and have been 
presented in section 3.4.5 as the mean ± SEM for boutons observed per 100 µm of co-
localised cell body. 
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Table 3.3:  Combinations of antibodies used for triple labelling for 
ChAT, GFP and either VGLUT1, VGLUT2 or GlyT2 IHC. 
Target 
Marker 
Primary Secondary Tertiary 
Antibody Conc Source Antibody Conc Source Antibody Conc Source 
ChAT Goat anti 
ChAT 
1:500 Millipore Alexa Fluor 
® 555 
donkey 
anti-goat 
1: 
1000 
Invitrogen    
GFP Rabbit 
anti-GFP 
1: 1000 Invitrogen Alexa Fluor 
® 488 
donkey 
anti-rabbit 
1: 
1000 
Invitrogen    
VGLUT1 Guinea 
pig anti-
VGLUT1  
1:30,000 Millipore Biotinylated 
donkey 
anti- guinea 
pig 
1 : 
500 
Jackson 
Immuno-
Research 
Laboratories 
Streptavidin 
pacific blue 
1 : 
1000 
Invitrogen 
VGLUT2 Guinea 
pig anti-
VGLUT 2 
1:10,000 Millipore Biotinylated 
donkey 
anti- guinea 
pig 
1 : 
500 
Jackson 
Immuno-
Research 
Laboratories 
Streptavidin 
pacific blue 
1 : 
1000 
Invitrogen 
GlyT2 Guinea 
pig anti-
GlyT2 
1:15,000 Millipore Biotinylated 
donkey 
anti- guinea 
pig 
1 : 
500 
Jackson 
Immuno-
Research 
Laboratories 
Streptavidin 
pacific blue 
1 : 
1000 
Invitrogen 
 
Table 3.4:  Combinations of antibodies used for triple labelling for 
ChAT, GFP and GAD67 IHC. 
Target 
Marker 
Primary Secondary Tertiary 
Antibody Conc Source Antibody Conc Source Antibody Conc Source 
ChAT Goat anti 
ChAT 
1:500 Millipore Biotinylated 
donkey 
anti- goat 
1 : 
500 
Jackson 
Immuno-
Research 
Laboratories 
Streptavidin 
pacific blue 
1 : 
1000 
Invitrogen 
GFP Rabbit 
anti-GFP 
1: 
1000 
Invitrogen Alexa Fluor 
® 488 
donkey 
anti-rabbit 
1: 
1000 
Invitrogen    
GAD67 Mouse 
anti-
GAD67 
1:500 Chemicon 
International 
Alexa Fluor 
® 555 
donkey 
anti-mouse 
1 : 
1000 
Invitrogen     
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3.4 Results 
3.4.1 Adult mice 
ChAT and GAD67-GFP immunoreactivity was observed in separate neurones in all 
studied levels (cervical, thoracic and lumbar) but there was limited co-localisation (see 
Figure 3.2). The morphology and distribution of ChAT-IR and/or GAD67-GFP-IR 
neurones, and the locations of neurones expressing co-localisation, within the major 
discrete areas of the grey matter of the spinal cord (including the ventral horn, dorsal 
horn, lateral horn, lamina VII and lamina X) were as follows: 
 
3.4.1.1 There are few ChAT/GAD67-GFP co-localised neurones in the 
ventral horn  
ChAT-IR neurones were observed in the motoneurone pool (lamina IX) of the ventral 
horn, (see Figure 3.2-Ai) in all studied levels; 2048 neurones for cervical (n = 3, nsc = 
30), 629 neurones for thoracic (n = 3, nsc = 30) and 1029 neurones for lumbar (n = 3, 
nsc = 30), see Table 3.5. GAD67-GFP-IR neurones were found throughout the ventral 
horn (see Figure 3.2-Aii and Table 3.5); 1435 neurones for cervical (n = 3, nsc = 30), 
929 neurones for thoracic (n = 3, nsc = 30) and 1441 neurones for lumbar (n = 3, nsc = 
30). Both ChAT-IR and GAD67-GFP-IR neurones exhibited oval or elliptical shaped cell 
bodies; the sizes of which were 18.82 ± 1.59 µm x 31.33 ± 2.30 µm (N = 10) for ChAT-
IR neurones and 10.89 ± 0.57 µm x 15.70 ± 1.09 µm (N = 10) for GAD67-GFP-IR 
neurones. Cross sectional areas of ChAT-IR soma and GAD67-GFP-IR soma were 
493.89 µm2 and 138.84 µm2 respectively. Only two co-localised neurones were 
observed, one in a thoracic section of animal 1 and one in a lumbar section of animal 2. 
The percentage of ChAT-IR neurones that exhibited co-localisation for GAD67-GFP in 
the cervical, thoracic and lumbar sections was therefore 0% (0/2048), 0.16% (1/629) 
and 0.10% (1/1029) respectively. Similarly, the percentage of GAD67-GFP-IR 
neurones which exhibited co-localisation for ChAT in the cervical, thoracic and lumbar 
sections was 0%, 0.11% and 0.07%, respectively.  
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Table 3.5: Numbers of ChAT-IR and GAD67-GFP-IR neurones per 50 
µm section in the ventral horns of each region of the spinal cord of 
adult mice (n = 3). Values are presented as mean ± SEM.  
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(30 sections) 0 68.27 ± 2.96 47.83 ± 2.72 
Thoracic      
(30 sections) 0.03 ± 0.03 20.97 ± 0.92 30.97 ± 2.04 
Lumbar       
(30 sections) 0.03 ± 0.03 34.30 ± 2.13 48.03 ± 2.28 
 
3.4.1.2 ChAT-IR and GAD67-GFP-IR neurones are present in the dorsal 
horn and a limited number are co-localised. 
Many neurones in the dorsal horn were GAD67-GFP-IR; totalling 5436 neurones for 
the cervical (n = 3, nsc = 30), 3853 for the thoracic (n = 3, nsc = 30) and 5361 for the 
lumbar sections (n = 3, nsc = 30) (see Figure 3.2-Bii and Table 3.6). These neurones 
were small in size (7.96 ± 0.25 µm x 10.26 ± 0.58 µm, N = 10), with a soma cross 
sectional area of 65.19 µm2. The dorsal horn also contained a limited number of ChAT-
IR neurones; totalling 175, 101 and 142 neurones for the cervical (n = 3, nsc = 30), 
thoracic (n = 3, nsc = 30) and lumbar (n = 3, nsc = 30) respectively (see Figure 3.2-Bi 
and Table 3.6). ChAT-IR neurones were located in lamina III of the dorsal horn. The 
size of the ChAT-IR neurones was 9.88 ± 0.69 µm x 14.29 ± 1.15 µm (N = 10), 
corresponding to a soma cross sectional area of 114.72 µm2. Both ChAT-IR and 
GAD67-GFP-IR neurones exhibited oval or elliptical cell bodies. A limited number of 
ChAT/GAD67-GFP co-localised neurones were also observed in the dorsal horn; 34 
neurones for the cervical (n = 3, nsc = 30), 13 for the thoracic (n = 3, nsc = 30) and 20 
for the lumbar sections (n = 3, nsc = 30), with the average number of co-localised 
neurones observed for both sides of the cord per 50 µm section being 1.13 ± 0.23 for  
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Figure 3.2:  Extent of ChAT-IR, GAD67-GFP-IR and ChAT/GAD67-GFP 
co-localised neurones in the thoracic cord sections of adult mice. 
Confocal images depict ChAT-IR and/or GAD67-GFP-IR neurones in the 
ventral horn (Ai and Aii respectively), dorsal horns (Bi and Bii), lateral horn 
(Ci and Cii) and lamina VII (Di and Dii) of the thoracic cord sections. Arrows 
(Bi to Biii) indicate ChAT/GAD67-GFP co-localised neurones. 
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the cervical, 0.43 ± 0.10 for the thoracic and 0.67 ± 0.15 for the lumbar section (see 
Table 3.6). The percentage of ChAT-IR neurones that contained GAD67-GFP in the 
cervical, thoracic and lumbar sections was 19.43%, 12.87% and 14.08% respectively. 
The percentage of GAD67-GFP-IR neurones that contained ChAT for the cervical, 
thoracic and lumbar sections was 0.63%, 0.34% and 0.37% respectively. The size of 
the co-localised neurones was 8.45 ± 0.29 µm x 11.85 ± 0.87 µm (N = 10), 
corresponding to a soma cross sectional area of 80.92 µm2.  
 
Table 3.6:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in the dorsal horns of each region of the spinal cord of 
adult mice (n = 3). 
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(30 sections) 1.13 ± 0.23 5.83 ± 0.58 181.20 ± 10.31 
Thoracic      
(30 sections) 0.43 ± 0.10 3.37 ± 0.28 128.43 ± 4.32 
Lumbar       
(30 sections) 0.67 ± 0.15 4.73 ± 0.42 178.70 ± 7.99 
 
3.4.1.3 Co-localisation was not observed in the lateral horn 
SPNs in the lateral horn of the thoracic (Figure 3.2-Ci) (490 neurones, n = 3, nsc = 30) 
and upper lumbar regions (152 neurones, n = 3, nsc = 13), were positive for ChAT 
labelling and had oval or elliptical shaped cell bodies. This corresponds to 
approximately 16.33 ± 1.10 and  11.69 ± 0.96 ChAT-IR neurones being observed on 
average, for both sides of a 50 µm thick section, in the thoracic and lumbar cord 
sections respectively (see Table 3.7).These ChAT-IR neurones were medium in size 
(12.46 ± 0.95 µm x 15.42 ± 5.06 µm, N = 10), with a soma cross sectional area of 
152.64 µm2. By comparison a relatively small number of GAD67-GFP-IR neurones 
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were observed in the lateral horn (see Table 3.7); 63 neurones in the thoracic sections 
(n = 3, nsc = 30) and 35 in the lumbar sections (n = 3, nsc = 13). The size of these 
neurones was 8.40 ± 0.39 µm x 12.47 ± 0.87 µm (N = 10), with a soma cross sectional 
area of 85.53 µm2. Co-localisation was not observed in any of the studied sections. 
 
Table 3.7:  Numbers of ChAT-IR and GAD67-GFP-IR neurones per 50 
µm section in the lateral horns of the thoracic and lumbar regions of 
the spinal cord of adult mice (n = 3). 
Regions ChAT-IR neurones GAD67-GFP-IR 
neurones 
Thoracic        
(30 sections) 16.33 ± 1.10 2.10 ± 0.34 
Lumbar          
(13 sections)  11.69 ± 0.96  2.69 ± 0.35 
 
3.4.1.4 ChAT-IR and GAD67-GFP-IR neurones are present in lamina VII 
but ChAT/GAD67-GFP co-localised neurones are almost absent 
in the lamina.  
ChAT-IR and GAD67-GFP-IR neurones were observed in lamina VII (Figure 3.2Di and 
Dii) of all the studied spinal regions; totalling 481, 297 and 283 ChAT-IR neurones, plus 
1695, 1300 and 1729 GAD67-GFP-IR neurones being found respectively in the cervical 
(n = 3, nsc = 30), thoracic (n = 3, nsc = 30) and lumbar sections (n = 3, nsc = 30). Both 
types of neurone exhibited oval or elliptical cell bodies. The size of ChAT-IR neurones 
was 14.54 ± 0.91 µm x 21.88 ± 1.30 µm (N = 10), while those of GAD67-GFP-IR 
neurones was 10.75 ± 0.36 µm x 14.95 ± 0.94 µm (N = 10). The cross sectional areas 
of the ChAT-IR and GAD67-GFP-IR soma were 260.48 µm2 and 129.70 µm2, 
respectively. A very limited number of ChAT/GAD67-GFP co-localised neurones were 
observed in the cervical (5 neurones, n = 3, nsc = 30) and lumbar regions (1 neurone, 
n = 3, nsc = 30)(see Table 3.8). Their size was 10.58 ± 1.23 x 12.95 ± 0.97 (N = 4) with 
a soma cross sectional area of 108.73 µm2. The percentage of ChAT-IR neurones 
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containing GAD67-GFP for the cervical, thoracic and lumbar sections was 1.04%, 0% 
and 0.35%, respectively. The percentage of GAD67-IR neurones containing ChAT for 
the cervical, thoracic and lumbar sections was 0.29%, 0% and 0.06%, respectively.  
 
Table 3.8:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in lamina VII of each region of the spinal cord of adult 
mice (n = 3).  
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(30 sections) 0.20 ± 0.07 16.03 ± 1.29 56.50 ± 4.07 
Thoracic        
(30 sections) 0 9.90 ± 0.81 43.33 ± 2.54 
Lumbar          
(30 sections) 0.10 ± 0.07 9.43 ± 0.82 57.63 ± 3.30 
 
3.4.1.5 ChAT-IR and GAD67-GFP-IR neurones are present in lamina X 
and a small number are co-localised. 
323 (n = 3, nsc = 30), 428 (n = 3, nsc = 30) and 411 (n = 3, nsc = 30) ChAT-IR 
neurones were counted in lamina X in cervical, thoracic and lumbar cord sections 
respectively (Figure 3.3 Ai, Bi and Ci). In addition, these cervical (n = 3, nsc = 30), 
thoracic (n = 3, nsc = 30) and lumbar cord sections (n = 3, nsc = 30) of lamina X 
section contained respectively 1015, 972 and 962 GAD67-GFP-IR neurones (Figure 
3.3 Aii, Bii and Cii). Both ChAT-IR and GAD67-GFP-IR neurones possessed oval or 
elliptical cell bodies. The size of the ChAT-IR neurones varied greatly however, ranging 
from 8 µm to 27 µm for the X-diameter and from 9 µm to 47 µm for the Y-diameter of 
the somata (raw data from 26 neurones (N = 26) randomly selected from all studied 
regions of the spinal cords). The average sizes of the ChAT-IR neurones and GAD67-
GFP-IR neurones were 13.62 ± 0.95 µm x 19.52 ± 1.68 µm (N = 10) and 11.14 ± 0.36 
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µm x 15.08 ± 0.57 µm (N = 10) respectively. The cross sectional area of ChAT-IR and 
GAD67-GFP-IR soma was 215.67 and 135.01 µm2 respectively. The intensity of the 
ChAT staining also varied from one neurone to another (see Figure 3.3-Ai, Bi and Ci).  
 
 
Figure 3.3:  Co-localisation of ChAT and GAD67-GFP in lamina X of 
the adult mice. Confocal images show ChAT/GAD67-GFP co-localisation 
in lamina X of the cervical, thoracic and lumbar sections (Ai to Aiii, Bi to Biii 
and Ci to Ciii respectively). Neurones which exhibit co-localisation are 
indicated by arrows. 
 
The number of ChAT/GAD67-GFP co-localised neurones observed in the cervical, 
thoracic and lumbar cord sections of lamina X was 121 (n = 3, nsc = 30), 114 (n = 3, 
nsc = 30) and 134 (n = 3, nsc = 30) respectively. In comparison to other investigated 
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areas within the spinal cord, lamina X contained the majority of co-localised neurones. 
The average number of co-localised neurones observed per 50 µm section in lamina X 
for each region of the spinal cord is shown in Table 3.9. The percentage of ChAT-IR 
neurones that contained GAD67-GFP for the cervical, thoracic and lumbar sections 
was 37.46%, 26.64% and 32.60%, respectively. The percentage of GAD67-GFP-IR 
neurones that contained ChAT-GFP for the cervical, thoracic and lumbar sections was 
11.92%, 11.73% and 13.93%, respectively.  
The ChAT/GAD67-GFP co-localised neurones were of size 11.35 ± 0.66 µm x 14.68 ± 
0.55 (N = 10), with a soma cross sectional area of 133.06 µm2. They were negative for 
Fluorogold labelling (see Figure 3.4-Aiii) which indicates that they were neither 
motoneurones nor preganglionic neurones (Ambalavanar and Morris, 1989). They also 
appeared to be lightly immunoreactive for both ChAT and GAD67-GFP (see Figure 3.3 
and Figure 3.7-B). 
 
 
Figure 3.4:  ChAT/GAD67-GFP co-localised neurones in lamina X were 
negative for Fluorogold labelling. Epifluorescent images show 
ChAT/GAD67-GFP co-localised neurones (indicated by arrows in Ai and 
Aii) in lamina X which are negative for Fluorogold (Aiii) suggesting that they 
are neither motoneurones nor preganglionic neurones. Open arrows in Bi 
mark the presence of ChAT-IR neurones in the ventral horn; these are not 
co-localised with GAD67-GFP (Bii), but are positive for Fluorogold (Biii) 
indicating that they are motoneurones.   
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3.4.1.5.1 The location of ChAT/GAD67-GFP co-localised neurones in lamina X of 
adult mice 
The location of ChAT/GAD67-GFP co-localised neurones in relation to the central 
canal was mapped from serial transverse sections of the upper thoracic cord region 
(approximately T2-T4) of a GAD67-GFP knock-in adult mouse using Reconstruct 
software to create a three dimensional diagram (see Figure 3.5).  In addition, serial 
sagittal sections of a GAD67-GFP knock-in adult mouse were used to map the sites of 
co-localised neurones throughout nearly the whole thoracic cord region (T1-T12) (see 
Figure 3.6 and Figure 3.7-A). The results suggested that while the majority of neurones 
exhibiting co-localisation were located ventral and ventrolateral to the central canal 
(see Figures 3.5 and 3.6), a small number of such neurones could also be found dorsal 
to the central canal. 
 
 
Figure 3.5:  Location of ChAT/GAD67-GFP co-localised neurones in 
relation to the central canal of T2-T4 cord sections. Each orange block 
represents a co-localised neurone. The blue box represents a 3-D scale 
bar, 50 µm x 50 µm x 50 µm. (Note: to aid visualisation, the size of each 
orange block does not represent the actual size of each co-localised 
neurone but represents the thickness of each studied cord section). 
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Figure 3.6:  Location of ChAT/GAD67-GFP co-localised neurones in 
serial sagittal sections from T1-T12 of a GAD67-GFP knock-in mouse. 
An orange star represents a co-localised neurone, while a blue star 
represents a co-localised neurone located deeper in a section. 
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Figure 3.7:  Location of co-localised neurones in lamina X in the 
thoracic cord of adult mice and a young mouse. Concocal images show 
that the majority of co-localised neurones (indicated by arrows in A) were 
observed ventral to the central canal in a sagittal thoracic cord section of an 
adult mouse. B and C show co-localised neurones (indicated by arrows) 
ventral to the central canal in a transverse thoracic cord section of an adult 
and a young mouse respectively. CC: central canal; D: dorsal; V: ventral.  
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Table 3.9:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in lamina X of each region of the spinal cord of adult 
mice (n = 3). 
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical          
(30 sections) 4.03 ± 0.41 10.77 ± 0.70 33.83 ± 2.21 
Thoracic        
(30 sections) 3.80 ± 0.31 14.27 ± 0.76 32.40 ± 1.43 
Lumbar          
(30 sections) 4.47 ± 0.27 13.70 ± 0.80 32.07 ± 2.33 
 
 
 
Figure 3.8:  Distribution of ChAT, GAD67-GFP and co-localisation in 
adult cervical spinal cord.  
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Figure 3.9:  Distribution of ChAT, GAD67-GFP and co-localisation in 
adult thoracic spinal cord. 
 
 
Figure 3.10:  Distribution of ChAT, GAD67-GFP and co-localisation in 
adult lumbar spinal cord. 
 
 
0
20
40
60
80
100
120
140
VH DH LH Lamina VII Lamina X
Adult Thoracic
ChAT
GAD67-GFP
Co-localised
0
20
40
60
80
100
120
140
160
180
200
VH DH LH Lamina VII Lamina X
Adult Lumbar
ChAT
GAD67-GFP
Co-localised
105  
 
3.4.2 Young mice 
An aim was to trace the axonal projections of ChAT/GAD67-GFP co-localised 
neurones in lamina X by juxtacellular labelling in spinal cord slices. Since optimal 
visualisation of slices is performed in young mice with reduced myelination, potential 
ChAT/GAD67-GFP co-localisation was first examined in these mice. 
 
3.4.2.1 Only one ChAT/GAD67-GFP co-localised neurone was observed 
in the ventral horn  
ChAT-IR neurones were observed predominantly in lamina IX of the ventral horn (see 
Table 3.10 and Figure 3.11-Ai) for all the studied cord regions; 1234 ChAT-IR neurones 
for the cervical (n = 3, nsc = 15), 478 for the thoracic (n = 3, nsc = 15) and 813 for the 
lumbar cord sections (n = 3, nsc = 15). These neurones exhibited oval or elliptical 
shaped cell bodies of size 24.46 ± 1.44 µm x 32.06 ± 1.96 µm (N = 10), with a soma 
cross sectional area of 627.32 µm2. In addition, they were found to be positive for 
Fluorogold, indicating that they were motoneurones (Ambalavanar and Morris, 1989).  
The ventral horn of the cervical, thoracic and lumbar cord sections contained 1204 (n = 
3, nsc = 15), 561 (n = 3, nsc = 15) and 884 GAD67-GFP-IR neurones (n = 3, nsc = 
15)(see Table 3.10 and Figure 3.11 Aii), respectively. GAD67-GFP-IR neurones in the 
ventral horn exhibited oval or elliptical shaped cell bodies of size 13.93 ± 0.74 µm x 
19.64 ± 0.90 µm (N = 10), with a soma cross sectional area of 221.30 µm2. 
Only one ChAT/GAD67-GFP co-localised neurone was observed in the ventral horn. It 
was located in a lumbar cord section of animal 2. The percentage of ChAT-IR neurones 
that contained GAD67-GFP for the lumbar sections (n=3, nsc = 15) was 0.12% and the 
percentage of GAD67-GFP-IR neurones that contained ChAT was 0.11%.  
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Table 3.10:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in the ventral horns of each region of the spinal cord of 
young mice (n = 3). 
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(15 sections) 0 82.27 ± 5.86  80.27 ± 6.60 
Thoracic          
(15 sections) 0 31.87 ± 1.66 37.40 ± 2.72 
Lumbar          
(15 sections) 0.07 ± 0.07 54.20 ± 3.82 58.93 ± 5.31 
 
3.4.2.2 ChAT-IR and GAD67-GFP-IR neurones are present in the dorsal 
horn and a limited number are co-localised. 
The cervical, thoracic and lumbar dorsal horns contained 214 (n = 3, nsc = 15), 245 (n 
= 3, nsc = 15) and 224 ChAT-IR neurones (n = 3, nsc = 15), respectively (see Figure 
3.11-Bi). These were predominantly located in lamina III of the dorsal horn and 
possessed oval or elliptical cell bodies. The size of the ChAT-IR neurones was 11.25 ± 
0.37 µm x 14.55 ± 0.46 µm (N = 10), with a soma cross sectional area of 130.72 µm2. 
A large number of GAD67-GFP-IR neurones were observed in the dorsal horn (see 
Figure 3.11-Bii) for all the cord regions; 4806, 3502 and 4118 neurones for the cervical 
(n = 3, nsc = 15), thoracic (n = 3, nsc = 15) lumbar cord sections (n = 3, nsc = 15), 
respectively. The size of the GAD67-GFP-IR neurones was 9.69 ± 0.38 µm x 11.81 ± 
0.35 µm (N = 10), with a soma cross sectional area of 90.77 µm2. They exhibited oval 
or elliptical cell bodies. 
A small number of ChAT/GAD67-GFP co-localised neurones were also observed in the 
dorsal horn of the cervical (26 neurones, n = 3, nsc = 15), thoracic (30 neurones, n = 3, 
nsc = 15) lumbar cord sections (26 neurones, n = 3, nsc = 15), respectively (see Figure 
3.11-Biii and Table 3.11). The percentage of ChAT-IR neurones containing GAD67- 
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Figure 3.11:  ChAT-IR and GAD67-GFP-IR neurones were present in 
various areas within the spinal cord of young mice. The confocal 
images present the distribution of ChAT-IR and GAD67-GFP-IR neurones 
in the ventral horn (Ai, Aii), dorsal horn (Bi, Bii), lateral horn (Ci, Cii) and 
lamina VII (Di, Dii). ChAT/GAD67-GFP co-localised neurones were 
observed in the dorsal horn as indicated by the arrows (Biii).  
108  
 
GFP was 12.15%, 12.24% and 11.61% for the cervical, thoracic and lumbar cord 
sections respectively. The percentage of GAD67-GFP-IR neurones containing ChAT 
was 0.54%, 0.86% and 0.63% for the cervical, thoracic and lumbar cord sections 
respectively. The average number of co-localised neurones observed for both sides of 
the cord per 50 µm section was aproximately 1.73 ± 0.56, 2.00 ± 0.38 and 1.73 ± 0.40 
for the cervical, thoracic and lumbar cord sections respectively. The size of the 
ChAT/GAD67-GFP co-localised neurones was 11.15 ± 0.39 µm x 14.33 ± 0.37 µm (N = 
10) with a soma cross sectional area of 127.49 µm2. 
 
Table 3.11:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in the dorsal horns of each region of the spinal cord of 
young mice (n = 3). 
Regions ChAT/GAD67-GFP  
co-localised neurones  
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(15 sections) 1.73 ± 0.56 14.27 ± 2.41 320.40 ± 18.63 
Thoracic        
(15 sections) 2.00 ± 0.38 16.33 ± 1.11 233.47± 11.11 
Lumbar          
(15 sections) 1.73 ± 0.40 14.93 ± 1.33 274.53 ± 14.09 
 
3.4.2.3 ChAT/GAD67-GFP co-localised neurones were not observed in 
the lateral horns  
The lateral horn of the thoracic (n = 3, nsc = 15) and lumbar cord (n = 3, nsc = 7) 
sections contained 205 and 61 ChAT-IR neurones respectively (Figure 3.11 Ci). The 
average number of ChAT-IR neurones observed for both sides of the cord per 50 µm 
section was as shown in Table 3.12. The ChAT-IR neurones (Figure 3.11-Ci) of young 
mice appeared as a cluster and exhibited oval or elliptical shaped cell bodies of size 
14.62 ± 0.51 µm x 18.31 ± 0.87 µm (N = 10), with a soma cross sectional area of 
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212.95 µm2. In addition, they were found to be positive for Fluorogold, so indicating that 
they were preganglionic neurones (Ambalavanar and Morris, 1989). 
The number of GAD67-GFP-IR neurones observed in the lateral horn (Figure 3.11-Cii) 
was markedly less than number of ChAT-IR neurones (see Table 3.12); 43 neurones 
for the thoracic and 26 for the lumbar sections. The average number of GAD67-GFP-IR 
neurones observed per 50 µm section was as shown in Table 3.12. The size of the 
GAD67-GFP-IR neurones was 12.49 ± 0.75 µm x 16.66 ± 2.03 µm (N = 6), with a soma 
cross sectional area of 166.86 µm2. 
ChAT/GAD67-GFP co-localised neurones were not observed in the lateral horns.  
 
Table 3.12:  Numbers of ChAT-IR and GAD67-GFP-IR neurones per 50 
µm section in the lateral horns of each region of the spinal cord of 
young mice (n = 3). 
Regions ChAT-IR neurones GAD67-GFP-IR 
neurones 
Thoracic        
(15 sections) 13.67 ± 1.22  2.87 ± 0.72 
Lumbar            
(7 sections) 8.71 ± 2.95  3.71 ± 1.15  
 
3.4.2.4 ChAT-IR and GAD67-GFP-IR neurones were present in lamina VII 
though only one neurone exhibited co-localisation 
Lamina VII of the cervical (n = 3, nsc = 15), thoracic (n = 3, nsc = 15) and lumbar cord 
sections (n = 3, nsc = 15) contained 156, 151 and 96 ChAT-IR neurones respectively 
(Figure 3.11-Di). The average number of ChAT-IR neurones observed for both sides of 
the cord per 50 µm section was as shown in Table 3.13. They possessed oval or 
elliptical cell bodies of size 15.46 ± 0.59 µm x 23.09 ± 1.28 µm (N = 7), with a soma 
cross sectional area of 291.83 µm2. 
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Lamina VII of the cervical (n = 3, nsc = 15), thoracic (n = 3, nsc = 15) and lumbar cord 
sections (n = 3, nsc = 15) contained 1199, 988 and 1503 GAD67-GFP-IR neurones 
respectively (Figure 3.11-Dii). They possessed oval or elliptical cell bodies of size 
12.81 ± 0.64 µm x 18.06 ± 1.53 µm (N = 10), with a soma cross sectional area of 
GAD67-GFP-IR 187.14 µm2. 
Only one ChAT/GAD67-GFP co-localised neurone was observed in lamina VII (see 
Table 3.13). This was located in a cervical cord section of one animal, animal 2. The 
percentage of ChAT-IR neurones which contained GAD67-GFP for the cervical 
sections was therefore 0.64%. Similarly, the percentage of GAD67-GFP-IR neurones 
that contained ChAT was 0.08%.  
  
Table 3.13:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in lamina VII of each region of the spinal cord of young 
mice (n = 3). 
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(15 sections) 0.07 ± 0.07 10.40 ± 0.94 79.93 ± 8.88 
Thoracic        
(15 sections) 0 10.07 ± 1.14 65.87 ± 4.79 
Lumbar          
(15 sections) 0 6.40 ± 1.19  100.20 ± 5.95 
 
3.4.2.5 ChAT-IR and GAD67-GFP-IR neurones are present in lamina X 
and a small number are co-localised, in similarity to adult mice 
observations. 
Lamina X of the cervical (n = 3, nsc = 15), thoracic (n = 3, nsc = 15) and lumbar cord 
sections (n = 3, nsc = 15) contained 146, 188 and 243 ChAT-IR neurones respectively 
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(Figure 3.12-Ai, Bi and Ci). The average number of ChAT-IR neurones observed for 
both side of the cord across 50 µm section was as shown in Table 3.14. The cell 
bodies for the ChAT-IR neurones were oval or elliptical in shape. Likewise, GAD67-
GFP-IR neurones were observed in the lamina X of all studied cord regions (Figure 
3.12-Aii, Bii and Cii) and possessed oval or elliptical cell bodies. Lamina X of the 
cervical, thoracic and lumbar cord regions contained 780 (n = 3, nsc = 15), 660 (n = 3, 
nsc = 15) and 761 GAD67-GFP-IR neurones (n = 3, nsc = 15), respectively.  The 
average number of GAD67-GFP-IR neurones observed per 50 µm section was as 
shown in Table 3.14. The size of the ChAT-IR neurones was 16.17 ± 0.57 µm x 21.60 ± 
1.13 µm (N = 10), with a soma cross sectional area of 280.14 µm2, whereas the size of 
the GAD67-GFP-IR neurones was 13.21 ± 0.63 µm x 16.17 ± 0.98 µm (N = 10), with a 
soma cross sectional area of 169.51 µm2. 
ChAT/GAD67-GFP co-localised neurones were observed in lamina X of the young 
mice (Figure 3.12-Aiii, Biii and Ciii); 60, 35 and 43 neurones for the cervical (n =3, nsc 
= 15), thoracic (n =3, nsc = 15) and lumbar cord sections (n =3, nsc = 15) respectively. 
Similar to the findings for the adult animals, it was discerned that the majority of co-
localised neurones were in lamina X when compared to other studied areas of the 
spinal cord, and these co-localised neurones were negative for Fluorogold labelling.  
The percentage of of ChAT-IR neurones which contained GAD67-GFP for the cervical, 
thoracic and lumbar sections was 41.10%, 18.62%, 17.70% respectively, while the 
percentage of of GAD67-GFP-IR neurones which contained ChAT for the cervical, 
thoracic and lumbar sections was 7.69%, 5.3% and 5.65% respectively. Aproximately 4 
± 0.26, 2.33 ± 0.43 and 2.87 ± 0.32 co-localised neurones were observed on average 
for both sides of the cord per 50 µm thick cervical, thoracic and lumbar cord section 
respectively (see Table 3.14).  
The size of ChAT/GAD67-GFP co-localised neurones was 12.68 ± 0.47 µm x 
16.90 ± 1.11 µm (N = 10), with a soma cross sectional area of 171.82 µm2.They 
also appeared to be lightly immunoreactive for both ChAT and GAD67-GFP (see 
Figure 3.7-C and Figure 3.12). 
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Figure 3.12:  Co-localisation of ChAT and GAD67-GFP in lamina X of 
young mice. ChAT/GAD67-GFP co-localised neurones are observed in the 
cervical, thoracic and lumbar sections of lamina X (marked respectively as 
areas in A, B and C in the figure). Neurones which exhibit co-localisation 
are indicated by arrows.  Images taken using confocal microscopy. 
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Table 3.14:  Numbers of ChAT-IR and/or GAD67-GFP-IR neurones per 
50 µm section in lamina X of each region of the spinal cord of young 
mice (n = 3). 
Regions ChAT/GAD67-GFP 
co-localised neurones 
ChAT-IR 
neurones 
GAD67-GFP-IR 
neurones 
Cervical             
(15 sections) 4 ± 0.26 9.73 ± 0.77 52 ± 5.98 
Thoracic        
(15 sections) 2.33 ± 0.43 12.53 ± 0.82 44 ± 3.21 
Lumbar          
(15 sections) 2.87 ± 0.32 16.20 ± 1.42 50.73 ± 2.69 
 
 
 
Figure 3.13:  Distribution of ChAT, GAD67-GFP and co-localisation in 
young cervical spinal cord. 
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Figure 3.14:  Distribution of ChAT, GAD67-GFP and co-localisation in 
young thoracic spinal cord. 
 
 
Figure 3.15:  Distribution of ChAT, GAD67-GFP and co-localisation in 
young lumbar spinal cord. 
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3.4.3 Comparison of the the relative abundance of each 
neurochemically-defined population in lamina X between juvenile 
and adult mice. 
For the cervical cord, the number of ChAT-IR neurones in lamina X for juvenile mice 
(9.73 ± 0.77) is not significantly different (p = 0.37) to that for adult mice (10.77 ± 0.70). 
The number of ChAT/GAD67-GFP co-localised neurones in the two age groups (4 ± 
0.26 for juvenile and 4.03 ± 0.41 for adult is also not significantly different (p = 0.95). 
However, the number GAD67-GFP-IR neurones in lamina X of the cervical cord is 
significantly different between the two groups (52 ± 5.98 for juvenile and 33.83 ± 2.21 
for adult mice, p = 0.01). 
For the thoracic cord, the number of ChAT-IR neurones in lamina X for juvenile mice 
(12.53 ± 0.82) is not significantly different (p = 0.16) to that for adult mice (14.27 ± 
0.76). However, the number of GAD67-GFP-IR neurones in the two age groups (44 ± 
3.21 for juvenile and 32.4 ± 1.43 for adult mice) is significantly different (p = 0). 
Similarly, the number of co-localised ChAT/GAD67-GFP neurones in lamina X of the 
thoracic cord is also significantly different between the juvenile (2.33 ± 0.43) and adult 
(3.8 ± 0.31) mice (p = 0.01). 
For the lumbar cord, the number of ChAT-IR neurones in lamina X for juvenile mice 
(16.20 ± 1.43) is not significantly different to that for adult mice (13.70 ± 0.80) (p = 
0.10). In contrast, the number of GAD67-GFP-IR neurones in the two age groups 
(50.73 ± 2.69 for juvenile and 32.07± 2.33 for adult mice) is significantly different (p = 
0). Similarly, the number of co-localised ChAT/GAD67-GFP neurones in lamina X of 
the lumbar cord is also significantly different between the juvenile (2.87 ± 0.32) and 
adult (4.47 ± 0.27) mice (p = 0). 
 
3.4.4 Morphological analysis of cells that express ChAT and GAD67-
GFP in neonatal spinal cords using juxtacellular labelling 
combined with IHC 
A total of 130 neurones in lamina X were recorded and 122 of them were processed 
utilising IHC. Out of these only 34 neurones were either recovered or partially 
recovered. While the numbers of recovered neurones exhibiting sole immunoreactive 
labelling for ChAT and GAD67-GFP were 1 and 7 respectively, only one ChAT/GAD67-
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GFP co-localised neurone was recorded and recovered. The morphology of the co-
localised neurone, plus the ChAT-IR neurones and GAD67-GFP-IR neurones were as 
follows. 
 
3.4.4.1 Morphology of a ChAT/GAD67-GFP co-localised neurone in 
lamina X 
In lamina X, the ChAT/GAD67-GFP co-localised neurone had an oval or elliptical 
shaped cell body. The size of the neurone was 12.30 x 13.85 µm (N = 1), with a soma 
cross sectional area of 134.29 µm2. 
The processes seemed to be relatively small and short, and thus were likely to be 
locally branching within lamina X. The neurone had some dendrites passing close to 
the ependymal cells lining the central canal, although one dendrite reached the ventral 
aspect of lamina X (see Figure 3.16).  
 
3.4.4.2 Morphology of a ChAT-IR neurone in lamina X 
In lamina X the ChAT-IR neurone had an oval or elliptical shaped cell body. Its 
processes branched extensively dorsally, ventrally and laterally within the grey matter. 
The neurone also sent a dendrite across the ventral aspect of the central canal to the 
contralateral side (see Figure 3.17). The size of the neurone was 12.40 x 15.55 µm    
(N = 1), corresponding to a soma cross sectional area of 153.41 µm2. 
 
3.4.4.3 Morphology of GAD67-GFP-IR neurones in lamina X 
In lamina X, GAD67-GFP-IR neurones had an oval or elliptical shaped cell body. The 
size of the cell body was 8.29 ± 0.49 x 13.42 ± 1.87 µm (N = 7), with a soma cross 
sectional area of 92.56 µm2. Only one process was observed which appeared to be 
very fine, sending local branching within the vicinity of lamina X itself and potentially 
into the area of the ventral horn (see Figure 3.18).  
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Figure 3.16:  Morphological study of a ChAT/ GAD67-GFP co-localised 
neurone using juxtacellular labelling in combination with IHC. The co-
localised neurone (indicated by the arrow in A) was visualised using double 
labelling fluorescent IHC for ChAT (Ai) and GFP (Aii), with streptavidin 
pacific blue being used to label the neurobiotin tracer (Aiii). The ChAT 
staining in Ai is pale due to the low permeability of the antibody into the 300 
µm thick spinal cord section. The focal plane which depicted the largest 
area of the soma was selected for viewing under a confocal microscope (Ai 
to Aiv). The labelled neurone was then processed using DAB protocol (B) 
to observe morphology; additionally illustrated in the drawing (C) using 
camera lucida. 
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Figure 3.17:  Morphological study of a ChAT-IR neurone using 
juxtacellular labelling in combination with IHC.  
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Figure 3.17 (continued):   
The neurone (indicated by an arrow in A) was visualised with streptavidin 
pacific blue to label the neurobiotin tracer (Aiii).  Double IHC revealed the 
neurobiotin labelled cell was ChAT-IR (Ai) yet did not contain 
immunoreactivity for GAD67-GFP (Aii). The labelled neurone was then 
processed using DAB protocol (Bi at lower magnification and Bii at higher 
magnification) to observe morphology; as additionally illustrated in the 
drawing (C) using camera lucida. Images shown are epifluoescent (Ai-Aiii) 
and brightfield photomicrographs (Bi-Bii). 
 
 
Figure 3.18:  Morphological study of a GAD67-GFP-IR neurone 
labelled juxtacellularly with neurobiotin.  
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Figure 3.18 (continued):  
Double IHC revealed the neurobiotin labelled cell (Aiii) did not contain 
ChAT immunoreactivity (Ai) yet contained immunoreactivity for GAD67-
GFP (Aii).  Visualisation of neurobiotin with DAB (B) and mapping using 
camera lucida (C) revealed a long, fine process (indicated by arrows in B 
and C) branching within the vicinity of lamina X (arrows).  Images shown 
are epifluoescent (Ai-Aiii) and brightfield photomicrographs (B). 
 
3.4.5 Close apposition between ChAT/GAD67-GFP co-localised 
neurones in lamina X and glutamatergic, glycinergic and 
GABAergic terminals.  
Possible inputs onto the ChAT/GAD67-GFP co-localised neurones in lamina X were 
investigated since this knowledge would indicate potential connections between the co-
localised neurones and other pathways. Using VGLUT1 and VGLUT2 as markers for 
glutamatergic terminals, possible projections were explored from glutamatergic 
terminals to the co-localised neurones of lamina X in adult mice. In addition, GlyT2 was 
used to label glycinergic terminals, while GAD67 was selected as a marker to label 
GABAergic terminals. 
 
3.4.5.1 Close apposition between ChAT/GAD67-GFP co-localised 
neurones in lamina X and glutamatergic terminals 
Both VGLUT1-IR and VGLUT2-IR terminals formed close appositions near the somata 
of ChAT/GAD67-GFP co-localised neurones in lamina X (see Figure 3.19 and 3.20). 
The average numbers of VGLUT1-IR and VGLUT2-IR terminals were 7.4 ± 3.41 (mean 
± SEM) boutons per 100 µm (membrane of co-localised neurone cell body) (N = 2) and 
18.23 ± 3.61 per 100 µm (N = 2) respectively. 
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Figure 3.19:  VGLUT1-IR terminals form close appositions with 
ChAT/GAD67-GFP co-localised neurones in lamina X. The arrows 
indicate the location of VGLUT1-IR terminals in close proximity to the cell 
body and proximal dendrites of a co-localised neurone. Images show 
immunoreactivity for ChAT (Ai), GAD67-GFP (Aii), VGLUT1 (Aiii) and the 
merged image (Aiv). Co-localisation of ChAT and GAD67-GFP appears as 
white in the merged image. Images acquired by confocal microscopy. 
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Figure 3.20:  VGLUT2-IR boutons form close appositions onto 
ChAT/GAD67-GFP co-localised neurones in lamina X. The arrows 
indicate the location of VGLUT2-IR terminals having close proximity to the 
cell body of a co-localised neurone. CC: central canal. Images acquired by 
confocal microscopy. 
 
3.4.5.2 Close apposition between ChAT/GAD67-GFP co-localised 
neurones in lamina X and glycinergic terminals  
GlyT2-IR terminals were also found in close proximity to ChAT/GAD67-GFP co-
localised neurones in lamina X (see Figure 3.21). The average number of GlyT2-IR 
terminals was 13.24 ± 1.86 per 100 µm (N = 2). 
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Figure 3.21:  GlyT2-IR terminals form close appositions with co-
localised neurones in lamina X. The arrows indicate the putative close 
contacts of GlyT2-IR terminals with the cell body of a co-localised neurone. 
CC: central canal. Images acquired by confocal microscopy. 
 
3.4.5.3 Close apposition between ChAT/GAD67-GFP co-localised 
neurones in lamina X and GABAergic terminals  
GAD67 was used as a marker for GABAergic terminals. The results suggested that 
GAD67-IR terminals were in close proximity to ChAT/GAD67-GFP co-localised 
neurones in lamina X (see Figure 3.22). The average number of GAD67 terminals was 
6.26 ± 2.53 per 100 µm (N = 2). 
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Figure 3.22:  GAD67-IR terminals in close proximity with co-localised 
neurones in lamina X. The arrows indicate the putative contacts of the 
GAD67-IR terminals onto the cell body of a co-localised neurone. Images 
acquired by confocal microscopy. 
 
3.5 Discussion 
3.5.1 Summary 
In this study, small populations of neurones in lamina X and the dorsal horn of cervical, 
thoracic and lumbar spinal cords of adult mice are described which contain the 
synthesizing enzymes for both ACh and GABA; with the larger number being contained 
in lamina X. The majority of co-localised neurones were located ventral and 
ventrolateral to the central canal. A very limited number of co-localised neurones were 
observed in lamina VII and the ventral horn of adult spinal cords. Moreover, co-
localisation was not observed in the lateral horn of adult mice.  
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In preparation for morphological and projection studies of these co-localised neurones 
using juxtacellular labelling under electrophysiological conditions, the spinal cords of 
young animals were likewise investigated; since the presence of co-localised neurones 
in the young animals needed to be established prior to undertaking the 
electrophysiological work. The results from the young animals were similar to those 
obtained from the adult mice, since lamina X contained the majority of co-localised 
neurones compared to the other areas. In addition there were a small number of co-
localised neurones in the dorsal horn of young mice, while a very limited number of co-
localised neurones were discerned in lamina VII and the ventral horn; similar to the 
observations for adult mice. Co-localised neurones were not observed in the lateral 
horn of young mice.  
Application of juxtacellular labelling, in combination with IHC, revealed the morphology 
and dendrites of the ChAT/GAD67-GFP co-localised neurones in lamina X of the 
mouse spinal cord. The axon was not identified, which may possibly be a result of the 
projections travelling in the sagittal plane and so the associated terminals were not 
located within the recovered section.  
Terminal labelling IHC suggested that the co-localised neurones in lamina X likely 
received input from VGLUT1-IR, VGLUT2-IR, GlyT2-IR and GAD67-IR terminals.  
 
3.5.2 Co-expression pattern of ChAT/GABA (or GAD) and other 
neurochemical markers with respect to previous studies  
The results of this study indicate the presence of a subgroup of interneurones that are 
predominantly observed in lamina X of the spinal cord, and which potentially utilise 
both ACh and GABA.  
In the spinal cord, co-expression of ChAT/GABA (Todd, 1991, Mesnage et al., 2011) as 
well as GABA/glycine (Todd, 1991)  have been previously reported in dorsal horn 
neurones. Kosaka et al. reported the co-localisation of ChAT and GAD (or GABA) in 
the area lateral to the central canal in lamina X and in the intermediate grey (lamina 
VII) (Kosaka et al., 1988).  The possible co-localisation of ChAT and GABA in neurones 
ventral to the central canal was proposed by Spike et al. (1993) who found that NADPH 
diaphorase positive neurones were mostly immunoreactive for GABA (Spike et al., 
1993).  Working from the postulations of Kosaka (1988) and Todd (1991) that some 
GABAergic neurones were likely to also produce acetylcholine, Spike et al.  also 
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established that many NADPH diaphorase positive neurones around the central canal 
additionally exhibited ChAT immunoreactivity.  Based on their findings they inferred 
that coexpression of ChAT and GABA occurred within at least a proportion of NADPH 
diaphorase neurones in lamina X, although they could not directly demonstrate the 
ChAT/GABA co-localisation.  A study by Miles et al. determined that the ChAT positive 
interneurones giving rise to the C boutons that innervate ventral horn motoneurones 
were discretely located lateral to the central canal in lamina X and medial lamina VII, 
plus that they co-localised with YFP in the transgenic mouse used (Dbx1-YFP) but not 
with NOS.  Moreover, some interneurones around the central canal that did not give 
rise to C boutons were demonstrated to be ChAT and NOS positive (Miles et al., 2007). 
Whilst the aforementioned studies provided strong evidence for the existence of a 
population of ChAT and GAD co-expressing neurones in lamina X, only Kosaka (1988) 
showed direct coexpression in the region.  By contrast, this study has described a 
population of GAD67-GFP expressing neurones predominantly located in the ventral 
aspect of lamina X for which direct evidence of ChAT immunoreactivity has been 
observed. 
 
3.5.3 Technical Summary  
3.5.3.1 Validation of IHC and Fluorogold labelling experiments. 
The antibodies used in this study have appropriate control and ChAT, GFP and GAD67 
antibodies have been characterised by Chapman et al 2003 (see details in Table 2.2). 
The validation of the staining of other antibodies have been compared to the literature 
and found to be reliable to use as desbribed in chapter 2 (see Table 2.2). 
In our study, Fluorogold injection (Ambalavanar and Morris, 1989) was made through 
IP injection to distinguish motoneurones and SPNs from interneurones. Although an 
adverse aspect of using Fluorogold is that it is non specific to a particular group of 
neurones and could diffuse from the injection site to be endocytosed by any neurones 
whose terminals make contact with it (Catapano et al., 2008), the IP injection of 
Fluorogold has become widely used to distinguish motoneurones and SPNs from 
interneurones in spinal cord studies (Anderson and Edwards, 1994, Al-Mosawie et al., 
2007). In our study, Fluorogold labelling is observed in cholinergic motoneurones of the 
ventral horn and cholinergic SPNs, but not for cholinergic dorsal horn cells. As such its 
labelling pattern is believed to be validated for use in this study.   
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3.5.3.2 Sample size and statistical approaches 
Ideally cell populations would be studied in their entirety but there are clear practical 
limitations to this approach depending on the numbers involved and tissue distribution.  
Where it is not feasible to study a population, due to time or technical constraints, a 
representative or sample population can be used to estimate and draw conclusions 
with regard to the whole population (Nayak, 2010).  For the purpose of this study, a 
statistical comparison between 2 groups was used to determine the similarity of a 
neurochemically defined population identified in young animals following maturation.  
Ordinarily sample size calculations precede the experimental phase of a study in order 
to predict the sample size required to give a meaningful observation (Nayak, 2010). 
This is useful in reducing the number of animals required for a study and predicting 
costs when writing grants but can be estimated reasonably accurately on previous 
experience or following best practices within a field (Dell et al., 2002, Charan and 
Kantharia, 2013). 
As this work was initiated as a speculative study investigating the occurrence and 
distribution of neurones co-localising ChAT and GAD67-GFP in regions of the medulla 
and spinal cord of adult mice, power analysis was not performed in advance of 
experimentation.  When it was determined that the juxtacellular labelling method should 
be used to investigate the connectivity of co-localised neurones in the spinal cord a 
new technical consideration was introduced.  The production of viable spinal cord 
slices for electrophysiology from adult animals is a difficult process facilitated by the 
use of neonates instead.  This required validating the population to ChAT/GAD67-GFP 
co-localised neurones observed in the ventral part of lamina X of adult animals are 
present in the juveniles to be used for electrophysiological investigation. As such, a 
quantitative description of the differences between this population of neurones in young 
and old animals was a secondary question considered after the data was collated.  
Owing to the circumstances, the sample size used was determined through previous 
experience of similar studies. 
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3.5.3.3 Problems encountered in labelling the ChAT/GAD67-GFP co-
localised neurones via juxtacellular labelling; approach, success 
rates, quality of fills and quality of immunolabelling 
The technique of juxtacellular labelling (Pinault, 1996, Joshi and Hawken, 2006) was 
utilised to observe the possible projections of co-localised neurones. One problem to 
obtaining increased numbers of labelled co-localised neurones from the juxtacellular 
activities was the nature of the selected transgenic mouse line, since it enabled the 
visualisation of only GABAergic (GAD67-GFP) neurones during the labelling process. 
Therefore, knowledge of whether the neurones being labelled during the juxtacellular 
labelling process were co-localised or not could not be determined. After the 
juxtacellular labelling process, co-localisation could only be confirmed once cell 
recovery had been completed utilising IHC. As a result, only one co-localised neurone 
(1/34 neurones = 3%) was labelled in this study from 34 neurones that were recovered.  
A potential solution for this difficulty would involve current transgenic technologies 
creating an animal line suitable for the study of neurones co-expressing both enzymes 
synthesising ACh and GABA, so allowing for detailed studies in relation to their 
possible function and how they fit in the spinal cord circuits. Saito et al. reported a 
study involving the use of a double transgenic rat model in which the neurones within 
the prepositus hypoglossi nucleus expressed both ChAT and vesicular GABA 
transporter (VGAT) (Saito et al., 2015). This rat model may prove to be a suitable 
candidate in aiding future studies to investigate the functions of our co-localised 
neurones.  
When undertaking triple labelling to label co-localised neurones along with a neuronal 
tracer, the availability of secondary antibodies and microscope filters prevented us from 
using tracer dyes such as rhodamine in addition to neurobiotin. As a result neurobiotin 
was the sole tracer used to label the neurones. One of the disadvantages to the use of 
neurobiotin is that it is colourless and cannot be visualised under a fluorescence 
microscope. Therefore, we could not confirm whether neurones were being filled with 
the dye during the passing of current.   
GAD67-GFP positive cells located in regions of the spinal cord which contained the 
majority of the small co-localised neurone population were visualized and targeted. 
Successful recovery of the filled neurones then required triple labelling with IHC for 
GAD67-GFP, ChAT and neurobiotin.  Since only a small percentage of all GAD67-GFP 
positive neurones in the lamina X also expressed ChAT, this proved to be technically 
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challenging.  Low yields have been described by other researchers when attempting to 
juxtacellularly fill and then co-label for only a single neurotransmitter, rather than the 
two that was attempted in this study. For example, with respect to the raphe nuclei, 
where a very high proportion of cells are known to be serotonergic, only 12.9 % of the 
juxtacellularly labelled cells were successfully identified as 5-HT immunopositive by 
Iceman et al. (Iceman et al., 2013). The low yield of recovered and triple co-labelled 
cells was therefore to be expected.     
The quality of fills also plays an important role for cell recovery. The quality of cell 
attachment, application of appropriate current, labelling time and the viability of the 
labelled cells, can all act to affect the quality of subsequent immunolabelling (Duque 
and Zaborszky, 2006).  
In relation to cell recovery utilising IHC, given the lack of reported information on the 
morphology of ChAT/GAD67-GFP co-localised neurones in the spinal cord we did not 
know which direction their processes were likely to travel within the spinal cord slice. 
As such, the whole 300 µm thick slice containing a labelled neurone was recovered 
without further re-sectioning. At this thickness it is difficult for the antibodies to 
penetrate into the sections, plus there was increased risk of cross reaction from the 
application of triple labelling, so making it particularly challenging to achieve successful 
staining through the application of IHC on these slices.  
 
3.5.4 Neurones located within lamina X which co-express the 
synthesising enzymes for ACh and GABA constitute a novel 
subgroup of interneurones.  
In this study, the majority of neurones which exhibit co-localisation are observed in 
lamina X of the cervical, thoracic and lumbar cord regions; particularly in the areas 
ventral and ventrolateral to the central canal. They are negative for Fluorogold labelling 
which suggests that they are neither motoneurones nor preganglionic neurones; 
Fluorogold is a retrograde tracer which labels motoneurones and preganglionic 
neurones (Ambalavanar and Morris, 1989). Therefore, it is proposed that these 
neurones constitute a novel subgroup of interneurones within the area around the 
central canal that potentially utilise both ACh and GABA as their neurotransmitters.  
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3.5.5 Challenges in establishing possible projections of co-localised 
neurones 
The results from the juxtacellular labelling made it clear how difficult it was to target and 
fill single co-localised cells and the technical difficulties in this are discussed below. 
The limited data obtained from juxtacellular labelling was not able to identify the 
potential targets for projections from these co-localised neurones in lamina X. A 
possible explanation for the lack of idendification may be that the neurone projections 
travelled in the sagittal plane and so the associated terminals were not located within 
the studied section. Furthermore, the relatively small size of the co-localised neurones 
suggests that their dendrites and axon might reasonably be expected to be fine and 
small, which in turn would have made observation of their termination sites 
considerably challenging.  
There have been no previous reports on the co-localisation of GABAergic and 
cholinergic machinery in presynaptic terminals in the spinal cord. Based on our data, 
combined with the known location of cholinergic boutons in the vicinity of lamina X and 
adjacent areas as reported by other studies, the co-localised neurones might project to 
three different regions; Firstly to SPNs in the IML, secondly to the cells surrounding the 
central canal and thirdly to cells within lamina X.  
Small sized cholinergic terminals have been detected in the lateral horn which contains 
SPNs  (Deuchars and Lall, 2015). As previously mentioned in section 1.6.4, in relation 
to autonomic control, ACh plays an important role in cardiovascular regulation; as 
evidenced by studies involving anaesthetised rats, where  injecting ACh into the IML of 
the thoracic cord resulted in increased heart rate (McKitrick and Calaresu, 1991). On 
the other hand, in the rat spinal cord slice, the weak effect of Ach was specifically 
remarked upon (Gibson and Logan, 1995), and potentially attributed to rapid 
metabolism of ACh by endogenous cholinesterase.  By instead using the enzyme-
resistant acetylcholine analogue carbachol, hyperpolarising responses in SPNs were 
subsequently observed and ascribed to M2 muscarinic receptor activation.  
ChAT-IR fibres possessing a terminal-like appearance were previously observed in the 
central grey matter in proximity to non-ChAT-IR cells of the ependymal layer by Barber 
et al. (Barber et al., 1984). Close apposition of cholinergic structures to cells 
surrounding the central canal in the spinal cord, including ependymal cells and 
131  
 
cerebrospinal fluid contacting cells (CSFcCs), has been observed (Corns et al., 2015). 
Both ependymal cells and CSFcCs reacted to ACh.  
Based on our results from juxtacellular labelling, plus reported evidence indicating that 
ACh has an effect on neurones within lamina X, the third possible target of projections 
from the co-localised neurones is likely to be to lamina X itself. According to Bordey et 
al. (Bordey et al., 1996a) DMPP, a selective nAChR agonist, gave rise to a direct 
depolarization of SPNs in the CAA, so suggesting that nicotinic excitation of such 
neurones could influence sympathetic outflow. In addition, DMPP application also 
depolarised what were seemingly non-SPNs in lamina X (predominantly located in the 
ventral part of the dorsal commissure and also in the pericanal region), so suggesting 
that those neurones possessed nAChRs (Bordey et al., 1996b).  
In addition, the ventral horn might also constitute a possible target for these co-
localised neurones. Although the main source of cholinergic input in the form of           
C boutons to motoneurones in the ventral horn is reported to originate from cholinergic 
interneurones lateral to the central canal (Miles et al., 2007), our hypothesis regarding 
possible projections from the co-localised neurones to the ventral horn cannot be ruled 
out, since small cholinergic fibres can be observed to have contact onto the 
motoneurones (Barber et al., 1984). 
Therefore, since the exact source of the cholinergic input onto all these regions in the 
spinal cord remains currently unknown, yet must be from a local source (Barber et al., 
1984, Gotts, Unpublished Data), the neurones described here may form part of this 
innervation. 
 
3.5.6 ChAT/GAD67-GFP co-localised neurones in lamina X likely receive 
both excitatory and inhibitory inputs; possible origins of VGLUT1, 
VGLUT2, GlyT2 and GAD67 inputs to co-localised neurones. 
The results indicate that the ChAT/GAD67-GFP co-localised neurones in lamina X of 
the spinal cord likely receive excitatory inputs from terminals immunoreactive for 
VGLUT1 and VGLUT2. VGLUT1 inputs onto these neurones may originate from 
primary afferents  (Todd et al., 2003, Alvarez et al., 2004) and/or the corticospinal tract 
(Du Beau et al., 2012), while VGLUT2 terminals are suggested to come from 
interneurones  (Todd et al., 2003, Alvarez et al., 2004) and descending projections (Du 
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Beau et al., 2012). In addition the co-localised neurones are also likely to receive 
inhibitory inputs from both GlyT2 and GAD67 terminals as indicated by close apposition 
of these terminals onto the co-localised neurones.  Suggested sources for GABAergic 
and glycinergic axons are local interneurones (Spike et al., 1993, Mackie et al., 2003). 
From these observations, it is suggested that ChAT/GAD67-GFP co-localised 
neurones are interneurones that form part of spinal circuits involved in modulating and 
integrating roles in different systems, or alternatively they may have a role in the 
provision of antagonistic feedback within the system in which they are involved, such 
as in efferent modulation.  
It should be noted that the visualisation of possible inputs onto the co-localised 
neurones was obtained using confocal microscopy. This approach only allows the 
assertion that terminals are in close apposition to the soma and may represent synaptic 
inputs.  Definitive proof that these close appositions are indeed synapses would require 
the visualisation of the synaptic contact by electron microscopy. 
 
3.5.7 ChAT/GAD67-GFP co-localised neurones in the dorsal horn 
In our study ChAT/GAD67-GFP co-localised neurones were observed in the dorsal 
horn. Todd (Todd, 1991) reported similar results in which 94% of ChAT-IR neurones 
within lamina III were also immunoreactive to GABA. Although Todd reported that 
GABAergic neurones in lamina III of the dorsal horn generally co-express glycine 
(Todd, 1991), GABA-IR neurones immunoreactive to ChAT constituted a different 
group (as they were not immunoreactive to glycine), so suggesting that these two 
neuronal populations possess different roles in sensory circuits.  
 
3.5.8 Functional consideration of co-transmission 
One neurone can release more than one neurotransmitter, a trait which is termed co-
transmission (Douglas and Poisner, 1966, Burnstock, 1976, Westfall et al., 1978, 
Sneddon and Burnstock, 1984, Lee et al., 2010, Ishibashi et al., 2013). Co-
transmission has been observed and reported in many CNS regions, including GABA-
glycine in spinal cord (Jonas et al., 1998, Ishibashi et al., 2013), ACh-GABA in retina 
(Lee et al., 2010) and ACh-glutamate in the brain (Ren et al., 2011, Guzman et al., 
2011). Through co-transmission each neurotransmitter can increase the capability of a 
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circuit to be involved in numerous distinctive tasks (Lee et al., 2010, Ishibashi et al., 
2013). In our study, although the function of ACh-GABA co-transmission of 
ChAT/GAD67-GFP co-localised neurones in lamina X has not been studied, it is likely 
that the co-transmission from these neurones not only enhances the ability of the 
associated circuits but also provides for fast synaptic transmission to the circuits in 
which they are involved, similar to what occurs in the retina (Lee et al., 2010). Within 
the spinal cord, each important circuit (motor, sensory or autonomic) has its own 
distinctive control. However, interconnection between circuits is also required in order 
for optimal or appropriate responses to be received and discharged. These neurones 
which exhibit co-localisation in the spinal cord could be a conduit for interconnection 
within or between these circuits.  
It is possible that ChAT/GAD67-GFP co-localised neurones in lamina X are 
interneurones that have a role in sympatho-motor integration. The key function of the 
autonomic nervous system is to maintain homeostasis of the body (Deuchars, 2007) . 
Sympathetic outflow from the spinal cord levels comes from SPNs, which comprise the 
sole connection between the CNS and the peripheral nervous system. SPNs are 
innervated by supraspinal inputs (see Figure1.13), with some circuits requiring 
interneurones in order to establish contact onto SPNs. However, identification of the 
sympathetic interneurones is challenging due to the spinal cord being heterogeneous 
with respect to its neuronal cell type population.  As a result the locations of 
interneurones controlling sympathetic activity in laminae V, VII and X, plus in the IML 
region, have only been established in the last few decades.  Along with supraspinal 
innervation, sympathetic interneurones also receive innervation from afferent 
pathways, which have a crucial contribution to the maintenance of sympathetic outflow. 
The observations from our study indicate potential synaptic inputs onto ChAT/GAD67-
GFP co-localised neurones in lamina X from various other pathways, including primary 
afferents  (Todd et al., 2003, Alvarez et al., 2004)  and/or the corticospinal tract (Du 
Beau et al., 2012) through VGLUT1 inputs , interneurones  (Todd et al., 2003, Alvarez 
et al., 2004) and descending projections (Du Beau et al., 2012) through VGLUT2-IR 
terminals, plus inhibitory inputs via both GlyT2-IR and GAD67-IR terminals (Spike et 
al., 1993, Mackie et al., 2003). ChAT/GAD67-GFP co-localised neurones may therefore 
be a further subgroup of sympathetic interneurones, one that potentially utilises both 
ACh and GABA to play a role in sympatho-motor integration. 
An alternate hypothesis is that the ChAT/GAD67-GFP co-localised neurones observed 
in lamina X could be postnatally newborn cells which are in the process of acquiring 
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their identity as cholinergic cells. This is because the area surrounding the central 
canal of the spinal cord contains the ependymal cell layer, which is the spinal cell niche 
(Corns et al., 2015), and as such it is likely that newborn cells would be located in close 
proximity to this region. The ChAT/GAD67-GFP co-localised neurones might therefore 
be in a transitional phase, changing from neuroblasts which are GABAergic, as 
observed from those in subventricular neurogenic zones (Platel et al., 2010), to 
become cholinergic neurones. As a result these neurones would be lightly 
immunoreactive for both GAD67-GFP and ChAT. Consistent with this was the finding 
that there were more GAD67-GFP-IR cells in lamina X of the young mouse compared 
to the older mouse.  However, the number of ChAT and GAD67-GFP dual labelled 
cells was not significantly different in lamina X between the two age groups. It therefore 
remains to be determined if either of these cell types are indeed born postnatally.  
The ChAT/GAD67-GFP co-localised neurones observed within lamina X in our study 
constitutes a newly identified subgroup of interneurones that potentially utilise both 
ACh and GABA. These neurones may play an important role in relation to sympatho-
motor integration within spinal cord circuits. 
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4 Co-expression of ChAT and GAD67-GFP 
reveals a novel neuronal phenotype in the 
mouse medulla oblongata  
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4.1 Rationale 
The presence of neurones expressing both ChAT and GAD67-GFP in lamina X 
throughout the cervical, thoracic and lumbar spinal cord was observed in this study.  An 
aspect of interest pertained to the rostral termination of this group of neurones and 
whether their presence in the medulla oblongata related to a particular area and thus 
could provide insight into a possible physiological role.  The aim of this chapter was to 
investigate the distribution, morphology and location of ChAT/GAD67-GFP co-localised 
neurones, with our preliminary findings leading us to focus primarily on the NTS. 
Supplemental observations were also made of the co-localisation in other areas within 
the medulla oblongata. 
 
4.2 Roles and presence of GABA and ACh in the NTS  
GABAergic systems play an important part in autonomic pathways and blockade of 
GABAergic signalling in the NTS broadly impacts cardiovascular (Mei et al., 2003), 
respiratory (Wasserman et al., 2002) and gastrointestinal regulation (Travagli et al., 
2006). IHC for GABA or its synthesizing enzyme GAD67 reveals GABAergic neurones 
and terminals throughout the NTS (Maqbool et al., 1991, Izzo et al., 1992, Kawai and 
Senba, 1999, Fong et al., 2005, Okada et al., 2008). Similarly in transgenic animals in 
which enhanced GFP expression was linked to GAD67 expression, labelled neurones 
were widespread across the NTS, and the majority were directly activated by solitary 
tract afferents (Bailey et al., 2008).   
A functional cholinergic system has also been described in the NTS. Microinjection of 
ACh into the rat NTS induces dose-dependent baroreflex-like hypotensive and 
bradycardic responses (Criscione et al., 1983, Tsukamoto et al., 1994, da Silva et al., 
2008), modulates sympathetic and phrenic nerve activity (Furuya et al., 2014) and 
elicits a swallowing response (Hashim and Bieger, 1987).  
Anatomically, some NTS neurones and terminals have been shown to contain the ACh 
hydrolysing enzyme - AChE (Kobayashi et al., 1978) and the enzyme responsible for 
synthesizing ACh - ChAT (Helke et al., 1983, Simon et al., 1985, Armstrong et al., 
1988, Ruggiero et al., 1990).  Two populations of ChAT-IR neurones in the NTS have  
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been described, one in medial NTS just dorsal to the dorsal vagal nucleus and one 
surrounding the medial and dorsal borders of the tractus (Armstrong et al., 1988). 
Although GAD67-IR (Fong et al., 2005) and ChAT-IR (Ruggiero et al., 1990) neurones 
have been observed in the rat NTS, to date there has been no report on the co-
localisation of the enzymes responsible for synthesising for both ACh and GABA within 
neurones in this region. A potential reason for this is the difficulty in labelling 
GABAergic neurones in the brainstem with IHC. We therefore utilised the GAD67-GFP 
knock-in mouse line and combined this with IHC for ChAT to identify ChAT/GAD67-
GFP co-localised neurones in the NTS and other areas of the medulla oblongata. 
 
4.3 Methods  
For the study of ChAT/GAD67-GFP co-localisation detailed in this section, adult 
GAD67-GFP knock-in mice of either sex (4-6 weeks, n = 4) (Tamamaki et al., 2003) 
and wild type mice (4-6 weeks, n = 1, female) were used. Immunohistochemistry was 
performed as described previously (see section 2.7), using the combinations of 
antibodies detailed in Table 3.1. The location of each NTS subnucleus was identified 
via literature reports as illustrated in Figure 4.1. The experimental, analytical and 
quantification methods used for these investigations were those detailed in section 
2.12.2. As the majority of neurones in the central subnucleus of the NTS use nitric 
oxide (Wiedner et al., 1995) we utilised triple labelling with neuronal nitric oxide 
synthase (nNOS) to define the region (Table 4.1).  Since ChAT immunoreactivity within 
the NTS was apparently weak, we attempted to quantitatively determine if the 
weakness was possibly a result of lower ChAT expression or due to an artefact of our 
method.  To achieve this we compared ChAT immunoreactivity in the NTS against that 
observed in the dorsal vagal nucleus for the same section of a wild type mouse using 
DAB staining. Details of the DAB IHC protocol used, involving a DAB solution from 
Sigma, was as described in section 2.8. 
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Figure 4.1:  Various NTS subnuclei in three NTS regions, 
corresponding to a) rostral, b) intermediate and c) caudal (Figure 
adapted from Ciriello, 1994, Poole et al., 2007, Okada et al., 2008, 
Ganchrow et al., 2014). 
NTS subnuclei; ce: central subnucleus; com: commissural subnucleus; dl: 
dorsolateral subnucleus; dm: dorsomedial subnucleus; ins: interstitial 
subnucleus; int: intermediate subnucleus; lat: lateral subnucleus; m: medial 
subnucleus; v: ventral subnucleus; vl: ventrolateral subnucleus. 
Other structures; AP: area postrema; CC: central canal; IV: fourth ventricle; 
ST: solitary tract; X: dorsal vagal nucleus. 
Note: In the rostral NTS region (a), subnucleus gelatinosus is included 
within the region described as medial subnucleus. 
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Table 4.1:  Combinations of antibodies used for the triple labelling 
study of ChAT, GFP and nNOS in the central subnucleus of the NTS 
Target 
Marker 
Primary Secondary Tertiary 
Antibody Conc Source Antibody Conc Source Antibody Conc Source 
ChAT Goatanti- 
ChAT 
1:500 Millipore Alexa Fluor 
® 555 
donkey 
anti-goat 
1 : 
1000 
Invitrogen Streptavidin 
Alexa Fluor  
® 555 
1 : 
1000 
Invitrogen 
GFP Rabbit 
anti-GFP 
1: 
1000 
Invitrogen Alexa Fluor 
® 488 
donkey 
anti-rabbit 
1: 
1000 
Invitrogen    
nNOS Mouse 
anti-nNOS 
1: 
250 
Santa Cruz Biotinylated 
horse anti-
mouse 
1: 
500 
Vector 
Laboratories 
Streptavidin 
pacific blue  
1: 
1000 
Invitrogen 
  
Other areas in the medulla oblongata including the area postrema, reticular formation, 
dorsal vagal nucleus, hypoglossal nucleus and nucleus ambiguus were also 
investigated for the presence of the ChAT/GAD67-GFP co-localisation; using the same 
immunohistochemical protocol as that applied to the NTS study. The locations of such 
nuclei were identified based on information contained within the Allen mouse brain 
atlas (http://mouse.brain-map.org/) and literature (see Figure 4.2). In accordance with 
these resources, the area postrema was ascribed to be located at the midpoint of the 
dorsal surface of the medulla about the level of the obex (VanderHorst and Ulfhake, 
2006, Hindmarch et al., 2011) in close apposition to the 4th ventricle (Walberg and 
Ottersen, 1992). The dorsal vagal nucleus lay in the dorsal aspect of the medulla 
oblongata (VanderHorst and Ulfhake, 2006, Ai et al., 2007) and dorsal to the 
hypoglossal nucleus (VanderHorst and Ulfhake, 2006). The nucleus ambiguus was 
located in the ventrolateral part of the medulla oblongata (VanderHorst and Ulfhake, 
2006, Ai et al., 2007). The reticular formation consisted of scattered cells which 
spanned across the ventrolateral portion of the medulla oblongata (VanderHorst and 
Ulfhake, 2006).  The experimental and quantification methods used for these 
investigations were those detailed in sections 2.12.2.  
 
140  
 
 
Figure 4.2:  Diagram illustrating the approximate location of major 
nuclei of the medulla oblongata (Figure adapted from VanderHorst 
and Ulfhake, 2006). AP = area postrema, Ecu = external cuneate nucleus, 
LPGN = lateral paragigantocellular nucleus, NA = nucleus ambiguus, NTS 
= nucleus of tractus solitarius, Py = pyramidal tract, RF = reticular 
formation, Sp5I = interpolar part of spinal trigeminal nucleus, X = dorsal 
vagal nucleus, XII = hypoglossal nucleus. 
 
4.4 Results 
4.4.1 ChAT-IR and GAD67-GFP-IR neurones are present in the NTS and 
a small number are co-localised. 
ChAT-IR neurones could be found throughout the subnuclei of the NTS. The cell 
bodies of ChAT-IR neurones were oval or elliptical shaped with a size of 12.33 ± 0.49 
µm x 15.68 ± 0.8 µm (N = 16 neurones randomly chosen from all NTS subnuclei). The 
cross sectional area of the ChAT-IR soma was 154.07µm2. GAD67-GFP-IR neurones 
were also found throughout the NTS with oval or elliptical shaped cell bodies and with a 
size of 10.03 ± 0.31 µm x 12.59 ± 0.49 µm (N = 12 neurones randomly chosen from all 
NTS subnuclei). The cross sectional area of the GAD67-GFP-IR soma was 100.48 
µm2.  
A limited number of ChAT/GAD67-GFP co-localised neurones were observed in the 
NTS (Figure 4.3). These neurones had small cell bodies (8.15 ± 0.48 µm x 12.57 ± 
0.67 µm, N = 12). The cross sectional area of the ChAT/GAD67-GFP co-localised 
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soma was 84.3074 µm2. The highest percentage of co-localised neurones was found in 
the intermediate subnucleus (81 co-localised neurones / 610 total number of ChAT-IR 
and/or GAD67-GFP-IR neurones, 13.28%,  number of sections counted (nsc) = 6 
sections, n = 3 animals, see Figure 4.3-A), followed by the central subnucleus (19/215, 
8.84%, nsc = 6, n = 3, see Figure 4.3-B), the ventrolateral subnucleus (10/330, 3.03%, 
nsc = 12 , n = 3), the ventral (10/343, 2.92%, nsc = 12, n = 3, see Figure 4.3-C), the 
dorsomedial (13/556, 2.34%, nsc = 11, n = 3), the dorsolateral (3/247, 1.21%, nsc = 12, 
n = 3), the medial (6/924, 0.65%, nsc = 18, n = 3) and the commissural (2/479, 0.42%, 
nsc = 12, n = 3) subnuclei. No co-localised neurones were observed in the lateral 
(0/141, 0%, nsc = 12, n = 3) or interstitial subnuclei (0/31, 0%, nsc = 6, n = 3). See 
Table 4.2 for the average number of neurones observed per 50 µm section in each 
subnucleus of the NTS. 
When examined under a confocal microscope, GAD67-GFP staining was observed 
throughout the cytoplasm and nucleus of the neurones whereas ChAT staining was 
observed in the cytoplasm (see Figure 4.4-A, B).  
 
4.4.2 DAB IHC labelling for ChAT to assess staining intensity between 
the NTS and the dorsal vagal nucleus 
The intensity of DAB staining for ChAT-IR neurones in the NTS was observed based 
on a comparison with the intensity level of stained ChAT-IR neurones present in the 
same sections for the dorsal vagal nucleus, as present in three pictures (see Figure 
4.5-Aii (caudal region), Bii (intermediate region) and Cii (rostral region)); the method of 
DAB staining being that described in section 2.8 and 4.3. The lightness level of 
neurones was measured for five randomly chosen ChAT-IR neurones of the dorsal 
vagal nucleus and five randomly chosen NTS ChAT-IR neurones from each picture, 
using Image J software, with the data obtained being presented in Table 4.3 as mean ± 
SEM (arbitrary units); the details of the analysis was as described in section 2.12.2. 
The degree of lightness level for ChAT-IR neurones in all three regions of the NTS was 
much greater than that for the dorsal vagal nucleus. This means that the ChAT-IR 
neurones located in all three regions of the NTS exhibit lighter or paler intensity for the 
ChAT staining when compared to the dorsal vagal nucleus (the higher the number, the 
lighter the shade of colour and paler the intensity). Moreover, the intensity of staining 
for ChAT-IR neurones in the rostral region appears to be much darker than that in the 
caudal and intermediate regions.   
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Figure 4.3:  Distribution of ChAT-IR and GAD67-GFP cells in rostral 
and intermediate NTS.  
Fluorescent images showing the distribution of ChAT-IR and GAD67-GFP 
cells in the intermediate (Ai-Aiii), central (Bi-Biii) and ventral (Ci-Ciii) 
subnuclei of the rostral and intermediate NTS.  In all of these NTS 
subnuclei, double labelled cells containing both ChAT-IR (Ai, Bi and Ci) and 
GAD67-GFP (Aii, Bii and Cii) can be observed (Aiii, Biii and Ciii).  Arrows 
indicate double labelled neurones.  The schematic diagram is adapted from 
Paxinos and Watson (Paxinos and Watson, 1997) and indicates the 
approximate position of the subnuclei.  
  
 
Table 4.2:  The number of ChAT-IR and/or GAD67-GFP-IR neurones in each subnuclei of the NTS (per 50 µm section) in 3 
animals (n = 3). nsc = number of sections counted. Values are presented as mean ± SEM. 
NTS subnucleus Side ChAT/GAD67-GFP 
co-localised neurones 
Mean ± SEM 
ChAT-IR  neurones 
 
Mean ± SEM 
GAD67-GFP-IR 
neurones   
Mean ± SEM 
ChAT-IR neruones total 
number 
 
GAD67-GFP-IR 
neurones total number 
 
Co-localised neurones 
total number 
 
Intermediate                  
(n = 3, nsc = 6) 
Right                      
Left 
6.8 ± 1.9                                 
6.7 ± 2.2 
17.5 ± 4.3                            
16.7 ± 3.3 
37.3 ± 8.2                             
30.2 ± 6.4 
105                                  
100 
224                                         
181 
41                                         
40 
Central                           
(n = 3, nsc = 6) 
Right                      
Left 
1.0 ± 0.7                                         
2.2 ± 1.4 
2.2 ± 1.3                 
2.8 ± 1.6 
16.3 ±2.6                               
14.5 ± 2.0 
13                                        
17 
98                                            
87 
6                                            
13 
Ventrolateral                   
(n = 3, nsc = 12) 
Right                      
Left 
0.3 ± 0.1                                
0.5 ± 0.3 
1.6 ± 0.7                                  
1.8 ± 0.7 
13.3 ± 3.1                                
10.8 ± 2.3 
19                                            
21 
160                                       
130 
4                                       
6 
Ventral                                           
(n = 3, nsc = 12) 
Right                            
Left 
0.4 ± 0.2                                   
0.4 ± 0.2 
1.1 ± 0.4                           
1.0 ± 0.5 
13.8 ± 3.3                       
12.7 ± 2.3 
13                                             
12 
166                                      
152 
5                                      
5 
Dorsomedial                    
(n = 3, nsc = 11) 
Right                          
Left 
0.6 ± 0.3                                
0.6 ± 0.6 
4.4 ± 1.7                                 
4.6 ± 2.1 
18.9 ± 3.9                            
22.6 ± 5.9 
48                                         
51 
208                                        
249 
6                                        
7 
Dorsolateral                        
(n = 3, nsc = 12) 
Right                      
Left 
0.3 ± 0.2                               
0.0 ± 0.0 
2.2 ± 1.0                            
0.9 ± 0.4 
10.2 ± 3.4                               
7.3 ± 1.5 
26                                            
11 
122                                         
88 
3                                         
0 
Medial                                
(n = 3, nsc = 18) 
Right                       
Left 
0.2 ± 0.1                                
0.2 ± 0.1 
2.1 ± 0.6                                 
1.3 ± 0.3 
25.4 ± 4.0                            
22.6 ± 3.8 
37                                        
23 
458                                       
406 
6                                       
7 
Commissural                  
(n = 3, nsc = 12) 
 0.2 ± 0.1 5.0 ± 2.0 34.9 ± 9.1 60 419 2 
Lateral                             
(n = 3, nsc = 12) 
Right                     
Left 
0.0 ± 0.0                                
0.0 ± 0.0 
0.1 ± 0.1                                 
0.1 ± 0.1 
5.9 ± 1.6                           
5.7 ± 2.0 
1                                           
1 
71                                      
68 
0                                      
0 
Interstitial                          
(n = 3, nsc = 6) 
Right                              
Left 
0.0 ± 0.0                             
0.0 ± 0.0 
0.7 ± 0.5                                  
0.0 ± 0.0 
3.3 ± 0.8                               
1.2 ± 0.5 
4                                          
20 
0                                          
7 
0                                          
0 
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Figure 4.4:  Examples of ChAT/GAD67-GFP co-localised neurones in 
the central and intermediate subnuclei of the NTS. Confocal images 
showing ChAT-IR staining is localised to the cytoplasm of the neurones in 
the central (Ai) and intermediate (Bi) subnuclei of the NTS whereas 
GAD67-GFP is present in the nucleus and the cytoplasm (Aii, Bii). 
 
Table 4.3:  The relative lightness level for ChAT staining of neurones 
between the dorsal vagal nucleus and the NTS (AU = Arbitrary Unit). 
The greater the number, the lighter (paler) the shade of colour. Note: for 
each region, 5 dorsal vagal neurones and 5 NTS neurones were measured 
using Image J software.  
NTS Regions DAB IHC 
 dorsal vagal nucleus  (AU) NTS (AU) 
Caudal  92.05 ± 9.46 169.82 ± 2.92 
Intermediate  95.47 ± 3.36 140.05 ± 1.47 
Rostral 67.50 ± 5.43 127.44 ± 2.80 
145  
 
 
Figure 4.5:  ChAT-IR neurones in the dorsal vagal nucleus, 
hypoglossal nucleus and the NTS in the medulla oblongata, visualised 
using DAB IHC. Ai, Bi and Ci indicate sections corresponding to the 
caudal, intermediate and rostral regions of the NTS respectively. Magnified 
views of the outline areas for the medial, central, and intermediate 
subnuclei of the NTS in Ai, Bi and Ci  are shown in Aii, Bii and Cii 
respectively. The marked area in Aii, Bii and Cii have been further 
magnified as shown in Aiii, Biii and Ciii respectively. ChAT-IR neurones 
located in the caudal, intermediate and rostral regions of the NTS exhibit 
lighter intensities for the ChAT staining when compared to the dorsal vagal 
nucleus. AP: area postrema; CC: central canal; HN: hypoglossal nerve; IV: 
fourth ventricle; VN: vagus nerve; X: dorsal vagal nucleus; XII: hypoglossal 
nucleus.  
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4.4.3 ChAT/GAD67-GFP co-localised neurones in the central 
subnucleus of the NTS do not contain nNOS 
Nitric oxide is the neurotransmitter of the majority of premotor neurones in the central 
subnucleus of the NTS (Wiedner et al., 1995). However, although ChAT/GAD67-GFP 
co-localised neurones were in close proximity to nNOS-IR neurones, they were not 
observed to contain nNOS immunoreactivity in the central subnucleus (see Figure 4.6-
Ai to Aiii) or any other subnuclei in the NTS (see Figure 4.6-Bi to Biii).  
 
4.4.4 Area postrema 
In the area postrema, ChAT-IR and GAD67-GFP-IR neurones were observed (see 
Figure 4.7). The ChAT-IR or GAD67-GFP-IR neurones in the region both had oval or 
elliptical shaped cell bodies, the sizes of which were 9.35 ± 0.43 µm x 12.77 ± 0.96 µm 
(N = 5) for ChAT-IR neurones and 9.26 ± 0.24 µm x 13.49 ± 0.60 µm (N = 5) for 
GAD67-GFP-IR neurones. The cross sectional areas of the ChAT-IR and GAD67-GFP-
IR soma were 96.09 and 101.64 µm2. 
A number of neurones in the area postrema were ChAT/GAD67-GFP co-localised (see 
Figure 4.7-Ai to Aiii, Bi to Biii); the size of these neurones was 10.50 ± 0.49 µm x 14.20 
± 0.97 µm) (N = 5). The cross sectional area of the ChAT/GAD67-GFP co-localised 
soma was 119.81 µm2. The mean number of co-localised neurones per 50 µm section 
was 8.83 ± 5.12 (nsc = 6 sections, n = 3). The percentage of co-localised neurones in 
all ChAT-IR and/or GAD67-GFP-IR neurones in the area postrema is 4.55% (53/1164 
neurones, nsc = 6, n = 3).  
 
4.4.5 Comparison of the the relative abundance of each 
neurochemically-defined population between NTS and area 
postrema. 
The number of ChAT/GAD67-GFP co-localised neurones in the NTS and area 
postrema (15.10 ± 7.60 for NTS and 8.83 ± 5.12 for area postrema) is not significantly 
different (p = 0.57). Similarly, the number of ChAT-IR neurones for NTS (58.30 ± 18.32) 
is not significantly different (p = 0.48) to that for the area postrema (38.67 ± 17.03). The  
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Figure 4.6:  ChAT/GAD67-GFP co-localised neurones in the NTS do 
not contain nNOS immunoreactivity. Fluorescent images illustrating that 
neurones in the central (Ai-Aiv) and intermediate (Bi-Biv) subnuclei of the 
NTS are ChAT/GAD67-GFP co-localised (arrows), but do not contain 
nNOS immunoreactivity (open arrows).  
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Figure 4.7:  All ChAT-IR neurones in the area postrema contain 
GAD67-GFP. Confocal images showing ChAT-IR and GAD67-GFP-IR 
neurones are found in the area postrema (Ai, Aii). Magnified views of the 
marked area in A are shown in B illustrates neurones that are 
immunoreactive to both ChAT (Ai, Bi) and GAD67-GFP (Aii, Bii) (Arrows 
indicate co-localised neurones). 
 
number GAD67-GFP-IR neurones between the two areas (329.40 ± 74.00 for NTS and 
155.33 ± 52.10 for area postrema, p = 0.12) is also not significantly different. 
 
4.4.6 Reticular formation and its adjacent regions 
ChAT/GAD67-GFP co-localised neurones could also be found throughout the reticular 
formation. The size of these neurones was 12.06 ± 0.41 µm x 15.03 ± 0.73 µm (N = 4) 
(see Figure 4.8-Ai to Aiv). The cross sectional area of the ChAT/GAD67-GFP co-
localised soma was 144.11 µm2. The mean number of co-localised neurones per 50 
µm section was 5.56 ± 1.29 and 5 ± 1.10 for the right and left side of the section 
respectively (nsc = 18 sections, n = 3), which was approximately 2% (190/>8903) of 
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the total ChAT-IR and/or GAD67-GFP-IR neurones. ChAT/GAD67-GFP co-localised 
neurones were also observed in the lateral paragigantocellular nucleus (see Figure 4.8-
Bi, Bii and Biv). These were 11.09 ± 0.94 µm x 20.03 ± 1.42 µm in size (N = 5) (see 
Figure 4.8-Bi to Biv). The cross sectional area of these ChAT/GAD67-GFP co-localised 
soma was 190.18 µm2. In the intermediate reticular formation and the lateral 
paragigantocellular nucleus occasional ChAT/GAD67-GFP co-localised neurones were 
also observed to be nNOS-IR (see Figure 4.8-A, B).  
 
4.4.7 The dorsal vagal nucleus  
In the dorsal vagal nucleus, a large number of neurones are ChAT-IR (see Figure 4.9-
Ai). These neurones were large in size (16.45 ± 1.07 µm x 23.87 ± 0.98 µm, N = 10) 
and possessed an oval or elliptical shaped cell body, typical of vagal preganglionic 
neurones. The cross sectional area of the ChAT-IR soma was 319.25 µm2. The dorsal 
vagal nucleus also contained occasional GAD67-GFP-IR neurones (see Figure 4.9-Aii), 
which similarly exhibited oval or elliptical shaped cell bodies, but were smaller in size 
(10.08 ± 0.58 µm x 13.86 ± 0.94 µm, N = 10). The cross sectional area of the GAD67-
GFP-IR soma was 112.55 µm2. No ChAT/GAD67-GFP co-localised neurones were 
observed in the dorsal vagal nucleus.   
 
4.4.8 The hypoglossal nucleus 
Many neurones in the hypoglossal nucleus were intensely ChAT-IR. These neurones 
were large in size (18.94 ± 0.94 µm x 25.42 ± 0.83 µm, N = 10) (see Figure 4.9-Bi). The 
cross sectional area of the ChAT-IR soma was 386.43 µm2. The hypoglossal nucleus 
also contained a limited number of GAD67-GFP-IR neurones (see Figure 4.9-Bii). Co-
localisation for ChAT and GAD67-GFP was not observed in the hypoglossal nucleus.  
 
4.4.9 Nucleus ambiguus 
The nucleus ambiguus contained intensely ChAT-IR neurones whose sizes, at 17.94 ± 
0.98 µm x 20.40 ± 1.25 µm (N = 5), were relatively large. The cross sectional area of 
the ChAT-IR soma was 288.66 µm2. Smaller GAD67-GFP-IR neurones (9.66 ± 0.64 
µm x 13.06 ± 0.89 µm, N = 5) were also found in this area. The cross sectional area of  
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Figure 4.8:  ChAT/GAD67-GFP co-localised neurones are observed in 
the intermediate reticular formation and the lateral paragigantocellular 
nucleus, some of which contain nNOS immunoreactivity.  
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Figure 4.8 (continued):  
Fluorescent images showing that neurones in intermediate reticular 
formation (IRF) (A) and the lateral paragigantocellular nucleus (LPGN) (B) 
are immunoreactive to both ChAT (Ai, Bi) and GAD67-GFP (Aii, Bii) 
(arrows). Some of these co-localised neurones are also nNOS-IR (Aiii, Biii). 
Open arrows in A show neurones that are not double and/or triple labelled. 
Open arrows in B show a neurone that is not triple labelled. 
 
the GAD67-GFP-IR soma was 101.37 µm2. Co-localisation of ChAT and GAD67-GFP 
was not observed (see Figure 4.9-Ci to Ciii). 
 
Figure 4.9:  No ChAT/GAD67-GFP co-localised neurones in the dorsal 
vagal nucleus, the hypoglossal nucleus or the nucleus ambiguus. 
Confocal (A and C) and fluorescent images (B) showing ChAT-IR and 
GAD67-GFP-IR neurones are present in the dorsal vagal nucleus (Ai, Aii), 
hypoglossal nucleus (Bi, Bii) and the nucleus ambiguus (Ci, Cii) and yet do 
not co-localise in these areas (Aiii, Biii, Ciii). 
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4.5 Discussion  
This study describes subpopulations of neurones containing enzymes responsible for 
the production of both ACh and GABA in areas of the medulla oblongata involved in 
autonomic control. ChAT/GAD67-GFP co-localised neurones were observed in the 
NTS, area postrema and the reticular formation of the mouse brainstem. Whilst 
neurones containing both ChAT and GAD (or GABA) immunoreactivity have previously 
been observed in neurones in the rat retina, cerebral cortex, basal forebrain and spinal 
cord (Kosaka et al., 1988), hypoglossal nucleus (Davidoff and Schulze, 1988), turtle 
retina (Nguyen and Grzywacz, 2000), and the tegmental nuclei of the cat (Jia et al., 
2003), these are the first such populations described throughout the medulla 
oblongata. 
 
4.5.1 ChAT-IR and GAD67-GFP-IR neurones in the NTS 
A very small number of ChAT/GAD67-GFP co-localised neurones was located 
throughout the NTS (with the exception of the lateral and interstitial subnuclei). The 
largest populations of co-localised neurones were observed in the intermediate and 
central subnuclei of the NTS. Their small size may correlate to the small cells with local 
axonal arborisation and no axonal projections (Okada et al., 2006, Kawai and Senba, 
1999) which include GABAergic neurones (Kawai and Senba, 1999) suggesting a 
potential role in integrating input information in local circuits of the NTS.  
Tracing studies have shown that the intermediate subnucleus of the NTS receives 
afferent input from the tongue (Hayakawa et al., 2001), soft palate, pharynx and larynx 
(Altschuler et al., 1989, Broussard and Altschuler, 2000) and contains pharyngeal 
premotor neurones. The central subnucleus of the NTS receives the majority of the 
sensory afferent inputs from the oesophagus (Altschuler et al., 1989) and contains 
oesophageal premotor neurones that project to the nucleus ambiguus. The small 
populations of ChAT/GAD67-GFP co-localised neurones in the intermediate and 
central subnuclei of the NTS may therefore play a role in the integration of several 
visceral sensory inputs that contribute to the reflex control of swallowing, gagging and 
phonation.  
The vast majority of premotor neurones in the central subnucleus of the NTS that 
project to the nucleus ambiguus use nitric oxide as a neurotransmitter (Wiedner et al., 
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1995). The fact that the ChAT/GAD67-GFP co-localised neurones in the central 
subnucleus of the NTS do not contain nNOS immunoreactivity may suggest these 
neurones are the small proportion of local interneurones that do not contain NOS. 
Indeed, it has been suggested that GABA interneurones in the intermediate and central 
subnuclei of the NTS inhibit the premotor neurones involved in the pharyngeal and 
oesophageal stages of swallowing (Wang and Bieger, 1991, Dong et al., 2000).  
It therefore seems likely that in the NTS ChAT/GAD67-GFPco-localised neurones are 
involved in circuitry mediating autonomic reflexes. Future studies may therefore 
investigate whether these co-localised neurones receive direct innervation from 
afferents or are otherwise involved in reflex arcs through their outputs. 
 
4.5.2 ChAT-IR and GAD67-GFP-IR neurones in the area postrema 
ChAT/GAD67-GFP co-localised neurones were observed in the area postrema and 
they contributed to a small percentage (4.55%, 53/1164) of all the ChAT-IR and/or 
GAD67-GFP-IR neurones in this area. The area postrema is a circumventricular organ 
located outside the blood brain barrier and a vital player in the control of autonomic 
functions. It receives blood borne information from the vasculature in addition to input 
from the vagus nerve, carotid sinus and other brain areas and projects to autonomic 
centres including the NTS, nucleus ambiguus, dorsal vagal nucleus and RVLM (Price 
et al., 2008). Previously GABA-IR (Walberg and Ottersen, 1992) and ChAT-IR (Tago et 
al., 1989) neurones have been observed in the rat area postrema but this is the first 
study to show a population of neurones which contain enzymes responsible for both 
ACh and GABA synthesis. The area postrema offers an attractive area in which to 
study the brainstem ChAT/GAD67-GFP neurones since all ChAT-IR neurones also 
contained GAD67-GFP. Transgenic mice in which ChAT neurones are labelled 
(Kolisnyk et al., 2013, Krasteva et al., 2012) would therefore enable specific targeting 
of these cells. 
 
4.5.3 ChAT-IR and GAD67-GFP-IR neurones in the reticular formation  
The reticular formation contains neurones involved in a wide range of autonomic and 
regulatory processes including ingestive responses and a role in organising rhythmic 
oromotor behaviours (St John, 1986, Inoue et al., 1994, Travers et al., 1997). We 
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observed 2% of neurones in this area were ChAT/GAD67-GFP co-localised, a 
subpopulation of which also contained nNOS immunoreactivity. Previously, Travers et 
al. (Travers et al., 2005) have shown that 6.7% of pre-oromotor neurones in the 
intermediate reticular formation contained both ChAT and NOS immunoreactivity and 
suggested that they may represent a subset of GABAergic neurones. This study has 
shown that there is indeed such a population of triple labelled neurones in the reticular 
formation, although their function remains to be determined. 
 
4.5.4 Unravelling functions of ChAT/GAD67-GFP co-localised neurones. 
A significant hurdle to unravelling the functions of the dual labelled neurones identified 
here are their small numbers and limited intensity of immunolabelling. However, current 
transgenic technologies may render these neurones amenable to further investigation, 
for example, the GAD67-GFP knock-in mice used in this study could feasibly be 
crossed with another line of mice bred to express a complementary reporter such as 
mCherry under control of the ChAT promoter (Nagode et al., 2011, Nelson et al., 
2014). It is possible that transgenic technologies may also enable selective expression 
of optogenetic proteins within these cells thus permitting selective activation/inhibition 
(Nagode et al., 2011) in future functional investigations. Indeed, recent technology has 
introduced transgenic mice for intersectional targeting of specific neurone populations 
for expression of neural sensors and effectors (Madisen et al., 2015), an approach that 
would be ideal for revealing the functions of dual expressing neurones such as these 
ChAT/GAD67-GFP co-localised neurones. Such approaches to reveal functions of 
these and other cell classes may therefore provide improved understanding of 
autonomic microcircuitry in the medulla oblongata. 
 
4.6 Conclusion 
Small populations of neurones in the NTS, area postrema, reticular formation and 
lateral paragigantocellular nucleus in the mouse medulla oblongata contain the 
synthesizing enzymes for both ACh and GABA. In all areas in the brainstem the 
function of these neurones is currently unknown.  
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5 General Discussion 
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5.1 ChAT/GAD67-GFP co-localised neurones are 
observed in the spinal cord and medulla 
oblongata 
In this study we have demonstrated that a population of neurones located in the ventral 
portion of the lamina X coexpress the enzymes ChAT and GAD67 suggesting they 
could potentially corelease acetylcholine and GABA.  These clusters of ChAT/GAD67-
GFP co-localised neurones were observed in cervical, thoracic and lumbar regions of 
the spinal cord implying they possess a more versatile role in the circuitry of the spinal 
cord than previously hypothesised.  We also investigated the coexpression of ChAT 
and GAD67 enzymes in the medulla oblongata nuclei associated with autonomic 
function, particularly the NTS, for which co-localisation was observed predominantly in 
the intermediate and central subnucleus of the NTS. 
ACh (Perry et al., 1999) and GABA (Krnjevic and Schwartz, 1967, Iversen and Kelly, 
1975, Clark et al., 1992, Liu et al., 1993, Gadea and Lopez-Colome, 2001) are major 
neurotransmitters within the CNS. In our study, ChAT-IR or GAD67-GFP-IR neurones 
were observed throughout the spinal cord and medulla oblongata. 
Observations on the co-existence of ACh and GABA within the same neurones in the 
spinal cord and medulla oblongata are limited. Neurones containing both ChAT and 
GAD (or GABA) have only been reported in the cervical cord regions (Kosaka et al., 
1988)(see section 1.6.4) and in the dorsal horn (Kosaka et al., 1988, Todd, 1991, 
Mesnage et al., 2011) of the spinal cord. In the medulla oblongata, neurones 
expressing both ChAT and GABA have only been found in the hypoglossal nucleus 
(Davidoff and Schulze, 1988). However, neurones of the hypoglossal nucleus are 
typically large motoneurones (Ladewig et al., 2003), and it is well established that 
motoneurones throughout the CNS are cholinergic (Barber et al., 1984, Connaughton 
et al., 1986, Johann et al., 2011, Zhou et al., 2014). Although the apparent presence of 
smaller GABAergic interneurones within the hypoglossal nucleus has been reported 
(Takasu et al., 1987, Takasu and Hashimoto, 1988). Given the absence of additional 
supporting evidence for the co-localisation of ChAT and GABA in hypoglossal 
motoneurones it is reasonable to suppose that the coexpression observed by Davidoff 
and Schulze could be an artefact of inappropriate GABA staining.  
157  
 
Given the overall lack of reports on the co-existence of these two major 
neurotransmitters in neurones within the spinal cord and medulla oblongata, 
establishing the presence, morphology and location of such neurones within these 
regions is essential prior to undertaking further investigations into their roles.  
With respect to the spinal cord, Kosaka (Kosaka et al 1988) discerned the presence of 
ChAT and GAD (or GABA) co-localised neurones in the central canal cluster cells and 
partition cells of the rat cervical spinal cord (Kosaka et al., 1988). Our study reports on 
the observation of neurones containing enzymes which synthesise both ACh and 
GABA in the cervical, thoracic and lumbar spinal cord regions of GAD67-GFP knock-in 
mice, utilising IHC for ChAT and GAD67-GFP. The majority of ChAT/GAD67-GFP co-
localised neurones were found in lamina X of the cervical, thoracic and lumbar cord 
regions. A smaller number of such co-localised neurones was additionally observed in 
the dorsal horn, which was also consistent with the reports of Kosaka et al. (Kosaka et 
al., 1988), Todd (Todd, 1991) and Mesnage et al. (Mesnage et al., 2011).  
In our study the presence of ChAT/GAD67-GFP co-localised neurones was discerned 
throughout the rostrocaudal axis, extending from the cervical to the lumbar spinal 
cords. Such co-localised neurones in the spinal cord may be involved in integrating 
different systems, or providing antagonistic feedback within a single system.  Given the 
fact that co-localised neurones were found to be present in the cervical, thoracic and 
lumbar cord segments, the hypothesis regarding the potential for integration of 
sympathetic and motor systems within the thoracic cord (Chizh et al., 1998) still 
remains a worthy line of investigation. Based on our observations, plus the limited 
information on the co-existence of ACh and GABA within the medulla (as previously 
mentioned), the distribution of ChAT/GAD67-GFP co-localised neurones was further 
investigated to determine whether it extended to reach the medulla oblongata; with a 
particular focus on the NTS due to its significance as a primary integration location for 
the autonomic nervous system (Loewy, 1990b). ChAT/GAD67-GFP co-localised 
neurones were observed in the NTS, the majority of which were in the intermediate and 
central subnucleus. Although the function of these neurones currently remains 
unknown, it seems probable that they may be involved in circuitry which mediates 
autonomic reflexes; as GABA interneurons in the intermediate and central subnuclei of 
the NTS have been previously suggested to inhibit premotor neurones involved in the 
pharyngeal and oesophageal stages of swallowing (Wang and Bieger, 1991, Dong et 
al., 2000).  
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For the cervical and lumbar cord levels, the presence of co-localised neurones may 
represent a pathway for coordinating other systems with motor output. Further studies 
to deduce these parallel functions are required. The role of these co-localised neurones 
in the integration of neuronal activity with motor output may in principle be the same 
across the regions, with level specificity pertaining to the system that is being 
integrated. If this is the case the role of these co-localised neurones for sympatho-
motor coordination within the thoracic region continues to be a viable hypothesis. 
ChAT/GAD67-GFP co-localised neurones were found in the area postrema. Indeed, all 
ChAT-IR neurones in the area postrema were co-localised with GAD67-GFP. 
ChAT/GAD67-GFP co-localised neurones were also found in the reticular formation. 
No co-localised neurones were observed in the hypoglossal nucleus.  
 
5.2 ChAT/GAD67-GFP co-localised neurones 
contribute to the neuronal cell type heterogeneity 
in lamina X 
The location of the majority of ChAT/GAD67-GFP co-localised neurones within lamina 
X was studied in order to aid us in establishing a specific area in which to perform 
subsequent juxtacellular labelling analyses. Our results showed that most of the 
ChAT/GAD67-GFP co-localised neurones in the thoracic spinal cord were located 
ventral and ventrolateral to the central canal. 
The reason behind selection of the thoracic spinal cord for our investigation into the 
location of ChAT/GAD67-GFP co-localised neurones was that SPNs in the IML of mice 
are only present in T1-L2 spinal cord levels (Anderson et al., 2009, Sengul and 
Watson, 2012, Sengul et al., 2012). The thoracic cord was therefore the most suitable 
region of study, because in order to establish all the possible projections of 
ChAT/GAD67-GFP co-localised neurones, the SPNs needed to be present in all the 
studied spinal cord slices. A further aim of the study was to provide for increased 
understanding regarding potential connections associated with autonomic circuits 
within the spinal cord. 
The lamina X of the spinal cord exhibits heterogeneity in relation to neuronal cell types. 
These include cholinergic central canal cluster cells (Barber et al., 1984), cholinergic 
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SPNs (in the CAA) (Barber et al., 1984), cholinergic medial partition neurones (Miles et 
al., 2007), GABAergic interneurones in the CAA (Deuchars et al., 2005), neurones co-
expressing both ChAT and GAD (or GABA) in the cervical spinal cord (Kosaka et al., 
1988), and V2 interneurones (Al-Mosawie et al., 2007); where V2 interneurones consist 
of several subpopulations, some of which are propriospinal cells which are active 
during locomotion.  
There is also variation in relation to projections. For example the cholinergic central 
canal cluster cells within lamina X contribute short range intersegmental propriospinal 
projections to various laminae (Sherriff and Henderson, 1994) and may have a 
neuromodulatory function.  Other neuronal cell types in lamina X and adjacent regions 
can give rise to long ascending projections targeting various brainstem regions 
particularly into the paramedian medullar and/or pontine reticular formation (Nahin et 
al., 1983), plus also to the cerebellum (Sengul et al., 2015).  While the majority of the 
neuronal cell types are located either lateral and/or dorsal to the central canal (and/or 
in lamina VII) (see Figure 5.1), our ChAT/GAD67-GFP co-localised neurones which 
potentially use both ACh and GABA as their neurotransmitters are predominantly 
situated ventral and ventrolateral to the central canal, so making lamina X even more 
heterogeneous in relation to cell types.  
Although Kosaka et al. (Kosaka et al., 1988) reported over a decade ago on the 
presence of ChAT and GAD (or GABA) co-expressing neurones amongst the central 
canal cluster cells and partition cells of the cervical spinal cord, these were respectively 
located lateral to the central canal in lamina X and in the intermediate grey (lamina VII). 
The ChAT/GAD67-GFP co-localised neurones in our study represent a novel 
observation since they are located ventral and ventrolateral to the central canal of the 
thoracic spinal cord. By virtue of the difference in location, the ChAT/GAD67-GFP co-
localised neurones from our study may constitute a different subgroup of neurones 
from those of Kosaka et al.; although another possible explanation that can not be 
discounted at this time is that the rostrocaudal distribution of such co-localised 
neurones within lamina X varies based on spinal cord level, and so our findings could 
correspond to the same population as reported by Kosaka et al., but with a shift in 
position relative to the central canal relating to the change of study area from cervical 
to thoracic spinal cord segments. 
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Figure 5.1:  Cell types and cholinergic receptor mediated effects 
reported in lamina X and adjacent regions. The majority of 
ChAT/GAD67-GFP co-localised neurones observed in our study are 
located ventral and ventrolateral to the central canal (marked by X).   
 
5.3 Functional significance of ACh and GABA 
transmission 
ChAT/GAD67-GFP co-localised neurones found in both the spinal cord and the 
medulla oblongata might have similar roles. A clear function of the co-transmission 
between ACh and GABA is demonstrated by starburst amacrine cells in the retina 
mediating fast transmission in two different circuits (Lee et al., 2010), those of motion 
and direction. In relation to our study, although the function of ACh-GABA co-
transmission of ChAT/GAD67-GFP co-localised neurones located in the spinal cord 
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and medulla oblongata is currently unknown, it is likely that the co-transmission from 
these neurones may provide for fast synaptic transmission to the circuits in which they 
play a role. In the medulla oblongata ChAT/GAD67-GFP co-localised neurones are 
observed in areas involved in autonomic control, including the NTS, area postrema and 
reticular formation. As a result it is possible that these co-localised neurones may be 
involved in autonomic-efferent modulation. With regard to the spinal cord, the locations 
of interneurones controlling sympathetic activity in laminae V, VII and X, and in the 
intermediolateral cell column region, have been reported. In addition to supraspinal 
innervation, sympathetic interneurones also receive innervation from afferent 
pathways, which have a crucial contribution to the maintenance of sympathetic outflow 
(Deuchars, 2007, Deuchars and Lall, 2015). Since the majority of ChAT/GAD67-GFP 
co-localised neurones in this study were found in lamina X, it is possible that a role of 
these ChAT/GAD67-GFP co-localised neurones are as interneurones involved in 
sympathetic activity. The observations from this study also suggested synaptic inputs 
onto ChAT/GAD67-GFP co-localised neurones from other pathways, including primary 
afferents (Todd et al., 2003, Alvarez et al., 2004) and/or the corticospinal tract (Du 
Beau et al., 2012) through VGLUT1 inputs, interneurones (Todd et al., 2003, Alvarez et 
al., 2004) and descending projections (Du Beau et al., 2012) through VGLUT2 
terminals, and inhibitory inputs via both GlyT2 and GAD67 terminals. ChAT/GAD67-
GFP co-localised neurones may therefore be a subgroup of sympathetic interneurones 
that utilises both ACh and GABA to play a role in sympatho-motor integration. 
The function of neurones in the spinal cord that contain both ACh and GABA has been 
well demonstrated for the dorsal horn. A primary driver behind a study by Mesnage et 
al. (Mesnage et al., 2011) into cholinergic neurones of the dorsal horn was the major 
role played by endogenous Ach in sensory modulation. The study used ChAT: EGFP 
transgenic mice, which express enhanced GFP (EGFP) in cholinergic neurones, in 
combination with IHC and electrophysiology. According to their results, the dorsal horn 
contained ChAT interneurones in very low abundance. Most of those observed (95.5% 
± 1.0%) were immunoreactive for GABA. Based on observations of processes running 
in the dorsal direction, plus dendrites and axon that extended through more than one 
spinal cord segment in a rostrocaudal direction, as determined via intrinsic 
fluorescence and intracellular labelling, these cholinergic interneurones were indicated 
as being the predominant group of neurones constituting the cholinergic plexus in 
lamina IIi. Through utilisation of electrophysiological techniques to record from 
ChAT:EGFP neurones in spinal slices from young adult mice (21 to 30 days postnatal), 
and application of depolarizing current pulses of increasing intensity, 10 neurones (out 
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of 15 tested) exhibited a repetitive firing pattern, 7 of which additionally exhibited 
rebound spikes following hyperpolarization. Based on their results Mesnage et al. 
suggested that while the numbers of these cholinergic dorsal horn interneurones were 
very low, their morphology and properties may allow them to collect segmental 
information in the dorsal horn and to be involved in modulating this information over 
different cord segments. The similarities of these ChAT neurones in lamina III and 
those we describe in lamina X are that they are rare and contain GABA (or GAD67). 
Although the cholinergic neurones we observe may not be a subpopulation of the 
cholinergic central cluster cells as described by Barber et al. (1984), based on the 
limited evidence we have our ChAT/GAD67-GFP co-localised neurones might project 
locally to other neurone populations within lamina X.  However, this would not confine 
their actions to lamina X as they may influence the function of externally projecting 
neurones such as SPN in the CAA. 
 
5.4 Technical consideration and limitations  
5.4.1 Sensitivity and specificity of the immunohistochemical method 
and animals used in the study 
Immunolabelling for GABA is difficult to achieve for various reasons (Zhao et al., 2013), 
including that it does not appear to fix readily and as such fixatives containing 
glutaraldehyde at elevated concentrations of 0.5 – 2.5 % have been recommended in 
order to preserve GABA by quickly binding it to the tissue (Zhao et al., 2013) . In 
addition, since it is a small molecule containing a single amino acid (Iversen and Kelly, 
1975, Bowery and Smart, 2006), it has low antigenicity. Moreover, the use of Triton X-
100 is not recommended as it reduces the intensity of staining (Zhao et al., 2013). 
Despite the remedial processes adopted to improve GABA immunolabelling, the level 
of labelled cell bodies remains low and so not sufficient for precise determinations 
(Zhao et al., 2013).   
In the past, the detection of GABAergic neurones proved to be challenging. In the 
research field, antibodies raised against GABA (Hodgson et al., 1985, Kosaka et al., 
1988, Davidoff and Schulze, 1988, Caffe et al., 1996) or against the GAD enzyme 
(McLaughlin et al., 1975, Ribak et al., 1976, Ruggiero et al., 1985, Kosaka et al., 1988, 
Gritti et al., 1993, Caffe et al., 1996) have been widely used; although to detect GABA 
in the soma of neurones it is typically necessary to inject animals with colchicine 
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(Kosaka et al., 1988, Barber et al., 1982). Since the antibodies available in our lab 
which have been raised against GAD and GABA (without injecting colchicine) can only 
detect GABAergic terminals but not the somata under normal IHC condition, this study 
has used GAD67-GFP knock-in mice (Tamamaki et al., 2003). This type of mouse has 
been extensively used in studies by other researchers (Edwards et al., 2014, Gotts et 
al., 2015), the reasons for which are detailed in section 2.1.1 and 2.1.2.  Furthermore, 
due to differences in expression during development, while around 50% of GAD65-
GFP cells in the GAD65-GFP mouse line indicate the presence of GABA during the 
embryonic period, the level rises to approximately 70% at 21 days postnatal. Hence the 
GAD65-GFP mouse line appears to have limitations in regards to its viability for studies 
into GABAergic neurones during mouse development. Since our strudy required the 
use of neonate mice, the GAD67-GFP knock-in mouse line is therefore more suited for 
our work than the GAD65-GFP mouse line (Lopez-Bendito et al., 2004).  
To label ChAT-IR neurones, an antibody raised against the ChAT enzyme is widely 
used (Jia et al., 2003, Barber et al., 1984, Stornetta et al., 2013, Gotts et al., 2015) and 
accepted as being the most reliable marker for cholinergic neurones (Bradford, 1986). 
Since the ChAT enzyme is synthesized and present in cell bodies (Bradford, 1986), 
there was therefore no difficulty in the present study to label the cell bodies (or 
occasionally even the terminals) of ChAT-IR neurones using the antibody raised 
against ChAT.  The specificity of the ChAT antibody used in this study was determined 
by experimental testing in the spinal cord, from which it was found to label known 
cholinergic regions of the spinal cord, such as ventral horn motoneurons, SPN of the 
IML, central canal cluster cells and lamina III dorsal horn neurones (Barber et al., 1984, 
Todd, 1991). Moreover, other regions not previously reported as containing cholinergic 
neurones were similarly discerned to be negative for ChAT-immunoreactivity in our 
tests. The ChAT antibody used was the same as that used by Chapman et al. (2013).  
 
5.4.2 Juxtacellular labelling vs other methods 
For observation of the possible projections from ChAT/GAD67-GFP co-localised 
neurones, juxtacellular labelling in combination with IHC seemed to be a more suitable 
method than other approaches such as tracing techniques. While the application of 
tracing agents in combination with IHC presents problems that would be difficult to 
overcome, given the relatively small numbers and pale intensity of immunolabelled 
ChAT/GAD67-GFP co-localised neurones, juxtacellular labelling, on the other hand, 
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allows a single neurone to be individually labelled, so making it a more suitable 
technique when the neurones of interest are only found in low numbers and possess 
pale immunostaining. 
Each technique carries its own advantages and disadvantages with appropriate 
selection determined by the objectives of an experiment. Whilst intracellular recording 
may give fills with better labelling of axons and dendrites (Pilowsky and Makeham, 
2001)  it is a very difficult procedure to carry out on small neurones. Conversely, the 
whole-cell patch-clamp technique enables recording of small cells but the dialysis of 
intracellular components affects the capacity to gain stable, long term recordings of 
some currents (Horn and Marty, 1988) and may affect the immunohistochemical 
staining of cytosolic components (Puche et al., 2004). Despite not experiencing the 
high success rate previously reported for juxtacellular labelling (Pinault, 1996)(see 
section 3.5.3.3 and 3.5.5), the ability to individually label cells (per juxtacellular 
labelling) without the trauma of going “whole-cell” combined with increased ease of 
electrode withdrawal undoubtedly contributes to preservation of cellular integrity and 
thus aids recovery. A compromise between these two approaches may be the 
combination of a “perforated” patch approach coupled with a cell permeant dye as 
demonstrated by Puche et al.(Puche et al., 2004). Here they combined the use of a 
perforated patch approach for “intracellular-like” recordings without compromising 
second messenger systems with a cell permeant dye for single neurone labelling. Upon 
entering the cell, the dye (Cell Tracker Green CMFDA) is converted by endogenous 
esterases and glutathione-S-transferase into an impermeant, fluorescent state. The 
use of this dye would also be well suited to juxtacellular labelling. Moreover, cells 
labelled with the permeant dye can be further processed via IHC for investigations 
utilising electron microscopy (MolecularProbes, 2001).   
While juxtacellular labelling is a suitable tool for studying morphology and projection, 
the full labelling of axon  is dependent on the quality of entrainment and labelling time 
(Duque and Zaborszky, 2006). In addition, although labelled neurones from 
juxtacellular labelling may be studied using electron microscopy (Duque and 
Zaborszky, 2006) good preservation of the ultrastructural morphology of labelled cells 
can be a challenge to achieve, due to the longer times required for the labelling 
process prior to the application of the fixative agent which preserves the tissue of the 
spinal cord slices (Notter et al., 2014) before the subsequent electron microscopic 
analysis.  
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5.4.3 Animals: juveniles and adults 
The reason for investigating the presence of ChAT/GAD67-GFP co-localised neurones 
within lamina X of the spinal cord in young GAD67-GFP knock-in mice after having 
undertaken the study in adult animals, was that in order to apply the juxtacellular 
labelling technique spinal cord slices from young animals were required. Once the 
presence of ChAT/GAD67-GFP co-localised neurones in the lamina X of young mice 
was confirmed, juxtacellular labelling could be subsequently performed. 
In relation to the preparation of spinal cord slices for electrophysiological studies, 
healthier tissue slices tend to be obtained from young animals; one reason for this is 
that tissue from young animals is more resistant to anoxia than that from adult animals 
(Gibb and Edwards, 1994, Mitra and Brownstone, 2012). As a result, young animals 
tend to be used for juxtacellular labelling. Gibb and Edwards (Gibb and Edwards, 1994) 
indicated that animals aged less than 3 weeks were the most suitable for these types of 
studies, generally though, for both mice and rats, spinal cord slices have been most 
commonly prepared from animals that are between the first and second week postnatal 
(Thurbon et al., 1998, Carlin et al., 2000, Deuchars et al., 2005). Visualisation of 
neuronal cell bodies during the juxtacellular labelling process is additionally aided by 
the fact that in young animals myelination is not complete (Gibb and Edwards, 1994, 
Mitra and Brownstone, 2012).  
In order to understand the development of the spinal circuitry, studies involving  the use 
of spinal cord slices from adult animals (Graham et al., 2003, Yasaka et al., 2007, 
Yasaka et al., 2010, Hughes et al., 2012, Hadzipasic et al., 2014) have the advantage 
that postnatal maturation should be complete but the preparation of adult spinal cord 
slices yielding viable neurones are more difficult to achieve (Mitra and Brownstone, 
2012). Time is crucial for each step of the preparation process, such as in respect of 
the period spanning dissection to tissue removal and placement into cold solution (Gibb 
and Edwards, 1994). For adult animals the vertebral columns are harder than those 
from young animals, so resulting in longer preparation times (Gibb and Edwards, 
1994), which likely has an adverse impact on the chances of neuronal survival.  To 
increase the probability of obtaining improved levels of viable neurones from 
preparations involving adult spinal cord slices a special protocol is required, which 
incorporates additional chemical compositions (Mitra and Brownstone, 2012). The 
reason for this is that tissue from adult animals is less resistant to anoxia than that from 
young animals (Gibb and Edwards, 1994, Mitra and Brownstone, 2012), possibly due 
to the cells having higher metabolic demands, plus also exhibits more myelination 
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(Mitra and Brownstone, 2012). Increased myelination causes the tissue to be less 
permeable to oxygen and therefore less tolerant to insults during the preparation 
process. The use of a protocol involving polyethylene glycol seemingly mitigates the 
amount of neuronal loss attributable to insult (Mitra and Brownstone, 2012). 
While it is suggested that neurogenesis of GABAergic neurones in each lamina of the 
mouse spinal cord varies, the majority of GABAergic neurones are typically generated 
before embryonic day 14.5 (Huang et al., 2013). For the cholinergic system, it is 
indicated that the expression of ChAT mRNA (detected through the use of northern blot 
analysis and ISH) in the rat spinal cord increases from birth until adulthood, with a 
significant rise occurring at day 1 postnatal, when the majority of synapses will have 
already been formed (Ibanez et al., 1991). As a result, it is therefore appropriate for our 
study to undertake juxtacellular labelling on the spinal cord slices from young animals, 
in order to investigate the morphology and projection of ChAT/GAD67-GFP co-
localised neurones, because the majority of GABAergic neurone and cholinergic 
neurone generation will be complete and mature at the age that we use.  
It is believed that the populations of ChAT/GAD67-GFP co-localised neurones reported 
in this study for young and old mice are the same on the basis of their co-localisation 
with the two markers plus their location within the ventral aspect of lamina X.  Whilst 
other groups of ChAT/GABA co-localised neurones have been reported within the 
spinal cord (Todd et al., 2003, Mesnage et al., 2011), particularly in the dorsal horn, we 
believe their locations are sufficiently anatomically distinct so as to be dismissed as 
possible sources of misidentification error for the neurones we have discerned.  
Moreover, these other neurone populations also appear to be present in both young 
(Mesnage et al., 2011) and adult animals (Todd, 1991), therefore suggesting that they 
do not migrate during maturation and so remain as distinct populations. 
In order to be certain that the population of neurones we observe in the adult and 
young animals are the same, costaining for other markers unique to the population 
would be required or demonstration that they have the same efferent projection.  An 
effective method to label the ChAT/GAD67-GFP co-localised neurones as a unique 
population would be to identify a transcription factor expressed during development 
that directly dictates the coexpression of these two enzymes.  This approach would 
necessitate a detailed developmental study building upon what is already known 
regarding GABAergic (Cheng et al., 2005, Glasgow et al., 2005) and cholinergic 
neurone cell fate (Zagoraiou et al., 2009, Cho et al., 2014) in the CNS.  Validating the 
outcomes of such a study would also be facilitated by the generation and 
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characterisation of a new line of transgenic mouse, which may use intersectional 
genetics to label only cells that express GAD67 and ChAT (Madisen et al., 2015, Saito 
et al., 2015).  
Cell physiology is another possible identifier but this can change from young to old 
depending on whether the cells undergo postnatal maturation. 
 
5.4.4 Animal model: wild type vs transgenic type  
Prior to the juxtacellular labelling method being considered, double labelled IHC 
analyses for VAChT and either GAD67 or GABA or VGAT was first undertaken on the 
spinal cord and medulla oblongata from both adult wild type and GAD67-GFP mice.  
The sections were then visualised through the use of both epifluorescent and confocal 
microscopy to observe the possible projections of co-localised neurones. Unfortunately, 
these investigations were not able to provide positive confirmation of the projections 
from such neurones. Consequently, juxtacellular labelling was employed in order to 
trace the projections of the co-localised neurones in this study. 
It should be possible to identify co-localised ChAT/GAD terminals by using antibodies 
against VGAT and VAChT which would label the boutons specifically.  However this 
approach would not identify the neurone supplying the bouton, plus it would require the 
use of electron microscopy to confirm true co-localisation as opposed spatial co-
localisation (boutons in close proximity to each other leading to a false positive result).  
If used in conjunction with soma immunolabelling, the method would in theory indicate 
the neurone from which the bouton arises and demonstrate at least spatial co-
localisation of the vesicular markers.  For our purpose though, this would require 
somatic staining for ChAT and GABA/GAD plus terminal stains for VGAT and VAChT, 
a process that would require each immunoreaction to work specifically and have its 
own identifiable fluorophore in order to prevent the signals mixing.  The next issue that 
arises would be on how to trace a co-labelled bouton back to a specific neuron or 
group of neurons when there is abundant labelling of cells and fibres.  The use of a 
transgenic mouse, such as the GAD67-GFP knock-in mice used in this study, would 
aid some aspects of this scenario, especially where reliable immunohistochemical 
detection of GABA has proven difficult.  However, the problem still remains of 
discerning individual neurones and their projections amidst the others that are labelled.  
We elected to use juxtacellular labelling to overcome some of these obstacles, by 
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individually labelling neurons in the area of interest and then identifying them through 
the subsequent application of immunohistochemistry to allow us to trace the specific 
projection from a ChAT/GAD67-GFP co-localised neurone.  A refinement to this 
procedure is the selection of GAD67-GFP knock-in mice for the juxtacellular labelling 
experiments, since their use aids identification of the appropriate cell population to 
target.  As ChAT/GAD67-GFP co-localised neurones are a subpopulation of the GFP- 
expressing neurones it should make the process more efficient than “blindly” labelling 
neurones in the ventral part of lamina X region.  It also provides somatic and terminal 
labelling for GAD67-GFP, which combined with the juxtacellular label would allow the 
projection of a single neurone to be traced.  Positive confirmation for ChAT co-
localisation could then be achieved via ChAT- or VAChT-immunoreactivity. 
Due to the difficulties in labelling the cell bodies of GABAergic neurones as discussed 
above, wild type animals were not suitable for use in relation to quantification studies, 
where the number of neuronal cell bodies needed to be counted. Instead, GAD67-GFP 
knock-in mice were selected for quantification work. 
 
5.5 Limitation of animals used in the study and future 
study  
Although the result from our study utilising juxtacellular labelling suggested that 
ChAT/GAD67-GFP co-localised neurones might project to lamina X, or in the vicinity of 
lamina X, only one juxtacellularly labelled neurone from 34 neurones recovered 
contained both ChAT and GAD67-GFP. A problem of obtaining these labelled co-
localised neurones was the nature of selected transgenic mouse line that was available 
and most suitable at that time, in respect to which GABAergic neurones could only be 
visualised during the labelling process. Confirmation of co-localisation was then 
possible only once cell recovery had been completed utilising IHC subsequent to the 
juxtacellular labelling process. 
Recent developments in transgenic technology involving creation of a more suitable 
double transgenic animal model would likely overcome such limitation. Recently Saito 
et al. reported a study involving the use of a double transgenic rat model in which the 
neurones within the prepositus hypoglossi nucleus expressed both ChAT and VGAT 
(Saito et al., 2015). This rat model may be a more suitable candidate in aiding future 
studies to examine the functions of neurones co-expressing both the ACh and GABA 
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synthesising enzyme within the spinal cord and medulla oblongata, since the neurones 
expressing both ChAT and VGAT in these transgenic rats can be visualised during 
juxtacellular labelling and/or electrophysiological studies, so potentially facilitating 
increased numbers of labelled and/or recorded ChAT/VGAT neurones to be obtained. 
Once the projection of such neurones is confirmed, which establish the systems 
modulated by their output, studies regarding the function of these neurones would then 
be pursued.   
Our reports suggest that studying the possible inputs from VGLUT1, VGLUT2, GlyT2 
and GAD67 terminals onto ChAT/GAD67-GFP co-localised neurones in lamina X could 
be beneficial future investigations. Such work would help identify the neuronal 
populations that influence the activity of ChAT/GAD67-GFP co-localised neurones, plus 
may resolve the physiological role of ChAT/GAD67 co-localised neurones and the 
pathway by which the systems they interact with are linked. 
 
5.6 Conclusion  
For the first time this study provides a complete anatomical report regarding the 
neurones containing enzymes responsible for the production of both ACh and GABA 
throughout the spinal cord and medulla oblongata. Within the spinal cord the majority of 
such neurones were observed in lamina X of the cervical, thoracic and lumbar cord 
regions. A smaller number of co-localised neurones was also found in the dorsal horn. 
The location of these co-localised neurones relative to the central canal within lamina X 
was also investigated, in order to narrow the specific area in which subsequent 
juxtacellular labelling would be focussed. Results indicated that the majority of the co-
localised neurones were located ventral and ventrolateral to the central canal. To trace 
the axonal projections of ChAT/GAD67-GFP co-localised neurones in lamina X, the 
juxtacellular labelling method was selected for spinal cord slices. Since the use of 
young mice with reduced myelination provides for optimal slice visualisation, potential 
ChAT/GAD67-GFP co-localisation in young animals was first examined prior to 
juxtacellular labelling being undertaken. In the young animals the presence of co-
localised neurones was predominantly observed in lamina X, similar to that observed 
for adult animals. A smaller number of co-localised neurones were additionally 
observed in the dorsal horn of the young mice. On application of juxtacellular labelling, 
the result obtained suggested the processes of a co-localised neurone to be seemingly 
relatively small and short, likely locally branching within lamina X. The neurone 
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appeared to have some dendrites that passed close to the ependymal cells lining the 
central canal, although one dendrite reached the ventral aspect of lamina X. The axon 
of the neurone, based on morphology, seemed to be located in lamina X. The possible 
inputs onto ChAT/GAD67-GFP co-localised neurones were also investigated, the 
results of which suggested that co-localised neurones in lamina X receive inputs from 
VGLUT1-IR, VGLUT2-IR, GlyT2-IR and GAD67-IR terminals. Having observed the 
presence of neurones expressing both ChAT and GAD67-GFP throughout the lamina X 
of the cervical, thoracic and lumbar spinal cord, the presence of such co-expression 
could additionally be observed along the rostrocaudal axis, extending to reach the 
medulla oblongata. The areas of the medulla oblongata containing such co-localised 
neurones were the NTS, area postrema and reticular formation; corresponding to 
regions known to be involved in autonomic control. Although the function of these co-
localised neurones is currently unknown, a complete anatomical knowledge regarding 
their morphology, location, possible projection and inputs has been explored and 
reported in this study, providing a foundation of knowledge upon which future research 
into the roles of such neurones within the circuits of the spinal cord and medulla 
oblongata can be based.  
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